TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-379724	tRNA Aminoacylation	8.85491055339422e-07	-13.9371234810287	42	15	0.0214285714285714	700	8202	833,79731,2058,2617,10352,3035,10667,23438,4141,8565,16,5464,6897,51067,7453	CARS,NARS2,EPRS,GARS,WARS2,HARS,FARS2,HARS2,MARS,YARS,AARS,PPA1,TARS,YARS2,WARS
R-HSA-379716	Cytosolic tRNA aminoacylation	1.24828678490569e-05	-11.2911534258245	24	10	0.0142857142857143	700	8202	833,2058,2617,3035,4141,8565,16,5464,6897,7453	CARS,EPRS,GARS,HARS,MARS,YARS,AARS,PPA1,TARS,WARS
R-HSA-74160	Gene Expression	2.68979715360623e-05	-10.5234596817811	1330	153	0.218571428571429	700	8202	8663,5565,25885,5578,23279,16,6621,80153,7587,58477,93587,8565,7551,30834,81929,10498,10291,4809,80205,7678,7748,340252,5468,8731,2649,3035,7247,6924,4774,79970,29115,10168,1207,51616,25929,6498,2744,6827,1107,9128,80746,27327,833,348180,6872,102157402,4092,8649,9887,677,10081,6748,5073,51067,54541,10643,54807,54482,4609,91801,9862,2965,64425,26986,5464,104,57459,171392,2967,23404,10780,10352,55253,1974,57677,5682,6829,79027,7025,10940,2058,6158,10919,6730,51586,10670,6834,54901,80264,57472,6907,6727,192669,9534,51123,6235,5520,163051,348995,85456,10556,7586,2107,51692,10794,27339,8819,55534,79731,2617,147657,8669,5451,8667,7453,4088,7421,84449,28996,2539,80818,3014,9477,2521,8891,51385,10946,10667,10644,9491,9883,93134,83860,23438,26019,84172,374655,10302,7003,4141,4221,9669,6897,3304,10622,7638,7562,339487,134637,1965,22916,6883,9533	EIF3C,PRKAB2,POLR1A,PRKCA,NUP160,AARS,SNAPC4,EDC3,ZNF37A,SRPRB,TRMT10A,YARS,ZNF3,ZNRD1,SEH1L,CARM1,SF3A1,SNU13,CHD9,ZNF124,ZNF195,ZNF680,PPARG,RNMT,NR6A1,HARS,TSN,TCEB3,NFIA,ZNF767P,SAP30BP,ZNF197,CLNS1A,TAF9B,GEMIN5,SKIL,GLS,SUPT4H1,CHD3,PRPF4,TSEN2,TNRC6A,CARS,CTU2,TAF1,AK6,SMAD7,LAMTOR3,SMG7,ZFP36L1,PDCD7,SSR4,PARN,YARS2,DDIT4,IGF2BP3,ZNF586,TRMT13,MYC,ALKBH8,MED24,GTF2H1,POLR1E,PABPC1,PPA1,ADARB1,GATAD2B,ZNF675,GTF2H3,EXOSC2,ZNF234,WARS2,TYW1,EIF4A2,ZFP14,PSMA1,SUPT5H,ZNF655,NR2F1,POP1,EPRS,RPL28,EHMT2,SRP68,MED15,RRAGA,SURF1,CDKAL1,ZNF430,CNOT6,TBL1X,SRP14,AGO3,ZNF254,ZNF706,RPS29,PPP2R2A,ZNF709,NUP43,TNKS1BP1,RPP30,ZKSCAN1,ETF1,CPSF3,ZNF460,PRPF19,SAP30,MAML3,NARS2,GARS,ZNF480,EIF3J,POU2F1,EIF3H,WARS,SMAD3,VDR,ZNF333,HIPK2,G6PD,ZNF436,H2AFX,MED20,FUS,EIF2B3,ZNF589,SF3A3,FARS2,IGF2BP2,PSMF1,POM121,ZNF561,TAF3,HARS2,UPF2,POLR1B,ZNF710,SNAPC5,TEAD1,MARS,MEN1,EIF5B,TARS,HSPA1B,POLR3G,ZNF221,ZNF708,ZBTB8OS,ADAT2,EIF2S1,NCBP2,TAF12,POLR1C
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.000123150434568557	-9.00210390462964	54	14	0.02	700	8202	80205,51141,3422,4598,6721,3638,9871,2224,6713,6907,1717,10498,2222,3156	CHD9,INSIG2,IDI1,MVK,SREBF2,INSIG1,SEC24D,FDPS,SQLE,TBL1X,DHCR7,CARM1,FDFT1,HMGCR
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.000123772004440323	-8.99706935866328	74	17	0.0242857142857143	700	8202	8924,10274,7508,22955,6612,672,348995,23279,6015,9883,6117,1912,286053,197370,648,7518,81929	HERC2,STAG1,XPC,SCMH1,SUMO3,BRCA1,NUP43,NUP160,RING1,POM121,RPA1,PHC2,NSMCE2,NSMCE1,BMI1,XRCC4,SEH1L
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.000123772004440323	-8.99706935866328	74	17	0.0242857142857143	700	8202	8924,10274,7508,22955,6612,672,348995,23279,6015,9883,6117,1912,286053,197370,648,7518,81929	HERC2,STAG1,XPC,SCMH1,SUMO3,BRCA1,NUP43,NUP160,RING1,POM121,RPA1,PHC2,NSMCE2,NSMCE1,BMI1,XRCC4,SEH1L
R-HSA-2990846	SUMOylation	0.000287641951099413	-8.15379407662333	79	17	0.0242857142857143	700	8202	8924,10274,7508,22955,6612,672,348995,23279,6015,9883,6117,1912,286053,197370,648,7518,81929	HERC2,STAG1,XPC,SCMH1,SUMO3,BRCA1,NUP43,NUP160,RING1,POM121,RPA1,PHC2,NSMCE2,NSMCE1,BMI1,XRCC4,SEH1L
R-HSA-1989781	PPARA activates gene expression	0.00044197040959968	-7.72426762473466	112	21	0.03	700	8202	3992,80205,5468,7003,27242,133522,23389,1374,51129,123,57761,6721,51,51586,9862,4199,6907,9477,10498,3156,2222	FADS1,CHD9,PPARG,TEAD1,TNFRSF21,PPARGC1B,MED13L,CPT1A,ANGPTL4,PLIN2,TRIB3,SREBF2,ACOX1,MED15,MED24,ME1,TBL1X,MED20,CARM1,HMGCR,FDFT1
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.00047234622070979	-7.65779832281895	41	11	0.0157142857142857	700	8202	80205,3422,4598,6721,2224,6713,6907,1717,10498,3156,2222	CHD9,IDI1,MVK,SREBF2,FDPS,SQLE,TBL1X,DHCR7,CARM1,HMGCR,FDFT1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.000486689141170687	-7.62788495250857	212	33	0.0471428571428571	700	8202	5565,27242,133522,84803,23389,253558,788,6721,9663,26027,9862,4199,79888,10498,6576,2222,3156,3992,51703,80205,5468,7003,56895,5095,1374,51129,123,57761,51,51586,56898,9477,6907	PRKAB2,TNFRSF21,PPARGC1B,GPAT3,MED13L,LCLAT1,SLC25A20,SREBF2,LPIN2,ACOT11,MED24,ME1,LPCAT1,CARM1,SLC25A1,FDFT1,HMGCR,FADS1,ACSL5,CHD9,PPARG,TEAD1,AGPAT4,PCCA,CPT1A,ANGPTL4,PLIN2,TRIB3,ACOX1,MED15,BDH2,MED20,TBL1X
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.000637714319017067	-7.35762015073634	115	21	0.03	700	8202	3992,80205,5468,7003,27242,133522,23389,1374,51129,123,57761,6721,51,51586,9862,4199,6907,9477,10498,3156,2222	FADS1,CHD9,PPARG,TEAD1,TNFRSF21,PPARGC1B,MED13L,CPT1A,ANGPTL4,PLIN2,TRIB3,SREBF2,ACOX1,MED15,MED24,ME1,TBL1X,MED20,CARM1,HMGCR,FDFT1
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.00124672339921106	-6.68723644987068	39	10	0.0142857142857143	700	8202	9156,5984,5983,675,7516,5890,7156,472,672,6117	EXO1,RFC4,RFC3,BRCA2,XRCC2,RAD51B,TOP3A,ATM,BRCA1,RPA1
R-HSA-73847	Purine metabolism	0.00135327546363298	-6.60522735581321	33	9	0.0128571428571429	700	8202	847,3251,2618,471,353,30833,3615,132,4907	CAT,HPRT1,GART,ATIC,APRT,NT5C,IMPDH2,ADK,NT5E
R-HSA-69190	DNA strand elongation	0.00135327546363298	-6.60522735581321	33	9	0.0128571428571429	700	8202	5984,4175,5983,328,5558,5422,4174,4171,6117	RFC4,MCM6,RFC3,APEX1,PRIM2,POLA1,MCM5,MCM2,RPA1
R-HSA-381042	PERK regulates gene expression	0.00179805820702716	-6.32104797024917	28	8	0.0114285714285714	700	8202	23404,440,468,3309,1965,5073,1649,9709	EXOSC2,ASNS,ATF4,HSPA5,EIF2S1,PARN,DDIT3,HERPUD1
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.00228435084363142	-6.08167338968936	42	10	0.0142857142857143	700	8202	9156,5984,5983,675,7516,5890,7156,472,672,6117	EXO1,RFC4,RFC3,BRCA2,XRCC2,RAD51B,TOP3A,ATM,BRCA1,RPA1
R-HSA-191273	Cholesterol biosynthesis	0.00232679196612244	-6.06326479869174	23	7	0.01	700	8202	6713,3422,4598,1717,2224,2222,3156	SQLE,IDI1,MVK,DHCR7,FDPS,FDFT1,HMGCR
R-HSA-4839726	Chromatin organization	0.00258766472989305	-5.95699945869032	261	36	0.0514285714285714	700	8202	57634,55904,102157402,23210,57492,317772,23028,6598,284058,23587,8242,4297,10498,8819,57459,51780,23135,10765,1019,5927,63976,79813,84159,55869,58508,6314,10919,6599,1107,3014,6883,6907,55689,64754,23081,7994	EP400,KMT2E,AK6,JMJD6,ARID1B,HIST2H2AB,KDM1A,SMARCB1,KANSL1,ELP5,KDM5C,KMT2A,CARM1,SAP30,GATAD2B,KDM3B,KDM6B,KDM5B,CDK4,KDM5A,PRDM16,EHMT1,ARID5B,HDAC8,KMT2C,ATXN7,EHMT2,SMARCC1,CHD3,H2AFX,TAF12,TBL1X,YEATS2,SMYD3,KDM4C,KAT6A
R-HSA-3247509	Chromatin modifying enzymes	0.00258766472989305	-5.95699945869032	261	36	0.0514285714285714	700	8202	57634,55904,102157402,23210,57492,317772,23028,6598,284058,23587,8242,4297,10498,8819,57459,51780,23135,10765,1019,5927,63976,79813,84159,55869,58508,6314,10919,6599,1107,3014,6883,6907,55689,64754,23081,7994	EP400,KMT2E,AK6,JMJD6,ARID1B,HIST2H2AB,KDM1A,SMARCB1,KANSL1,ELP5,KDM5C,KMT2A,CARM1,SAP30,GATAD2B,KDM3B,KDM6B,KDM5B,CDK4,KDM5A,PRDM16,EHMT1,ARID5B,HDAC8,KMT2C,ATXN7,EHMT2,SMARCC1,CHD3,H2AFX,TAF12,TBL1X,YEATS2,SMYD3,KDM4C,KAT6A
R-HSA-418457	cGMP effects	0.00287166364207211	-5.85286375092496	18	6	0.00857142857142857	700	8202	5138,5140,10846,5152,3778,5139	PDE2A,PDE3B,PDE10A,PDE9A,KCNMA1,PDE3A
R-HSA-68962	Activation of the pre-replicative complex	0.0029068099663799	-5.84069903058452	30	8	0.0114285714285714	700	8202	4175,55388,5558,5422,4174,5001,4171,6117	MCM6,MCM10,PRIM2,POLA1,MCM5,ORC5,MCM2,RPA1
R-HSA-15869	Metabolism of nucleotides	0.0035810943252673	-5.63208684783039	82	15	0.0214285714285714	700	8202	847,790,3251,2618,204,654364,7378,471,7372,353,30833,3615,51727,132,4907	CAT,CAD,HPRT1,GART,AK2,NME1-NME2,UPP1,ATIC,UMPS,APRT,NT5C,IMPDH2,CMPK1,ADK,NT5E
R-HSA-162587	HIV Life Cycle	0.00359512194614596	-5.62817736734244	140	22	0.0314285714285714	700	8202	27243,2967,137492,6872,8731,102157402,6924,348995,6829,23279,9883,51616,6827,3836,83860,79720,2965,22916,6883,7518,81929,92421	CHMP2A,GTF2H3,VPS37A,TAF1,RNMT,AK6,TCEB3,NUP43,SUPT5H,NUP160,POM121,TAF9B,SUPT4H1,KPNA1,TAF3,VPS37B,GTF2H1,NCBP2,TAF12,XRCC4,SEH1L,CHMP4C
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.00498396345967134	-5.30152982905048	26	7	0.01	700	8202	472,9156,672,675,7516,5890,7156	ATM,EXO1,BRCA1,BRCA2,XRCC2,RAD51B,TOP3A
R-HSA-162599	Late Phase of HIV Life Cycle	0.00522996422990077	-5.25335084033581	127	20	0.0285714285714286	700	8202	27243,2967,137492,6872,8731,102157402,6924,348995,6829,23279,9883,51616,6827,83860,79720,2965,22916,6883,81929,92421	CHMP2A,GTF2H3,VPS37A,TAF1,RNMT,AK6,TCEB3,NUP43,SUPT5H,NUP160,POM121,TAF9B,SUPT4H1,TAF3,VPS37B,GTF2H1,NCBP2,TAF12,SEH1L,CHMP4C
R-HSA-426048	Arachidonate production from DAG	0.00542922809557619	-5.21595831065218	5	3	0.00428571428571429	700	8202	221955,11343,57406	DAGLB,MGLL,ABHD6
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.00548900687436964	-5.205007937025	33	8	0.0114285714285714	700	8202	9156,675,7516,5890,7156,472,146956,672	EXO1,BRCA2,XRCC2,RAD51B,TOP3A,ATM,EME1,BRCA1
R-HSA-72306	tRNA processing	0.00558505471555311	-5.18766104963285	94	16	0.0228571428571429	700	8202	348180,55253,348995,23279,9883,10940,10556,2058,54482,339487,134637,91801,54901,93587,80746,81929	CTU2,TYW1,NUP43,NUP160,POM121,POP1,RPP30,EPRS,TRMT13,ZBTB8OS,ADAT2,ALKBH8,CDKAL1,TRMT10A,TSEN2,SEH1L
R-HSA-400253	Circadian Clock	0.00627839369881611	-5.07064111166272	63	12	0.0171428571428571	700	8202	56938,80205,3091,5187,4209,6907,8553,8204,25819,1374,10498,4208	ARNTL2,CHD9,HIF1A,PER1,MEF2D,TBL1X,BHLHE40,NRIP1,NOCT,CPT1A,CARM1,MEF2C
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.00637665087196027	-5.05511226115459	48	10	0.0142857142857143	700	8202	57459,2967,10919,1107,25885,2965,84172,9533,30834,64425	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,GTF2H1,POLR1B,POLR1C,ZNRD1,POLR1E
R-HSA-5693537	Resolution of D-Loop Structures	0.0066537427429857	-5.01257576414321	34	8	0.0114285714285714	700	8202	9156,675,7516,5890,7156,472,146956,672	EXO1,BRCA2,XRCC2,RAD51B,TOP3A,ATM,EME1,BRCA1
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.00673018533206587	-5.00115259750766	21	6	0.00857142857142857	700	8202	10667,79731,23438,2617,10352,51067	FARS2,NARS2,HARS2,GARS,WARS2,YARS2
R-HSA-69186	Lagging Strand Synthesis	0.00673018533206587	-5.00115259750766	21	6	0.00857142857142857	700	8202	5984,5983,328,5558,5422,6117	RFC4,RFC3,APEX1,PRIM2,POLA1,RPA1
R-HSA-1430728	Metabolism	0.00769102428117171	-4.86770130782318	1691	170	0.242857142857143	700	8202	6723,1591,2678,4598,57128,5565,27242,133522,113278,5578,6535,3163,1352,8867,23279,57019,5906,6721,517,3373,4199,2395,5567,81929,10498,55454,80205,5468,7378,56261,2788,10087,23760,25902,4953,4257,51660,2770,5831,2744,3251,3141,3638,56898,8714,9942,204,50515,9871,84803,5646,3028,30849,23389,81579,783,471,9862,8871,5832,79888,5631,2222,4907,4522,3156,3992,5095,314,11069,6916,5682,3615,6616,23236,1374,51129,5226,847,1462,728294,51586,2224,3099,6834,6566,6713,1800,7372,6907,2686,1717,57107,5576,9653,8802,6528,91942,54947,57214,5166,6513,7389,10162,348995,79642,253558,4709,790,80308,440,3422,9663,2941,30833,26275,51727,11343,2787,55217,51703,5163,80270,27010,123,54331,8372,210,51181,2539,171586,949,9477,10295,115677,51141,6819,9334,8604,353,51447,3628,5305,9491,9883,788,128,2618,3038,26027,6472,85007,27132,5106,960,6576,10243,29968,7003,56895,5291,4758,57761,2110,654364,221914,51,4725,132,8776	SRM,CYP24A1,GGT1,MVK,LYRM4,PRKAB2,TNFRSF21,PPARGC1B,SLC52A3,PRKCA,SLC6A8,HMOX2,COX10,SYNJ1,NUP160,CIAPIN1,RAP1A,SREBF2,ATP5G2,HYAL1,ME1,FXN,PRKACB,SEH1L,CARM1,CSGALNACT2,CHD9,PPARG,UPP1,GPCPD1,GNG7,COL4A3BP,PITPNB,MTHFD1L,ODC1,MGST1,MPC1,GNAI1,PYCR1,GLS,HPRT1,HLCS,INSIG1,BDH2,ABCC3,XYLB,AK2,CHST11,SEC24D,GPAT3,PRSS3,HSD17B10,PIK3R4,MED13L,PLA2G12A,CACNB2,ATIC,MED24,SYNJ2,ALDH18A1,LPCAT1,PRPS1,FDFT1,NT5E,MTHFD1,HMGCR,FADS1,PCCA,AOC2,RAPGEF4,TBXAS1,PSMA1,IMPDH2,SNAP25,PLCB1,CPT1A,ANGPTL4,PGD,CAT,VCAN,D2HGDH,MED15,FDPS,HK2,SURF1,SLC16A1,SQLE,DPEP1,UMPS,TBL1X,GGT7,DHCR7,PDSS2,PRKAR2A,HS2ST1,SUCLG1,SLC5A5,NDUFAF2,LPCAT2,CEMIP,PDK4,SLC2A1,UROD,LPCAT3,NUP43,ARSJ,LCLAT1,NDUFB3,CAD,FLAD1,ASNS,IDI1,LPIN2,GSTA4,NT5C,HIBCH,CMPK1,MGLL,GNG5,TMLHE,ACSL5,PDK1,HSD3B7,TPK1,PLIN2,GNG2,HYAL3,ALAD,DCXR,G6PD,ABHD3,SCARB1,MED20,BCKDK,NOSTRIN,INSIG2,SULT1C2,B4GALT5,SLC25A12,APRT,IP6K2,INPP1,PIP4K2A,PSMF1,POM121,SLC25A20,ADH5,GART,HAS3,ACOT11,SHMT2,PHYKPL,CPNE7,PCK2,CD44,SLC25A1,GPHN,PSAT1,TEAD1,AGPAT4,PIK3CB,NEU1,TRIB3,ETFDH,NME1-NME2,GPC2,ACOX1,NDUFS5,ADK,MTMR1
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.0078300342511917	-4.84978839463501	42	9	0.0128571428571429	700	8202	56938,80205,3091,5187,6907,8553,8204,25819,10498	ARNTL2,CHD9,HIF1A,PER1,TBL1X,BHLHE40,NRIP1,NOCT,CARM1
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.00810316629279352	-4.8155003933405	65	12	0.0171428571428571	700	8202	9156,5984,5983,675,51426,7516,5890,7156,472,672,146956,6117	EXO1,RFC4,RFC3,BRCA2,POLK,XRCC2,RAD51B,TOP3A,ATM,BRCA1,EME1,RPA1
R-HSA-2262752	Cellular responses to stress	0.00879066071116985	-4.73406540387896	379	46	0.0657142857142857	700	8202	8091,57634,27243,23043,3397,9588,5565,8649,30849,348995,23279,9883,6015,5606,1912,54386,65057,64422,10393,1021,81929,23135,79065,1019,79813,3309,475,22955,9140,7324,3304,6117,847,817,8881,10919,3091,3014,10670,10533,472,648,573,192669,27327,92421	HMGA2,EP400,CHMP2A,TNIK,ID1,PRDX6,PRKAB2,LAMTOR3,PIK3R4,NUP43,NUP160,POM121,RING1,MAP2K3,PHC2,TERF2IP,ACD,ATG3,ANAPC10,CDK6,SEH1L,KDM6B,ATG9A,CDK4,EHMT1,HSPA5,ATOX1,SCMH1,ATG12,UBE2E1,HSPA1B,RPA1,CAT,CAMK2D,CDC16,EHMT2,HIF1A,H2AFX,RRAGA,ATG7,ATM,BMI1,BAG1,AGO3,TNRC6A,CHMP4C
R-HSA-167172	Transcription of the HIV genome	0.0103186677658557	-4.57380061971771	67	12	0.0171428571428571	700	8202	2967,6827,6872,83860,8731,102157402,6924,2965,22916,6883,6829,51616	GTF2H3,SUPT4H1,TAF1,TAF3,RNMT,AK6,TCEB3,GTF2H1,NCBP2,TAF12,SUPT5H,TAF9B
R-HSA-3000157	Laminin interactions	0.0108134360273405	-4.52696584146843	23	6	0.00857142857142857	700	8202	3910,3908,3691,3915,3911,3673	LAMA4,LAMA2,ITGB4,LAMC1,LAMA5,ITGA2
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.0108134360273405	-4.52696584146843	23	6	0.00857142857142857	700	8202	5984,5983,328,5558,5422,6117	RFC4,RFC3,APEX1,PRIM2,POLA1,RPA1
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.0112770885710243	-4.4849821716328	37	8	0.0114285714285714	700	8202	5984,5983,51426,9100,25898,9636,10459,6117	RFC4,RFC3,POLK,USP10,RCHY1,ISG15,MAD2L2,RPA1
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.0112770885710243	-4.4849821716328	37	8	0.0114285714285714	700	8202	25,9156,5984,5983,7156,472,672,6117	ABL1,EXO1,RFC4,RFC3,TOP3A,ATM,BRCA1,RPA1
R-HSA-176187	Activation of ATR in response to replication stress	0.0112770885710243	-4.4849821716328	37	8	0.0114285714285714	700	8202	5984,4175,5983,55388,4174,5001,4171,6117	RFC4,MCM6,RFC3,MCM10,MCM5,ORC5,MCM2,RPA1
R-HSA-5655862	Translesion synthesis by POLK	0.011604555707907	-4.45635752452915	17	5	0.00714285714285714	700	8202	5984,5983,51426,10459,6117	RFC4,RFC3,POLK,MAD2L2,RPA1
R-HSA-2142845	Hyaluronan metabolism	0.011604555707907	-4.45635752452915	17	5	0.00714285714285714	700	8202	3373,8372,960,3038,57214	HYAL1,HYAL3,CD44,HAS3,CEMIP
R-HSA-5674135	MAP2K and MAPK activation	0.0132468893471223	-4.32399252036673	38	8	0.0114285714285714	700	8202	5906,673,4893,2335,5908,8649,283455,7414	RAP1A,BRAF,NRAS,FN1,RAP1B,LAMTOR3,KSR2,VCL
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0134022826995317	-4.31233023582198	24	6	0.00857142857142857	700	8202	5138,5140,10846,5152,3778,5139	PDE2A,PDE3B,PDE10A,PDE9A,KCNMA1,PDE3A
R-HSA-352230	Amino acid transport across the plasma membrane	0.0137207743420569	-4.28884421935158	31	7	0.01	700	8202	6541,6520,23657,92745,81539,54407,8501	SLC7A1,SLC3A2,SLC7A11,SLC38A5,SLC38A1,SLC38A2,SLC43A1
R-HSA-73772	RNA Polymerase I Promoter Escape	0.0137207743420569	-4.28884421935158	31	7	0.01	700	8202	2965,2967,84172,9533,30834,64425,25885	GTF2H1,GTF2H3,POLR1B,POLR1C,ZNRD1,POLR1E,POLR1A
R-HSA-73893	DNA Damage Bypass	0.0142566624673673	-4.25053093996134	46	9	0.0128571428571429	700	8202	5984,5983,56852,51426,25898,9100,9636,10459,6117	RFC4,RFC3,RAD18,POLK,RCHY1,USP10,ISG15,MAD2L2,RPA1
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.0154568170911203	-4.169705137283	39	8	0.0114285714285714	700	8202	348180,2058,54482,134637,55253,91801,54901,93587	CTU2,EPRS,TRMT13,ADAT2,TYW1,ALKBH8,CDKAL1,TRMT10A
R-HSA-73863	RNA Polymerase I Transcription Termination	0.0163063976682238	-4.11619775319237	32	7	0.01	700	8202	2965,2967,84172,9533,30834,64425,25885	GTF2H1,GTF2H3,POLR1B,POLR1C,ZNRD1,POLR1E,POLR1A
R-HSA-380994	ATF4 activates genes	0.0163948962837456	-4.11078519479608	25	6	0.00857142857142857	700	8202	23404,440,468,5073,9709,1649	EXOSC2,ASNS,ATF4,PARN,HERPUD1,DDIT3
R-HSA-422356	Regulation of insulin secretion	0.0171799627607226	-4.0640115300231	80	13	0.0185714285714286	700	8202	54331,5906,783,2788,11069,6513,6616,5578,23236,2787,5576,5567,2770	GNG2,RAP1A,CACNB2,GNG7,RAPGEF4,SLC2A1,SNAP25,PRKCA,PLCB1,GNG5,PRKAR2A,PRKACB,GNAI1
R-HSA-3214842	HDMs demethylate histones	0.0186410469236063	-3.98238930587239	48	9	0.0128571428571429	700	8202	23135,51780,10765,5927,84159,23210,8242,23028,23081	KDM6B,KDM3B,KDM5B,KDM5A,ARID5B,JMJD6,KDM5C,KDM1A,KDM4C
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.0205713437405842	-3.88385625219156	65	11	0.0157142857142857	700	8202	2967,6827,6872,83860,102157402,6924,2965,22916,6883,6829,51616	GTF2H3,SUPT4H1,TAF1,TAF3,AK6,TCEB3,GTF2H1,NCBP2,TAF12,SUPT5H,TAF9B
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.0205843730183001	-3.88322308240726	3	2	0.00285714285714286	700	8202	10644,10643	IGF2BP2,IGF2BP3
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0236744062479747	-3.7433607195075	42	8	0.0114285714285714	700	8202	3910,3915,2247,3673,3908,5578,3691,3911	LAMA4,LAMC1,FGF2,ITGA2,LAMA2,PRKCA,ITGB4,LAMA5
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.0236744062479747	-3.7433607195075	42	8	0.0114285714285714	700	8202	80205,56652,133522,4209,6907,11232,10498,4208	CHD9,C10orf2,PPARGC1B,MEF2D,TBL1X,POLG2,CARM1,MEF2C
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.0236967608110627	-3.74241691482058	27	6	0.00857142857142857	700	8202	5906,5747,2335,6464,11069,5908	RAP1A,PTK2,FN1,SHC1,RAPGEF4,RAP1B
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.0263411581814941	-3.6366226131897	14	4	0.00571428571428571	700	8202	5984,5983,5558,5422	RFC4,RFC3,PRIM2,POLA1
R-HSA-69091	Polymerase switching	0.0263411581814941	-3.6366226131897	14	4	0.00571428571428571	700	8202	5984,5983,5558,5422	RFC4,RFC3,PRIM2,POLA1
R-HSA-69109	Leading Strand Synthesis	0.0263411581814941	-3.6366226131897	14	4	0.00571428571428571	700	8202	5984,5983,5558,5422	RFC4,RFC3,PRIM2,POLA1
R-HSA-1592230	Mitochondrial biogenesis	0.0269393677638191	-3.61416657658194	51	9	0.0128571428571429	700	8202	80205,56652,5565,133522,6907,4209,11232,10498,4208	CHD9,C10orf2,PRKAB2,PPARGC1B,TBL1X,MEF2D,POLG2,CARM1,MEF2C
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.0287346451525009	-3.54965173606333	21	5	0.00714285714285714	700	8202	2254,4893,6464,2247,2260	FGF9,NRAS,SHC1,FGF2,FGFR1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0303048351755657	-3.49644800244649	628	67	0.0957142857142857	700	8202	1591,2678,4598,5565,54947,27242,133522,10162,79642,8867,253558,3422,6721,9663,4199,11343,5567,10498,51703,80205,5468,56261,10087,23760,80270,123,3638,171586,56898,8714,9477,949,51141,9871,84803,30849,23389,81579,5305,788,26027,9862,8871,27132,79888,6576,3156,2222,3992,7003,56895,5095,6916,1374,5291,51129,4758,57761,51,51586,2224,6713,1800,6907,8776,1717,57107	CYP24A1,GGT1,MVK,PRKAB2,LPCAT2,TNFRSF21,PPARGC1B,LPCAT3,ARSJ,SYNJ1,LCLAT1,IDI1,SREBF2,LPIN2,ME1,MGLL,PRKACB,CARM1,ACSL5,CHD9,PPARG,GPCPD1,COL4A3BP,PITPNB,HSD3B7,PLIN2,INSIG1,ABHD3,BDH2,ABCC3,MED20,SCARB1,INSIG2,SEC24D,GPAT3,PIK3R4,MED13L,PLA2G12A,PIP4K2A,SLC25A20,ACOT11,MED24,SYNJ2,CPNE7,LPCAT1,SLC25A1,HMGCR,FDFT1,FADS1,TEAD1,AGPAT4,PCCA,TBXAS1,CPT1A,PIK3CB,ANGPTL4,NEU1,TRIB3,ACOX1,MED15,FDPS,SQLE,DPEP1,TBL1X,MTMR1,DHCR7,PDSS2
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.0317881300698859	-3.44866232712052	78	12	0.0171428571428571	700	8202	80205,6721,5468,1019,51586,23389,9862,6907,9477,7026,51129,10498	CHD9,SREBF2,PPARG,CDK4,MED15,MED13L,MED24,TBL1X,MED20,NR2F2,ANGPTL4,CARM1
R-HSA-180786	Extension of Telomeres	0.0329054442697559	-3.41411715557712	29	6	0.00857142857142857	700	8202	5984,5983,328,5558,5422,6117	RFC4,RFC3,APEX1,PRIM2,POLA1,RPA1
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.0335571084462522	-3.39450656181472	15	4	0.00571428571428571	700	8202	5906,5747,2335,5908	RAP1A,PTK2,FN1,RAP1B
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.0335571084462522	-3.39450656181472	15	4	0.00571428571428571	700	8202	5906,5747,2335,5908	RAP1A,PTK2,FN1,RAP1B
R-HSA-194840	Rho GTPase cycle	0.0339154459147542	-3.38388473666067	124	17	0.0242857142857143	700	8202	23092,55114,7204,4983,84033,23365,9743,11214,100288637,10144,5881,58480,1123,93663,101928168,94134,79658	ARHGAP26,ARHGAP17,TRIO,OPHN1,OBSCN,ARHGEF12,ARHGAP32,AKAP13,LOC100288637,FAM13A,RAC3,RHOU,CHN1,ARHGAP18,LOC101928168,ARHGAP12,ARHGAP10
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.0346567381722755	-3.36226310840553	22	5	0.00714285714285714	700	8202	5984,5983,328,10038,6117	RFC4,RFC3,APEX1,PARP2,RPA1
R-HSA-446107	Type I hemidesmosome assembly	0.035192469699002	-3.34692314826978	9	3	0.00428571428571429	700	8202	667,1308,3691	DST,COL17A1,ITGB4
R-HSA-162906	HIV Infection	0.036002814987996	-3.32415814947203	221	27	0.0385714285714286	700	8202	27243,2967,137492,6872,8731,102157402,6924,5682,55690,348995,162,6829,23279,9491,9883,51616,6827,3836,83860,79720,8907,2965,22916,6883,7518,81929,92421	CHMP2A,GTF2H3,VPS37A,TAF1,RNMT,AK6,TCEB3,PSMA1,PACS1,NUP43,AP1B1,SUPT5H,NUP160,PSMF1,POM121,TAF9B,SUPT4H1,KPNA1,TAF3,VPS37B,AP1M1,GTF2H1,NCBP2,TAF12,XRCC4,SEH1L,CHMP4C
R-HSA-5656169	Termination of translesion DNA synthesis	0.0382712161448065	-3.26305720202993	30	6	0.00857142857142857	700	8202	9100,5984,5983,51426,9636,6117	USP10,RFC4,RFC3,POLK,ISG15,RPA1
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.0388498652390312	-3.2480506709253	4	2	0.00285714285714286	700	8202	10973,51008	ASCC3,ASCC1
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.0412798776572341	-3.18738012154302	23	5	0.00714285714285714	700	8202	2744,440,5832,29968,5831	GLS,ASNS,ALDH18A1,PSAT1,PYCR1
R-HSA-429947	Deadenylation of mRNA	0.0412798776572341	-3.18738012154302	23	5	0.00714285714285714	700	8202	57472,85456,5073,26986,1974	CNOT6,TNKS1BP1,PARN,PABPC1,EIF4A2
R-HSA-1483257	Phospholipid metabolism	0.0414985933633661	-3.18209574717858	146	19	0.0271428571428571	700	8202	54947,56895,84803,56261,30849,81579,10162,23760,253558,8867,5291,5305,171586,9663,8871,27132,8776,11343,79888	LPCAT2,AGPAT4,GPAT3,GPCPD1,PIK3R4,PLA2G12A,LPCAT3,PITPNB,LCLAT1,SYNJ1,PIK3CB,PIP4K2A,ABHD3,LPIN2,SYNJ2,CPNE7,MTMR1,MGLL,LPCAT1
R-HSA-110312	Translesion synthesis by REV1	0.041810235878762	-3.17461409194668	16	4	0.00571428571428571	700	8202	5984,5983,10459,6117	RFC4,RFC3,MAD2L2,RPA1
R-HSA-392517	Rap1 signalling	0.041810235878762	-3.17461409194668	16	4	0.00571428571428571	700	8202	5906,5567,11069,5908	RAP1A,PRKACB,RAPGEF4,RAP1B
R-HSA-69183	Processive synthesis on the lagging strand	0.041810235878762	-3.17461409194668	16	4	0.00571428571428571	700	8202	328,5558,5422,6117	APEX1,PRIM2,POLA1,RPA1
R-HSA-73894	DNA Repair	0.0444069910607834	-3.11435836561495	306	35	0.05	700	8202	8924,51008,7508,22909,25898,4292,10459,25,9577,51138,7516,2965,27339,5984,2967,5983,328,51426,10038,7156,6612,9100,672,9636,6117,9156,10973,675,56852,5890,3014,472,146956,7518,4595	HERC2,ASCC1,XPC,FAN1,RCHY1,MLH1,MAD2L2,ABL1,BRE,COPS4,XRCC2,GTF2H1,PRPF19,RFC4,GTF2H3,RFC3,APEX1,POLK,PARP2,TOP3A,SUMO3,USP10,BRCA1,ISG15,RPA1,EXO1,ASCC3,BRCA2,RAD18,RAD51B,H2AFX,ATM,EME1,XRCC4,MUTYH
R-HSA-2559583	Cellular Senescence	0.0469997180136037	-3.05761367700064	187	23	0.0328571428571429	700	8202	23135,8091,57634,23043,3397,1019,79813,22955,6015,5606,7324,1912,54386,8881,10919,65057,10393,3014,472,648,1021,192669,27327	KDM6B,HMGA2,EP400,TNIK,ID1,CDK4,EHMT1,SCMH1,RING1,MAP2K3,UBE2E1,PHC2,TERF2IP,CDC16,EHMT2,ACD,ANAPC10,H2AFX,ATM,BMI1,CDK6,AGO3,TNRC6A
R-HSA-74259	Purine catabolism	0.0471582911837538	-3.05424543841063	10	3	0.00428571428571429	700	8202	847,30833,4907	CAT,NT5C,NT5E
R-HSA-381183	ATF6-alpha activates chaperone genes	0.0471582911837538	-3.05424543841063	10	3	0.00428571428571429	700	8202	468,1649,3309	ATF4,DDIT3,HSPA5
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.0471582911837538	-3.05424543841063	10	3	0.00428571428571429	700	8202	55690,162,8907	PACS1,AP1B1,AP1M1
R-HSA-73848	Pyrimidine metabolism	0.0486160868562499	-3.02380079757322	24	5	0.00714285714285714	700	8202	790,7372,30833,7378,4907	CAD,UMPS,NT5C,UPP1,NT5E
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.0486160868562499	-3.02380079757322	24	5	0.00714285714285714	700	8202	2744,6616,6857,10550,54407	GLS,SNAP25,SYT1,ARL6IP5,SLC38A2
R-HSA-5696400	Dual Incision in GG-NER	0.0501291989660652	-2.99315162696734	40	7	0.01	700	8202	2965,2967,5984,5983,51426,10038,6117	GTF2H1,GTF2H3,RFC4,RFC3,POLK,PARP2,RPA1
R-HSA-5656121	Translesion synthesis by POLI	0.0511042913165274	-2.97388680650149	17	4	0.00571428571428571	700	8202	5984,5983,10459,6117	RFC4,RFC3,MAD2L2,RPA1
R-HSA-435354	Zinc transporters	0.0511042913165274	-2.97388680650149	17	4	0.00571428571428571	700	8202	23516,7781,7922,148867	SLC39A14,SLC30A3,SLC39A7,SLC30A7
R-HSA-189445	Metabolism of porphyrins	0.0511042913165274	-2.97388680650149	17	4	0.00571428571428571	700	8202	210,3163,1352,7389	ALAD,HMOX2,COX10,UROD
R-HSA-1632852	Macroautophagy	0.0565487232667495	-2.87265265374385	67	10	0.0142857142857143	700	8202	27243,79065,64422,5565,10533,10670,8649,30849,9140,92421	CHMP2A,ATG9A,ATG3,PRKAB2,ATG7,RRAGA,LAMTOR3,PIK3R4,ATG12,CHMP4C
R-HSA-425410	Metal ion SLC transporters	0.0566713845009174	-2.87048587816702	25	5	0.00714285714285714	700	8202	23516,30061,7781,7922,148867	SLC39A14,SLC40A1,SLC30A3,SLC39A7,SLC30A7
R-HSA-2980766	Nuclear Envelope Breakdown	0.0593888492022541	-2.82364879410365	50	8	0.0114285714285714	700	8202	10783,9663,348995,5578,23279,81929,9883,7112	NEK6,LPIN2,NUP43,PRKCA,NUP160,SEH1L,POM121,TMPO
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.0608429579360171	-2.79945919449515	11	3	0.00428571428571429	700	8202	3615,2618,471	IMPDH2,GART,ATIC
R-HSA-196757	Metabolism of folate and pterines	0.0608429579360171	-2.79945919449515	11	3	0.00428571428571429	700	8202	6472,25902,4522	SHMT2,MTHFD1L,MTHFD1
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0608429579360171	-2.79945919449515	11	3	0.00428571428571429	700	8202	1374,5565,788	CPT1A,PRKAB2,SLC25A20
R-HSA-189451	Heme biosynthesis	0.0608429579360171	-2.79945919449515	11	3	0.00428571428571429	700	8202	210,1352,7389	ALAD,COX10,UROD
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.0608429579360171	-2.79945919449515	11	3	0.00428571428571429	700	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.0611302900013987	-2.79474779094165	5	2	0.00285714285714286	700	8202	10973,51008	ASCC3,ASCC1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0611302900013987	-2.79474779094165	5	2	0.00285714285714286	700	8202	3038,57214	HAS3,CEMIP
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.0611302900013987	-2.79474779094165	5	2	0.00285714285714286	700	8202	80308,113278	FLAD1,SLC52A3
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.0611302900013987	-2.79474779094165	5	2	0.00285714285714286	700	8202	9942,51181	XYLB,DCXR
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.0614302715926882	-2.78985254264257	18	4	0.00571428571428571	700	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-210993	Tie2 Signaling	0.0614302715926882	-2.78985254264257	18	4	0.00571428571428571	700	8202	4893,6464,5291,285	NRAS,SHC1,PIK3CB,ANGPT2
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.0627016649812582	-2.76936727697082	42	7	0.01	700	8202	54331,5906,5576,2787,2788,5567,11069	GNG2,RAP1A,PRKAR2A,GNG5,GNG7,PRKACB,RAPGEF4
R-HSA-109582	Hemostasis	0.0629279084560331	-2.76576551803514	515	54	0.0771428571428571	700	8202	7273,2335,3798,11311,7042,5578,57406,5139,23028,5583,10019,25,5906,6464,6281,23657,10846,960,3273,7414,11343,2787,5567,285,4602,3048,6520,4893,10257,3778,2788,3309,11069,7035,56992,5908,5747,5138,5140,5291,7114,1525,2770,54331,2627,221955,3673,2734,5890,6566,1191,5576,5152,57572	TTN,FN1,KIF5A,VPS45,TGFB2,PRKCA,ABHD6,PDE3A,KDM1A,PRKCH,SH2B3,ABL1,RAP1A,SHC1,S100A10,SLC7A11,PDE10A,CD44,HRG,VCL,MGLL,GNG5,PRKACB,ANGPT2,MYB,HBG2,SLC3A2,NRAS,ABCC4,KCNMA1,GNG7,HSPA5,RAPGEF4,TFPI,KIF15,RAP1B,PTK2,PDE2A,PDE3B,PIK3CB,TMSB4X,CXADR,GNAI1,GNG2,GATA6,DAGLB,ITGA2,GLG1,RAD51B,SLC16A1,CLU,PRKAR2A,PDE9A,DOCK6
R-HSA-177929	Signaling by EGFR	0.0631547665925771	-2.76216695254995	336	37	0.0528571428571429	700	8202	200734,673,2335,2308,4763,5786,8649,5578,8027,9491,55824,5906,6464,7414,5567,6709,6199,5796,2254,4893,5829,8831,2247,58513,5908,5682,1742,283455,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,STAM,PSMF1,PAG1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,PTPRK,FGF9,NRAS,PXN,SYNGAP1,FGF2,EPS15L1,RAP1B,PSMA1,DLG4,KSR2,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-1483206	Glycerophospholipid biosynthesis	0.063523157734674	-2.75635075083124	96	13	0.0185714285714286	700	8202	54947,56895,84803,56261,171586,9663,81579,10162,27132,23760,253558,11343,79888	LPCAT2,AGPAT4,GPAT3,GPCPD1,ABHD3,LPIN2,PLA2G12A,LPCAT3,CPNE7,PITPNB,LCLAT1,MGLL,LPCAT1
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.0654459579223046	-2.72653054678691	26	5	0.00714285714285714	700	8202	4088,56937,7048,51377,4092	SMAD3,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-69242	S Phase	0.0654850856599177	-2.72593286211706	125	16	0.0228571428571429	700	8202	5984,4175,114799,5983,328,10274,5558,5422,1019,5682,4171,9491,6117,4609,4174,5001	RFC4,MCM6,ESCO1,RFC3,APEX1,STAG1,PRIM2,POLA1,CDK4,PSMA1,MCM2,PSMF1,RPA1,MYC,MCM5,ORC5
R-HSA-5693538	Homology Directed Repair	0.0667181795082859	-2.70727780685118	135	17	0.0242857142857143	700	8202	8924,5984,5983,51426,10038,7156,672,6117,9156,25,675,9577,7516,5890,3014,472,146956	HERC2,RFC4,RFC3,POLK,PARP2,TOP3A,BRCA1,RPA1,EXO1,ABL1,BRCA2,BRE,XRCC2,RAD51B,H2AFX,ATM,EME1
R-HSA-163685	Integration of energy metabolism	0.0702421999782935	-2.65580600927029	107	14	0.02	700	8202	54331,5906,5565,783,2788,11069,6513,6616,5578,23236,2787,5576,5567,2770	GNG2,RAP1A,PRKAB2,CACNB2,GNG7,RAPGEF4,SLC2A1,SNAP25,PRKCA,PLCB1,GNG5,PRKAR2A,PRKACB,GNAI1
R-HSA-109704	PI3K Cascade	0.0711345742160607	-2.64318178447279	79	11	0.0157142857142857	700	8202	3667,57761,2254,2247,5565,10670,8649,30849,5140,5291,2260	IRS1,TRIB3,FGF9,FGF2,PRKAB2,RRAGA,LAMTOR3,PIK3R4,PDE3B,PIK3CB,FGFR1
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.07214572876195	-2.62906719493318	70	10	0.0142857142857143	700	8202	3836,1974,348995,23279,9636,4734,2317,7324,9883,81929	KPNA1,EIF4A2,NUP43,NUP160,ISG15,NEDD4,FLNB,UBE2E1,POM121,SEH1L
R-HSA-1169408	ISG15 antiviral mechanism	0.07214572876195	-2.62906719493318	70	10	0.0142857142857143	700	8202	3836,1974,348995,23279,9636,4734,2317,7324,9883,81929	KPNA1,EIF4A2,NUP43,NUP160,ISG15,NEDD4,FLNB,UBE2E1,POM121,SEH1L
R-HSA-4086398	Ca2+ pathway	0.0724884839063776	-2.62432757240899	61	9	0.0128571428571429	700	8202	54331,7976,2788,5578,23236,2787,6934,192669,27327	GNG2,FZD3,GNG7,PRKCA,PLCB1,GNG5,TCF7L2,AGO3,TNRC6A
R-HSA-69618	Mitotic Spindle Checkpoint	0.0727676528695673	-2.62048375123749	19	4	0.00571428571428571	700	8202	8881,7324,10393,8379	CDC16,UBE2E1,ANAPC10,MAD1L1
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.0727676528695673	-2.62048375123749	19	4	0.00571428571428571	700	8202	5984,5983,328,6117	RFC4,RFC3,APEX1,RPA1
R-HSA-110320	Translesion Synthesis by POLH	0.0727676528695673	-2.62048375123749	19	4	0.00571428571428571	700	8202	25898,5984,5983,6117	RCHY1,RFC4,RFC3,RPA1
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.0731483882461993	-2.61526518530353	35	6	0.00857142857142857	700	8202	5984,5983,328,10038,4595,6117	RFC4,RFC3,APEX1,PARP2,MUTYH,RPA1
R-HSA-73884	Base Excision Repair	0.0731483882461993	-2.61526518530353	35	6	0.00857142857142857	700	8202	5984,5983,328,10038,4595,6117	RFC4,RFC3,APEX1,PARP2,MUTYH,RPA1
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.0731483882461993	-2.61526518530353	35	6	0.00857142857142857	700	8202	22916,348995,51692,23279,9883,81929	NCBP2,NUP43,CPSF3,NUP160,POM121,SEH1L
R-HSA-180024	DARPP-32 events	0.0749344118095286	-2.59114205725837	27	5	0.00714285714285714	700	8202	5533,5141,5576,5567,5142	PPP3CC,PDE4A,PRKAR2A,PRKACB,PDE4B
R-HSA-1368082	RORA activates gene expression	0.0749344118095286	-2.59114205725837	27	5	0.00714285714285714	700	8202	80205,6907,8204,1374,10498	CHD9,TBL1X,NRIP1,CPT1A,CARM1
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.07614541482054	-2.5751104139221	12	3	0.00428571428571429	700	8202	7431,4137,6709	VIM,MAPT,SPTAN1
R-HSA-2160916	Hyaluronan uptake and degradation	0.07614541482054	-2.5751104139221	12	3	0.00428571428571429	700	8202	3373,8372,960	HYAL1,HYAL3,CD44
R-HSA-190373	FGFR1c ligand binding and activation	0.07614541482054	-2.5751104139221	12	3	0.00428571428571429	700	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-73621	Pyrimidine catabolism	0.07614541482054	-2.5751104139221	12	3	0.00428571428571429	700	8202	30833,7378,4907	NT5C,UPP1,NT5E
R-HSA-176974	Unwinding of DNA	0.07614541482054	-2.5751104139221	12	3	0.00428571428571429	700	8202	4175,4171,4174	MCM6,MCM2,MCM5
R-HSA-381033	ATF6-alpha activates chaperones	0.07614541482054	-2.5751104139221	12	3	0.00428571428571429	700	8202	468,1649,3309	ATF4,DDIT3,HSPA5
R-HSA-382556	ABC-family proteins mediated transport	0.0770305993778867	-2.56355254155073	44	7	0.01	700	8202	1965,8714,1244,21,10257,23,10347	EIF2S1,ABCC3,ABCC2,ABCA3,ABCC4,ABCF1,ABCA7
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.0817591233551472	-2.50397787475708	36	6	0.00857142857142857	700	8202	22916,348995,51692,23279,9883,81929	NCBP2,NUP43,CPSF3,NUP160,POM121,SEH1L
R-HSA-5655302	Signaling by FGFR1 in disease	0.0817591233551472	-2.50397787475708	36	6	0.00857142857142857	700	8202	2254,4893,2247,7750,2260,1523	FGF9,NRAS,FGF2,ZMYM2,FGFR1,CUX1
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.0819578268725538	-2.50155047045107	129	16	0.0228571428571429	700	8202	8924,5984,5983,51426,7156,672,6117,9156,25,675,9577,7516,5890,3014,472,146956	HERC2,RFC4,RFC3,POLK,TOP3A,BRCA1,RPA1,EXO1,ABL1,BRCA2,BRE,XRCC2,RAD51B,H2AFX,ATM,EME1
R-HSA-2028269	Signaling by Hippo	0.0850856940744477	-2.4640963647677	20	4	0.00571428571428571	700	8202	23286,154810,154796,6789	WWC1,AMOTL1,AMOT,STK4
R-HSA-3000170	Syndecan interactions	0.0850856940744477	-2.4640963647677	20	4	0.00571428571428571	700	8202	3691,5578,2247,3673	ITGB4,PRKCA,FGF2,ITGA2
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0850856940744477	-2.4640963647677	20	4	0.00571428571428571	700	8202	54331,23236,2787,2788	GNG2,PLCB1,GNG5,GNG7
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.0851260785958132	-2.46362184386365	28	5	0.00714285714285714	700	8202	5451,9533,6621,10302,10622	POU2F1,POLR1C,SNAPC4,SNAPC5,POLR3G
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.0851260785958132	-2.46362184386365	28	5	0.00714285714285714	700	8202	54331,783,2787,2788,2770	GNG2,CACNB2,GNG5,GNG7,GNAI1
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.0851260785958132	-2.46362184386365	28	5	0.00714285714285714	700	8202	27243,137492,8027,79720,92421	CHMP2A,VPS37A,STAM,VPS37B,CHMP4C
R-HSA-1483166	Synthesis of PA	0.0851260785958132	-2.46362184386365	28	5	0.00714285714285714	700	8202	81579,79888,253558,56895,84803	PLA2G12A,LPCAT1,LCLAT1,AGPAT4,GPAT3
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.0853450377945477	-2.46105297092163	1	1	0.00142857142857143	700	8202	29880	ALG5
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.0853450377945477	-2.46105297092163	1	1	0.00142857142857143	700	8202	2260	FGFR1
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.0853450377945477	-2.46105297092163	1	1	0.00142857142857143	700	8202	23760	PITPNB
R-HSA-68952	DNA replication initiation	0.0866092617730355	-2.44634852025205	6	2	0.00285714285714286	700	8202	5558,5422	PRIM2,POLA1
R-HSA-500753	Pyrimidine biosynthesis	0.0866092617730355	-2.44634852025205	6	2	0.00285714285714286	700	8202	790,7372	CAD,UMPS
R-HSA-190370	FGFR1b ligand binding and activation	0.0866092617730355	-2.44634852025205	6	2	0.00285714285714286	700	8202	2247,2260	FGF2,FGFR1
R-HSA-174430	Telomere C-strand synthesis initiation	0.0866092617730355	-2.44634852025205	6	2	0.00285714285714286	700	8202	5558,5422	PRIM2,POLA1
R-HSA-73942	DNA Damage Reversal	0.0866092617730355	-2.44634852025205	6	2	0.00285714285714286	700	8202	10973,51008	ASCC3,ASCC1
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0866092617730355	-2.44634852025205	6	2	0.00285714285714286	700	8202	4088,7048	SMAD3,TGFBR2
R-HSA-5683057	MAPK family signaling cascades	0.0892291409213317	-2.41654760080519	273	30	0.0428571428571429	700	8202	2254,200734,673,4893,8831,10435,2335,2308,2247,4763,5786,5908,8649,5682,1742,283455,5747,3570,9491,2260,3667,817,5906,6464,4609,7414,192669,5567,27327,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,CDC42EP2,FN1,FOXO1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,IL6R,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,MYC,VCL,AGO3,PRKACB,TNRC6A,SPTAN1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.0909088585246521	-2.39789782903046	37	6	0.00857142857142857	700	8202	5906,5747,2335,6464,11069,5908	RAP1A,PTK2,FN1,SHC1,RAPGEF4,RAP1B
R-HSA-74217	Purine salvage	0.0929456066800922	-2.37574083134225	13	3	0.00428571428571429	700	8202	353,3251,132	APRT,HPRT1,ADK
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	2965,2967,6883,6872,83860,102157402,51616	GTF2H1,GTF2H3,TAF12,TAF1,TAF3,AK6,TAF9B
R-HSA-73776	RNA Polymerase II Promoter Escape	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	2965,2967,6883,6872,83860,102157402,51616	GTF2H1,GTF2H3,TAF12,TAF1,TAF3,AK6,TAF9B
R-HSA-167161	HIV Transcription Initiation	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	2965,2967,6883,6872,83860,102157402,51616	GTF2H1,GTF2H3,TAF12,TAF1,TAF3,AK6,TAF9B
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	2965,2967,6883,6872,83860,102157402,51616	GTF2H1,GTF2H3,TAF12,TAF1,TAF3,AK6,TAF9B
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	2965,2967,6883,6872,83860,102157402,51616	GTF2H1,GTF2H3,TAF12,TAF1,TAF3,AK6,TAF9B
R-HSA-418597	G alpha (z) signalling events	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	54331,5583,26575,5578,2787,2788,2770	GNG2,PRKCH,RGS17,PRKCA,GNG5,GNG7,GNAI1
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.0931161979193225	-2.37390712573676	46	7	0.01	700	8202	2965,2967,6883,6872,83860,102157402,51616	GTF2H1,GTF2H3,TAF12,TAF1,TAF3,AK6,TAF9B
R-HSA-6784531	tRNA processing in the nucleus	0.0932458213674361	-2.37251603253533	55	8	0.0114285714285714	700	8202	10556,10940,339487,348995,80746,23279,81929,9883	RPP30,POP1,ZBTB8OS,NUP43,TSEN2,NUP160,SEH1L,POM121
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.0960053774149783	-2.34335107434371	29	5	0.00714285714285714	700	8202	80205,6907,7003,28996,10498	CHD9,TBL1X,TEAD1,HIPK2,CARM1
R-HSA-375170	CDO in myogenesis	0.0960053774149783	-2.34335107434371	29	5	0.00714285714285714	700	8202	6938,25,4209,6929,4208	TCF12,ABL1,MEF2D,TCF3,MEF2C
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.0960053774149783	-2.34335107434371	29	5	0.00714285714285714	700	8202	348995,3836,23279,81929,9883	NUP43,KPNA1,NUP160,SEH1L,POM121
R-HSA-525793	Myogenesis	0.0960053774149783	-2.34335107434371	29	5	0.00714285714285714	700	8202	6938,25,4209,6929,4208	TCF12,ABL1,MEF2D,TCF3,MEF2C
R-HSA-1839124	FGFR1 mutant receptor activation	0.0960053774149783	-2.34335107434371	29	5	0.00714285714285714	700	8202	2254,2247,7750,2260,1523	FGF9,FGF2,ZMYM2,FGFR1,CUX1
R-HSA-500657	Presynaptic function of Kainate receptors	0.0983447644108605	-2.31927596982069	21	4	0.00571428571428571	700	8202	54331,23236,2787,2788	GNG2,PLCB1,GNG5,GNG7
R-HSA-111885	Opioid Signalling	0.100163831447237	-2.30094811909484	84	11	0.0157142857142857	700	8202	54331,5141,2788,5142,5533,5578,23236,2787,5576,5567,2770	GNG2,PDE4A,GNG7,PDE4B,PPP3CC,PRKCA,PLCB1,GNG5,PRKAR2A,PRKACB,GNAI1
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.100589024797096	-2.29671212471243	38	6	0.00857142857142857	700	8202	348995,3836,23279,9636,81929,9883	NUP43,KPNA1,NUP160,ISG15,SEH1L,POM121
R-HSA-3000178	ECM proteoglycans	0.101115774278425	-2.29148913863375	56	8	0.0114285714285714	700	8202	3910,3915,1462,3673,7148,3908,7042,3911	LAMA4,LAMC1,VCAN,ITGA2,TNXB,LAMA2,TGFB2,LAMA5
R-HSA-2559585	Oncogene Induced Senescence	0.10755220966815	-2.22977887798295	30	5	0.00714285714285714	700	8202	3397,1021,1019,192669,27327	ID1,CDK6,CDK4,AGO3,TNRC6A
R-HSA-72086	mRNA Capping	0.10755220966815	-2.22977887798295	30	5	0.00714285714285714	700	8202	2965,2967,22916,6829,8731	GTF2H1,GTF2H3,NCBP2,SUPT5H,RNMT
R-HSA-69481	G2/M Checkpoints	0.110198299685779	-2.205473811731	105	13	0.0185714285714286	700	8202	8924,5984,4175,9577,5983,55388,4174,5001,3014,472,672,4171,6117	HERC2,RFC4,MCM6,BRE,RFC3,MCM10,MCM5,ORC5,H2AFX,ATM,BRCA1,MCM2,RPA1
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.111110456268719	-2.19723047093512	14	3	0.00428571428571429	700	8202	9156,4292,6117	EXO1,MLH1,RPA1
R-HSA-2024101	CS/DS degradation	0.111110456268719	-2.19723047093512	14	3	0.00428571428571429	700	8202	3373,8372,1462	HYAL1,HYAL3,VCAN
R-HSA-69166	Removal of the Flap Intermediate	0.111110456268719	-2.19723047093512	14	3	0.00428571428571429	700	8202	5558,5422,6117	PRIM2,POLA1,RPA1
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.111110456268719	-2.19723047093512	14	3	0.00428571428571429	700	8202	9156,4292,6117	EXO1,MLH1,RPA1
R-HSA-877312	Regulation of IFNG signaling	0.111110456268719	-2.19723047093512	14	3	0.00428571428571429	700	8202	5771,8651,3460	PTPN2,SOCS1,IFNGR2
R-HSA-5423646	Aflatoxin activation and detoxification	0.11249765912756	-2.18482286530917	22	4	0.00571428571428571	700	8202	2678,1800,2686,4257	GGT1,DPEP1,GGT7,MGST1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.11249765912756	-2.18482286530917	22	4	0.00571428571428571	700	8202	54331,2787,2788,2770	GNG2,GNG5,GNG7,GNAI1
R-HSA-381119	Unfolded Protein Response (UPR)	0.113486875315674	-2.17606808473229	86	11	0.0157142857142857	700	8202	7709,58477,23404,440,468,6464,3309,1965,5073,9709,1649	ZBTB17,SRPRB,EXOSC2,ASNS,ATF4,SHC1,HSPA5,EIF2S1,PARN,HERPUD1,DDIT3
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	4088,7048	SMAD3,TGFBR2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	4088,7048	SMAD3,TGFBR2
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	7781,148867	SLC30A3,SLC30A7
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	328,10038	APEX1,PARP2
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	4088,7048	SMAD3,TGFBR2
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	4088,7048	SMAD3,TGFBR2
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	2539,5226	G6PD,PGD
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	192669,27327	AGO3,TNRC6A
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.114580173976888	-2.16648049161494	7	2	0.00285714285714286	700	8202	4609,6934	MYC,TCF7L2
R-HSA-69306	DNA Replication	0.116381599907893	-2.15088083257286	106	13	0.0185714285714286	700	8202	5984,4175,5983,55388,328,5558,5422,4174,5001,5682,4171,9491,6117	RFC4,MCM6,RFC3,MCM10,APEX1,PRIM2,POLA1,MCM5,ORC5,PSMA1,MCM2,PSMF1,RPA1
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.119742380338688	-2.12241267445513	31	5	0.00714285714285714	700	8202	348995,23279,81929,9883,3304	NUP43,NUP160,SEH1L,POM121,HSPA1B
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.119742380338688	-2.12241267445513	31	5	0.00714285714285714	700	8202	348995,3836,23279,81929,9883	NUP43,KPNA1,NUP160,SEH1L,POM121
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.121492868492252	-2.10789971346121	40	6	0.00857142857142857	700	8202	5451,9533,6621,10302,4774,10622	POU2F1,POLR1C,SNAPC4,SNAPC5,NFIA,POLR3G
R-HSA-168253	Host Interactions with Influenza Factors	0.121492868492252	-2.10789971346121	40	6	0.00857142857142857	700	8202	348995,3836,23279,9636,81929,9883	NUP43,KPNA1,NUP160,ISG15,SEH1L,POM121
R-HSA-74158	RNA Polymerase III Transcription	0.121492868492252	-2.10789971346121	40	6	0.00857142857142857	700	8202	5451,9533,6621,10302,4774,10622	POU2F1,POLR1C,SNAPC4,SNAPC5,NFIA,POLR3G
R-HSA-373760	L1CAM interactions	0.121979433871679	-2.10390282328151	97	12	0.0171428571428571	700	8202	26052,3915,3786,287,3673,1742,5962,23114,8829,9252,2260,6709	DNM3,LAMC1,KCNQ3,ANK2,ITGA2,DLG4,RDX,NFASC,NRP1,RPS6KA5,FGFR1,SPTAN1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.122665852114626	-2.09829126987326	68	9	0.0128571428571429	700	8202	3309,472,348995,23279,573,81929,9883,3304,6117	HSPA5,ATM,NUP43,NUP160,BAG1,SEH1L,POM121,HSPA1B,RPA1
R-HSA-73857	RNA Polymerase II Transcription	0.122762580749777	-2.09750302672612	107	13	0.0185714285714286	700	8202	2967,6827,8731,6872,83860,102157402,6924,2965,22916,6883,6829,51692,51616	GTF2H3,SUPT4H1,RNMT,TAF1,TAF3,AK6,TCEB3,GTF2H1,NCBP2,TAF12,SUPT5H,CPSF3,TAF9B
R-HSA-70895	Branched-chain amino acid catabolism	0.127490876280212	-2.05971047553066	23	4	0.00571428571428571	700	8202	26275,10295,3028,55217	HIBCH,BCKDK,HSD17B10,TMLHE
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.127490876280212	-2.05971047553066	23	4	0.00571428571428571	700	8202	5984,5983,51426,6117	RFC4,RFC3,POLK,RPA1
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.127490876280212	-2.05971047553066	23	4	0.00571428571428571	700	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-69239	Synthesis of DNA	0.128882684696094	-2.0488527093551	98	12	0.0171428571428571	700	8202	5984,4175,5983,328,5558,5422,4174,5001,5682,4171,9491,6117	RFC4,MCM6,RFC3,APEX1,PRIM2,POLA1,MCM5,ORC5,PSMA1,MCM2,PSMF1,RPA1
R-HSA-191859	snRNP Assembly	0.130405506858295	-2.03710639987287	50	7	0.01	700	8202	25929,22916,348995,23279,9883,81929,1207	GEMIN5,NCBP2,NUP43,NUP160,POM121,SEH1L,CLNS1A
R-HSA-194441	Metabolism of non-coding RNA	0.130405506858295	-2.03710639987287	50	7	0.01	700	8202	25929,22916,348995,23279,9883,81929,1207	GEMIN5,NCBP2,NUP43,NUP160,POM121,SEH1L,CLNS1A
R-HSA-429914	Deadenylation-dependent mRNA decay	0.130405506858295	-2.03710639987287	50	7	0.01	700	8202	57472,23404,85456,5073,26986,1974,80153	CNOT6,EXOSC2,TNKS1BP1,PARN,PABPC1,EIF4A2,EDC3
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.130498793224859	-2.03639129958124	15	3	0.00428571428571429	700	8202	5578,9663,7112	PRKCA,LPIN2,TMPO
R-HSA-5358508	Mismatch Repair	0.130498793224859	-2.03639129958124	15	3	0.00428571428571429	700	8202	9156,4292,6117	EXO1,MLH1,RPA1
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.132548035361289	-2.02081016822576	32	5	0.00714285714285714	700	8202	1742,54331,23236,2787,2788	DLG4,GNG2,PLCB1,GNG5,GNG7
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.132548035361289	-2.02081016822576	32	5	0.00714285714285714	700	8202	4088,56937,7048,51377,4092	SMAD3,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.132548035361289	-2.02081016822576	32	5	0.00714285714285714	700	8202	22916,348995,23279,9883,81929	NCBP2,NUP43,NUP160,POM121,SEH1L
R-HSA-70153	Glucose transport	0.132686425057105	-2.01976664086392	41	6	0.00857142857142857	700	8202	348995,23279,9883,81929,6513,3099	NUP43,NUP160,POM121,SEH1L,SLC2A1,HK2
R-HSA-1433557	Signaling by SCF-KIT	0.135859699022707	-1.99613255057027	307	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,10019,5906,6464,8651,7414,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,SH2B3,RAP1A,SHC1,SOCS1,VCL,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,AGO3,TNRC6A
R-HSA-1483255	PI Metabolism	0.140743161715347	-1.96081859775826	51	7	0.01	700	8202	23760,8871,8867,8776,5291,5305,30849	PITPNB,SYNJ2,SYNJ1,MTMR1,PIK3CB,PIP4K2A,PIK3R4
R-HSA-196854	Metabolism of vitamins and cofactors	0.142999749315561	-1.9449124017618	90	11	0.0157142857142857	700	8202	80308,10243,3141,5095,113278,5646,6513,6472,25902,27010,4522	FLAD1,GPHN,HLCS,PCCA,SLC52A3,PRSS3,SLC2A1,SHMT2,MTHFD1L,TPK1,MTHFD1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.142999749315561	-1.9449124017618	90	11	0.0157142857142857	700	8202	80308,10243,3141,5095,113278,5646,6513,6472,25902,27010,4522	FLAD1,GPHN,HLCS,PCCA,SLC52A3,PRSS3,SLC2A1,SHMT2,MTHFD1L,TPK1,MTHFD1
R-HSA-70268	Pyruvate metabolism	0.143265834164568	-1.94305339431562	24	4	0.00571428571428571	700	8202	6566,5163,5166,51660	SLC16A1,PDK1,PDK4,MPC1
R-HSA-112399	IRS-mediated signalling	0.144348518860727	-1.93552463367591	277	29	0.0414285714285714	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5565,5786,5908,8649,30849,5682,1742,283455,5747,5140,9491,5291,2260,3667,57761,817,5906,6464,10670,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PRKAB2,PTPRA,RAP1B,LAMTOR3,PIK3R4,PSMA1,DLG4,KSR2,PTK2,PDE3B,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,RRAGA,VCL,SPTAN1
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.144433448360081	-1.93493644250441	8	2	0.00285714285714286	700	8202	4233,5364	MET,PLXNB1
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.144433448360081	-1.93493644250441	8	2	0.00285714285714286	700	8202	4793,3551	NFKBIB,IKBKB
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.144433448360081	-1.93493644250441	8	2	0.00285714285714286	700	8202	4088,7048	SMAD3,TGFBR2
R-HSA-72731	Recycling of eIF2:GDP	0.144433448360081	-1.93493644250441	8	2	0.00285714285714286	700	8202	1965,8891	EIF2S1,EIF2B3
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.145938106532638	-1.92457267501527	33	5	0.00714285714285714	700	8202	348995,10783,23279,9883,81929	NUP43,NEK6,NUP160,POM121,SEH1L
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.145938106532638	-1.92457267501527	33	5	0.00714285714285714	700	8202	22916,348995,23279,9883,81929	NCBP2,NUP43,NUP160,POM121,SEH1L
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.145938106532638	-1.92457267501527	33	5	0.00714285714285714	700	8202	8871,8867,8776,5291,5305	SYNJ2,SYNJ1,MTMR1,PIK3CB,PIP4K2A
R-HSA-163359	Glucagon signaling in metabolic regulation	0.145938106532638	-1.92457267501527	33	5	0.00714285714285714	700	8202	54331,5576,2787,2788,5567	GNG2,PRKAR2A,GNG5,GNG7,PRKACB
R-HSA-5654716	Downstream signaling of activated FGFR4	0.148261342553499	-1.90877873439527	310	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5654687	Downstream signaling of activated FGFR1	0.148261342553499	-1.90877873439527	310	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5654708	Downstream signaling of activated FGFR3	0.148261342553499	-1.90877873439527	310	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5654696	Downstream signaling of activated FGFR2	0.148261342553499	-1.90877873439527	310	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5693532	DNA Double-Strand Break Repair	0.148553965528317	-1.90680698252362	162	18	0.0257142857142857	700	8202	8924,5984,5983,51426,10038,7156,672,6117,9156,25,675,9577,7516,5890,3014,472,146956,7518	HERC2,RFC4,RFC3,POLK,PARP2,TOP3A,BRCA1,RPA1,EXO1,ABL1,BRCA2,BRE,XRCC2,RAD51B,H2AFX,ATM,EME1,XRCC4
R-HSA-1433559	Regulation of KIT signaling	0.150965383379589	-1.89070471759061	16	3	0.00428571428571429	700	8202	10019,8651,5578	SH2B3,SOCS1,PRKCA
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.150965383379589	-1.89070471759061	16	3	0.00428571428571429	700	8202	93183,5283,54872	PIGM,PIGH,PIGG
R-HSA-446353	Cell-extracellular matrix interactions	0.150965383379589	-1.89070471759061	16	3	0.00428571428571429	700	8202	10979,2318,5829	FERMT2,FLNC,PXN
R-HSA-190242	FGFR1 ligand binding and activation	0.150965383379589	-1.89070471759061	16	3	0.00428571428571429	700	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-166520	Signalling by NGF	0.151917547584117	-1.88441735541964	430	43	0.0614285714285714	700	8202	200734,26052,673,2335,2308,4763,5786,7204,8649,57142,5578,9252,9491,5906,6464,3551,7414,5567,5046,6709,6199,2254,4893,8831,2247,5908,5682,1742,283455,84033,23365,11214,5747,5291,2260,3667,57761,817,57498,5576,192669,27327,4208	SPRED2,DNM3,BRAF,FN1,FOXO1,NF1,PTPRA,TRIO,LAMTOR3,RTN4,PRKCA,RPS6KA5,PSMF1,RAP1A,SHC1,IKBKB,VCL,PRKACB,PCSK6,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,PSMA1,DLG4,KSR2,OBSCN,ARHGEF12,AKAP13,PTK2,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,KIDINS220,PRKAR2A,AGO3,TNRC6A,MEF2C
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.156053034798623	-1.85755936285033	355	36	0.0514285714285714	700	8202	200734,26052,673,2335,2308,4763,5786,8649,5578,9252,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,5682,1742,283455,5747,5291,2260,3667,817,57761,57498,5576,192669,27327,4208	SPRED2,DNM3,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,RPS6KA5,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,PSMA1,DLG4,KSR2,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,KIDINS220,PRKAR2A,AGO3,TNRC6A,MEF2C
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.156464832113812	-1.85492400918183	43	6	0.00857142857142857	700	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.156464832113812	-1.85492400918183	43	6	0.00857142857142857	700	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-167169	HIV Transcription Elongation	0.156464832113812	-1.85492400918183	43	6	0.00857142857142857	700	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-74751	Insulin receptor signalling cascade	0.15793970665513	-1.84554192223284	280	29	0.0414285714285714	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5565,5786,5908,8649,30849,5682,1742,283455,5747,5140,9491,5291,2260,3667,57761,817,5906,6464,10670,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PRKAB2,PTPRA,RAP1B,LAMTOR3,PIK3R4,PSMA1,DLG4,KSR2,PTK2,PDE3B,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,RRAGA,VCL,SPTAN1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.157998926395366	-1.8451670409443	72	9	0.0128571428571429	700	8202	4088,6498,56937,51377,4609,4092,4221,7048,56288	SMAD3,SKIL,PMEPA1,UCHL5,MYC,SMAD7,MEN1,TGFBR2,PARD3
R-HSA-180292	GAB1 signalosome	0.158591313440396	-1.84142474151843	102	12	0.0171428571428571	700	8202	3667,57761,2254,5829,2308,2247,55824,5291,2260,192669,27327,6199	IRS1,TRIB3,FGF9,PXN,FOXO1,FGF2,PAG1,PIK3CB,FGFR1,AGO3,TNRC6A,RPS6KB2
R-HSA-68874	M/G1 Transition	0.159023849944496	-1.83870108835981	82	10	0.0142857142857143	700	8202	4175,55388,5558,5422,4174,5001,5682,4171,9491,6117	MCM6,MCM10,PRIM2,POLA1,MCM5,ORC5,PSMA1,MCM2,PSMF1,RPA1
R-HSA-69002	DNA Replication Pre-Initiation	0.159023849944496	-1.83870108835981	82	10	0.0142857142857143	700	8202	4175,55388,5558,5422,4174,5001,5682,4171,9491,6117	MCM6,MCM10,PRIM2,POLA1,MCM5,ORC5,PSMA1,MCM2,PSMF1,RPA1
R-HSA-162588	Budding and maturation of HIV virion	0.159760015056504	-1.83408249563006	25	4	0.00571428571428571	700	8202	27243,137492,79720,92421	CHMP2A,VPS37A,VPS37B,CHMP4C
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.159760015056504	-1.83408249563006	25	4	0.00571428571428571	700	8202	93183,54344,5283,54872	PIGM,DPM3,PIGH,PIGG
R-HSA-1482788	Acyl chain remodelling of PC	0.159760015056504	-1.83408249563006	25	4	0.00571428571428571	700	8202	81579,10162,79888,54947	PLA2G12A,LPCAT3,LPCAT1,LPCAT2
R-HSA-113418	Formation of the Early Elongation Complex	0.159878756569517	-1.83333952244273	34	5	0.00714285714285714	700	8202	2965,2967,22916,6827,6829	GTF2H1,GTF2H3,NCBP2,SUPT4H1,SUPT5H
R-HSA-390522	Striated Muscle Contraction	0.159878756569517	-1.83333952244273	34	5	0.00714285714285714	700	8202	7134,7431,7273,7168,7171	TNNC1,VIM,TTN,TPM1,TPM4
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.159878756569517	-1.83333952244273	34	5	0.00714285714285714	700	8202	348995,3836,23279,81929,9883	NUP43,KPNA1,NUP160,SEH1L,POM121
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.159878756569517	-1.83333952244273	34	5	0.00714285714285714	700	8202	2965,22916,2967,6827,6829	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H
R-HSA-5654741	Signaling by FGFR3	0.161308634349222	-1.82443576553025	313	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5654743	Signaling by FGFR4	0.161308634349222	-1.82443576553025	313	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-2428924	IGF1R signaling cascade	0.162627526740632	-1.81629280504876	281	29	0.0414285714285714	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5565,5786,5908,8649,30849,5682,1742,283455,5747,5140,9491,5291,2260,3667,57761,817,5906,6464,10670,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PRKAB2,PTPRA,RAP1B,LAMTOR3,PIK3R4,PSMA1,DLG4,KSR2,PTK2,PDE3B,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,RRAGA,VCL,SPTAN1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.162627526740632	-1.81629280504876	281	29	0.0414285714285714	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5565,5786,5908,8649,30849,5682,1742,283455,5747,5140,9491,5291,2260,3667,57761,817,5906,6464,10670,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PRKAB2,PTPRA,RAP1B,LAMTOR3,PIK3R4,PSMA1,DLG4,KSR2,PTK2,PDE3B,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,RRAGA,VCL,SPTAN1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.162627526740632	-1.81629280504876	281	29	0.0414285714285714	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5565,5786,5908,8649,30849,5682,1742,283455,5747,5140,9491,5291,2260,3667,57761,817,5906,6464,10670,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PRKAB2,PTPRA,RAP1B,LAMTOR3,PIK3R4,PSMA1,DLG4,KSR2,PTK2,PDE3B,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,RRAGA,VCL,SPTAN1
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	3304	HSPA1B
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	79658	ARHGAP10
R-HSA-75102	C6 deamination of adenosine	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	104	ADARB1
R-HSA-75064	mRNA Editing: A to I Conversion	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	104	ADARB1
R-HSA-141424	Amplification of signal from the kinetochores	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	8379	MAD1L1
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	7048	TGFBR2
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	8379	MAD1L1
R-HSA-165160	PDE3B signalling	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	5140	PDE3B
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	328	APEX1
R-HSA-77042	Formation of editosomes by ADAR proteins	0.163415818613387	-1.81145729210248	2	1	0.00142857142857143	700	8202	104	ADARB1
R-HSA-1266738	Developmental Biology	0.165591871589	-1.79822912284315	710	68	0.0971428571428571	700	8202	6938,200734,26052,71,4763,5786,10096,8912,5087,55740,57556,5364,27,5906,6464,6721,4233,7414,10498,80205,4893,51466,5468,2649,287,1019,1742,283455,4209,2260,4088,817,3673,9477,23114,8829,4208,1948,673,2308,2335,7204,6929,8649,23389,9723,9252,9491,25,783,9862,5962,6709,5046,2254,3786,3915,8831,2247,5908,5682,23365,5747,51129,3667,51586,6907,7026	TCF12,SPRED2,DNM3,ACTG1,NF1,PTPRA,ACTR3,CACNA1H,PBX1,ENAH,SEMA6A,PLXNB1,ABL2,RAP1A,SHC1,SREBF2,MET,VCL,CARM1,CHD9,NRAS,EVL,PPARG,NR6A1,ANK2,CDK4,DLG4,KSR2,MEF2D,FGFR1,SMAD3,CAMK2D,ITGA2,MED20,NFASC,NRP1,MEF2C,EFNB2,BRAF,FOXO1,FN1,TRIO,TCF3,LAMTOR3,MED13L,SEMA3E,RPS6KA5,PSMF1,ABL1,CACNB2,MED24,RDX,SPTAN1,PCSK6,FGF9,KCNQ3,LAMC1,SYNGAP1,FGF2,RAP1B,PSMA1,ARHGEF12,PTK2,ANGPTL4,IRS1,MED15,TBL1X,NR2F2
R-HSA-5654736	Signaling by FGFR1	0.165799321196705	-1.79697713039846	314	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.167949313463926	-1.78409305067303	83	10	0.0142857142857143	700	8202	2967,5984,5983,51138,7508,51426,10038,6612,2965,6117	GTF2H3,RFC4,RFC3,COPS4,XPC,POLK,PARP2,SUMO3,GTF2H1,RPA1
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.169007079386734	-1.77781467507409	44	6	0.00857142857142857	700	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.169007079386734	-1.77781467507409	44	6	0.00857142857142857	700	8202	2965,6612,2967,7508,10038,6117	GTF2H1,SUMO3,GTF2H3,XPC,PARP2,RPA1
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.169007079386734	-1.77781467507409	44	6	0.00857142857142857	700	8202	2965,2967,22916,6827,6829,6924	GTF2H1,GTF2H3,NCBP2,SUPT4H1,SUPT5H,TCEB3
R-HSA-112382	Formation of RNA Pol II elongation complex	0.169007079386734	-1.77781467507409	44	6	0.00857142857142857	700	8202	2965,2967,22916,6827,6829,6924	GTF2H1,GTF2H3,NCBP2,SUPT4H1,SUPT5H,TCEB3
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.172364188826605	-1.75814566375303	17	3	0.00428571428571429	700	8202	8881,7324,10393	CDC16,UBE2E1,ANAPC10
R-HSA-176412	Phosphorylation of the APC/C	0.172364188826605	-1.75814566375303	17	3	0.00428571428571429	700	8202	8881,7324,10393	CDC16,UBE2E1,ANAPC10
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.172364188826605	-1.75814566375303	17	3	0.00428571428571429	700	8202	7187,9020,329	TRAF3,MAP3K14,BIRC2
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.172638460993706	-1.75655569205267	145	16	0.0228571428571429	700	8202	57459,2967,25885,4774,5451,6621,10622,10919,1107,3014,2965,84172,9533,30834,64425,10302	GATAD2B,GTF2H3,POLR1A,NFIA,POU2F1,SNAPC4,POLR3G,EHMT2,CHD3,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,POLR1E,SNAPC5
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.174333817957057	-1.74678332372079	35	5	0.00714285714285714	700	8202	5451,9533,6621,10302,10622	POU2F1,POLR1C,SNAPC4,SNAPC5,POLR3G
R-HSA-5654738	Signaling by FGFR2	0.174989995133228	-1.7430264773602	316	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	57128,2395	LYRM4,FXN
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	328,4595	APEX1,MUTYH
R-HSA-162592	Integration of provirus	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	3836,7518	KPNA1,XRCC4
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	27,25	ABL2,ABL1
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	192669,7247	AGO3,TSN
R-HSA-2179392	EGFR Transactivation by Gastrin	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	4893,5578	NRAS,PRKCA
R-HSA-447041	CHL1 interactions	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	8829,3673	NRP1,ITGA2
R-HSA-2428933	SHC-related events triggered by IGF1R	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	4893,6464	NRAS,SHC1
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.175645156550223	-1.73928947508702	9	2	0.00285714285714286	700	8202	2308,6199	FOXO1,RPS6KB2
R-HSA-76002	Platelet activation, signaling and aggregation	0.175667688769726	-1.73916120070232	230	24	0.0342857142857143	700	8202	7273,2335,10257,2788,11069,3309,5908,5747,7042,5578,57406,5291,7114,2770,5583,54331,5906,6464,221955,1191,3273,11343,7414,2787	TTN,FN1,ABCC4,GNG7,RAPGEF4,HSPA5,RAP1B,PTK2,TGFB2,PRKCA,ABHD6,PIK3CB,TMSB4X,GNAI1,PRKCH,GNG2,RAP1A,SHC1,DAGLB,CLU,HRG,MGLL,VCL,GNG5
R-HSA-264876	Insulin processing	0.176908025441953	-1.73212531173436	26	4	0.00571428571428571	700	8202	3800,3798,60412,148867	KIF5C,KIF5A,EXOC4,SLC30A7
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.176908025441953	-1.73212531173436	26	4	0.00571428571428571	700	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-190236	Signaling by FGFR	0.179688784980427	-1.71652889682062	317	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-1226099	Signaling by FGFR in disease	0.181953549050654	-1.70400384947719	45	6	0.00857142857142857	700	8202	2254,4893,2247,7750,2260,1523	FGF9,NRAS,FGF2,ZMYM2,FGFR1,CUX1
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.181953549050654	-1.70400384947719	45	6	0.00857142857142857	700	8202	6566,5163,8802,5166,728294,51660	SLC16A1,PDK1,SUCLG1,PDK4,D2HGDH,MPC1
R-HSA-72649	Translation initiation complex formation	0.18576603257061	-1.68326728648121	55	7	0.01	700	8202	1965,8663,8669,26986,8667,6235,1974	EIF2S1,EIF3C,EIF3J,PABPC1,EIF3H,RPS29,EIF4A2
R-HSA-170984	ARMS-mediated activation	0.186817651084971	-1.67762226576191	232	24	0.0342857142857143	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,57498,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,KIDINS220,VCL,SPTAN1
R-HSA-69620	Cell Cycle Checkpoints	0.189046433940509	-1.66576261187252	179	19	0.0271428571428571	700	8202	8924,5984,4175,5983,55388,5682,672,4171,9491,7324,6117,8881,9577,4174,5001,10393,8379,3014,472	HERC2,RFC4,MCM6,RFC3,MCM10,PSMA1,BRCA1,MCM2,PSMF1,UBE2E1,RPA1,CDC16,BRE,MCM5,ORC5,ANAPC10,MAD1L1,H2AFX,ATM
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.193976395267192	-1.64001880120213	96	11	0.0157142857142857	700	8202	10723,6541,6520,23657,92745,6528,81539,54407,9497,6553,8501	SLC12A7,SLC7A1,SLC3A2,SLC7A11,SLC38A5,SLC5A5,SLC38A1,SLC38A2,SLC4A7,SLC9A5,SLC43A1
R-HSA-1227986	Signaling by ERBB2	0.194190779689308	-1.63891420267992	320	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.194550972270451	-1.63706108202897	18	3	0.00428571428571429	700	8202	8881,7324,10393	CDC16,UBE2E1,ANAPC10
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.194550972270451	-1.63706108202897	18	3	0.00428571428571429	700	8202	8881,7324,10393	CDC16,UBE2E1,ANAPC10
R-HSA-114508	Effects of PIP2 hydrolysis	0.194642566940872	-1.63659039244714	27	4	0.00571428571428571	700	8202	5583,221955,11343,57406	PRKCH,DAGLB,MGLL,ABHD6
R-HSA-3371556	Cellular response to heat stress	0.19610351035787	-1.62911264508401	86	10	0.0142857142857143	700	8202	817,3309,472,348995,23279,573,81929,9883,3304,6117	CAMK2D,HSPA5,ATM,NUP43,NUP160,BAG1,SEH1L,POM121,HSPA1B,RPA1
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.19610351035787	-1.62911264508401	86	10	0.0142857142857143	700	8202	7273,2335,10257,3309,1191,5578,3273,7042,7414,7114	TTN,FN1,ABCC4,HSPA5,CLU,PRKCA,HRG,TGFB2,VCL,TMSB4X
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.197858926610863	-1.62020099409489	56	7	0.01	700	8202	1965,8663,8669,26986,8667,6235,1974	EIF2S1,EIF3C,EIF3J,PABPC1,EIF3H,RPS29,EIF4A2
R-HSA-5684996	MAPK1/MAPK3 signaling	0.19832488507206	-1.61784875928719	234	24	0.0342857142857143	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,3570,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,IL6R,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-186763	Downstream signal transduction	0.204189034797358	-1.58870907304128	322	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-169893	Prolonged ERK activation events	0.204208964215195	-1.58861147502219	235	24	0.0342857142857143	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,57498,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,KIDINS220,VCL,SPTAN1
R-HSA-168799	Neurotoxicity of clostridium toxins	0.207766872892253	-1.57133863125329	10	2	0.00285714285714286	700	8202	6616,6857	SNAP25,SYT1
R-HSA-74749	Signal attenuation	0.207766872892253	-1.57133863125329	10	2	0.00285714285714286	700	8202	3667,6464	IRS1,SHC1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.207766872892253	-1.57133863125329	10	2	0.00285714285714286	700	8202	23516,7922	SLC39A14,SLC39A7
R-HSA-399997	Acetylcholine regulates insulin secretion	0.207766872892253	-1.57133863125329	10	2	0.00285714285714286	700	8202	5578,23236	PRKCA,PLCB1
R-HSA-189200	Hexose transport	0.208957663926732	-1.56562361248024	47	6	0.00857142857142857	700	8202	348995,23279,9883,81929,6513,3099	NUP43,NUP160,POM121,SEH1L,SLC2A1,HK2
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.208957663926732	-1.56562361248024	47	6	0.00857142857142857	700	8202	55869,6907,3091,7090,4609,55534	HDAC8,TBL1X,HIF1A,TLE3,MYC,MAML3
R-HSA-597592	Post-translational protein modification	0.209107958835375	-1.56490461093151	411	40	0.0571428571428571	700	8202	8924,93183,9871,5589,7508,9334,6480,5283,54344,348995,79642,23279,6015,9883,4121,1912,149111,54872,89978,374378,81929,83696,10274,57188,22955,6612,672,122553,8869,4758,6117,4247,29880,4905,286053,197370,55568,8775,648,7518	HERC2,PIGM,SEC24D,PRKCSH,XPC,B4GALT5,ST6GAL1,PIGH,DPM3,NUP43,ARSJ,NUP160,RING1,POM121,MAN1A1,PHC2,CNIH3,PIGG,DPH6,GALNT18,SEH1L,TRAPPC9,STAG1,ADAMTSL3,SCMH1,SUMO3,BRCA1,TRAPPC6B,ST3GAL5,NEU1,RPA1,MGAT2,ALG5,NSF,NSMCE2,NSMCE1,GALNT10,NAPA,BMI1,XRCC4
R-HSA-1643685	Disease	0.212799616058367	-1.54740432575327	657	62	0.0885714285714286	700	8202	27243,2308,6872,102157402,6235,54894,348995,162,7048,23279,9491,5606,9883,182,6464,83860,4609,3551,8907,2965,7750,81929,6199,55534,2967,2254,4893,137492,2247,8731,5095,1523,6924,5682,55869,55690,6616,6829,6857,5291,9636,2260,6934,3304,51616,22943,3667,4088,3836,6827,221914,6158,1462,79720,22916,7187,6907,6883,4793,7518,5947,92421	CHMP2A,FOXO1,TAF1,AK6,RPS29,RNF43,NUP43,AP1B1,TGFBR2,NUP160,PSMF1,MAP2K3,POM121,JAG1,SHC1,TAF3,MYC,IKBKB,AP1M1,GTF2H1,ZMYM2,SEH1L,RPS6KB2,MAML3,GTF2H3,FGF9,NRAS,VPS37A,FGF2,RNMT,PCCA,CUX1,TCEB3,PSMA1,HDAC8,PACS1,SNAP25,SUPT5H,SYT1,PIK3CB,ISG15,FGFR1,TCF7L2,HSPA1B,TAF9B,DKK1,IRS1,SMAD3,KPNA1,SUPT4H1,GPC2,RPL28,VCAN,VPS37B,NCBP2,TRAF3,TBL1X,TAF12,NFKBIB,XRCC4,RBP1,CHMP4C
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.212895315001874	-1.54695471295248	28	4	0.00571428571428571	700	8202	5984,5983,56852,6117	RFC4,RFC3,RAD18,RPA1
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.212895315001874	-1.54695471295248	28	4	0.00571428571428571	700	8202	2965,2967,6829,8731	GTF2H1,GTF2H3,SUPT5H,RNMT
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.212895315001874	-1.54695471295248	28	4	0.00571428571428571	700	8202	2965,2967,6829,8731	GTF2H1,GTF2H3,SUPT5H,RNMT
R-HSA-202040	G-protein activation	0.212895315001874	-1.54695471295248	28	4	0.00571428571428571	700	8202	54331,2787,2788,2770	GNG2,GNG5,GNG7,GNAI1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.217385344657296	-1.52608371844728	19	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-157579	Telomere Maintenance	0.218944815202355	-1.51893556629666	78	9	0.0128571428571429	700	8202	54386,5984,5983,328,5558,65057,5422,3014,6117	TERF2IP,RFC4,RFC3,APEX1,PRIM2,ACD,POLA1,H2AFX,RPA1
R-HSA-418346	Platelet homeostasis	0.218944815202355	-1.51893556629666	78	9	0.0128571428571429	700	8202	54331,10846,3778,2788,5138,5140,5152,2787,5139	GNG2,PDE10A,KCNMA1,GNG7,PDE2A,PDE3B,PDE9A,GNG5,PDE3A
R-HSA-5663205	Infectious disease	0.219642392924976	-1.51575454187131	347	34	0.0485714285714286	700	8202	27243,6872,102157402,6235,348995,162,23279,9491,5606,9883,83860,8907,2965,81929,2967,137492,8731,6924,5682,55690,6616,6829,6857,9636,51616,3304,3836,6827,6158,79720,22916,6883,7518,92421	CHMP2A,TAF1,AK6,RPS29,NUP43,AP1B1,NUP160,PSMF1,MAP2K3,POM121,TAF3,AP1M1,GTF2H1,SEH1L,GTF2H3,VPS37A,RNMT,TCEB3,PSMA1,PACS1,SNAP25,SUPT5H,SYT1,ISG15,TAF9B,HSPA1B,KPNA1,SUPT4H1,RPL28,VPS37B,NCBP2,TAF12,XRCC4,CHMP4C
R-HSA-2424491	DAP12 signaling	0.219664217001122	-1.51565518494988	325	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.220397701394514	-1.51232163100225	38	5	0.00714285714285714	700	8202	7431,5747,329,4137,6709	VIM,PTK2,BIRC2,MAPT,SPTAN1
R-HSA-1442490	Collagen degradation	0.220397701394514	-1.51232163100225	38	5	0.00714285714285714	700	8202	8754,85007,1308,4316,4323	ADAM9,PHYKPL,COL17A1,MMP7,MMP14
R-HSA-75109	Triglyceride Biosynthesis	0.221386065589875	-1.50784719840337	68	8	0.0114285714285714	700	8202	51703,56895,84803,9663,26027,253558,79888,6576	ACSL5,AGPAT4,GPAT3,LPIN2,ACOT11,LCLAT1,LPCAT1,SLC25A1
R-HSA-202733	Cell surface interactions at the vascular wall	0.222152555317474	-1.50439094699938	99	11	0.0157142857142857	700	8202	6520,4893,2335,6464,23657,2734,6566,960,5291,285,1525	SLC3A2,NRAS,FN1,SHC1,SLC7A11,GLG1,SLC16A1,CD44,PIK3CB,ANGPT2,CXADR
R-HSA-912526	Interleukin receptor SHC signaling	0.222364243054997	-1.50343850716223	238	24	0.0342857142857143	700	8202	2254,200734,673,4893,2335,8831,4763,2247,5786,5908,8649,5682,1742,283455,5747,5291,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PIK3CB,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-74752	Signaling by Insulin receptor	0.224869391735964	-1.49223552649563	304	30	0.0428571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5565,5786,5908,8649,30849,5682,1742,535,283455,5747,5140,9491,5291,2260,3667,57761,817,5906,6464,10670,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PRKAB2,PTPRA,RAP1B,LAMTOR3,PIK3R4,PSMA1,DLG4,ATP6V0A1,KSR2,PTK2,PDE3B,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,RRAGA,VCL,SPTAN1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-180336	SHC1 events in EGFR signaling	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-5673001	RAF/MAP kinase cascade	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,2335,8831,4763,2247,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-179812	GRB2 events in EGFR signaling	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-112412	SOS-mediated signalling	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.227838615049732	-1.47911772938597	228	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.231597705017858	-1.46275344258171	29	4	0.00571428571428571	700	8202	348995,23279,81929,9883	NUP43,NUP160,SEH1L,POM121
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.231597705017858	-1.46275344258171	29	4	0.00571428571428571	700	8202	348995,23279,9883,81929	NUP43,NUP160,POM121,SEH1L
R-HSA-445355	Smooth Muscle Contraction	0.231597705017858	-1.46275344258171	29	4	0.00571428571428571	700	8202	5829,7168,7414,7171	PXN,TPM1,VCL,TPM4
R-HSA-445095	Interaction between L1 and Ankyrins	0.231597705017858	-1.46275344258171	29	4	0.00571428571428571	700	8202	23114,3786,287,6709	NFASC,KCNQ3,ANK2,SPTAN1
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.234270657630096	-1.45127817549737	229	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.234270657630096	-1.45127817549737	229	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.234270657630096	-1.45127817549737	229	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.234270657630096	-1.45127817549737	229	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-5653890	Lactose synthesis	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	6513	SLC2A1
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	4595	MUTYH
R-HSA-1483152	Hydrolysis of LPE	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	56261	GPCPD1
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	200894	ARL13B
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	4121	MAN1A1
R-HSA-111458	Formation of apoptosome	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	5631	PRPS1
R-HSA-977347	Serine biosynthesis	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	29968	PSAT1
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	4088	SMAD3
R-HSA-110331	Cleavage of the damaged purine	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	4595	MUTYH
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	6934	TCF7L2
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	2260	FGFR1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	6857	SYT1
R-HSA-5602571	TRAF3 deficiency - HSE	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	7187	TRAF3
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	4088	SMAD3
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	6616	SNAP25
R-HSA-73927	Depurination	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	4595	MUTYH
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	3091	HIF1A
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	6857	SYT1
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	728294	D2HGDH
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	6616	SNAP25
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.234831541415206	-1.44888686693592	3	1	0.00142857142857143	700	8202	54344	DPM3
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.237264087435005	-1.43858146523592	49	6	0.00857142857142857	700	8202	2254,5578,2247,5576,2260,5567	FGF9,PRKCA,FGF2,PRKAR2A,FGFR1,PRKACB
R-HSA-196780	Biotin transport and metabolism	0.240416631769037	-1.42538189498273	11	2	0.00285714285714286	700	8202	3141,5095	HLCS,PCCA
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.240416631769037	-1.42538189498273	11	2	0.00285714285714286	700	8202	114799,10274	ESCO1,STAG1
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.240416631769037	-1.42538189498273	11	2	0.00285714285714286	700	8202	137492,79720	VPS37A,VPS37B
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.240416631769037	-1.42538189498273	11	2	0.00285714285714286	700	8202	137492,79720	VPS37A,VPS37B
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.240416631769037	-1.42538189498273	11	2	0.00285714285714286	700	8202	8867,3628	SYNJ1,INPP1
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.241237550983636	-1.42197314223485	241	24	0.0342857142857143	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,5578,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PRKCA,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-421837	Clathrin derived vesicle budding	0.245292696659071	-1.40530310125888	70	8	0.0114285714285714	700	8202	27243,8773,10717,8907,25977,162,8775,55330	CHMP2A,SNAP23,AP4B1,AP1M1,NECAP1,AP1B1,NAPA,BLOC1S4
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.245292696659071	-1.40530310125888	70	8	0.0114285714285714	700	8202	27243,8773,10717,8907,25977,162,8775,55330	CHMP2A,SNAP23,AP4B1,AP1M1,NECAP1,AP1B1,NAPA,BLOC1S4
R-HSA-399719	Trafficking of AMPA receptors	0.250681627377048	-1.38357156179637	30	4	0.00571428571428571	700	8202	1742,817,5578,4905	DLG4,CAMK2D,PRKCA,NSF
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.250681627377048	-1.38357156179637	30	4	0.00571428571428571	700	8202	1742,817,5578,4905	DLG4,CAMK2D,PRKCA,NSF
R-HSA-2132295	MHC class II antigen presentation	0.251858342038653	-1.37888848429495	102	11	0.0157142857142857	700	8202	1778,26052,9871,3798,7879,51164,56992,8907,79659,162,114876	DYNC1H1,DNM3,SEC24D,KIF5A,RAB7A,DCTN4,KIF15,AP1M1,DYNC2H1,AP1B1,OSBPL1A
R-HSA-114608	Platelet degranulation	0.252396088064236	-1.3767556473883	81	9	0.0128571428571429	700	8202	7273,2335,10257,3309,1191,3273,7042,7414,7114	TTN,FN1,ABCC4,HSPA5,CLU,HRG,TGFB2,VCL,TMSB4X
R-HSA-187706	Signalling to p38 via RIT and RIN	0.254034540140065	-1.37028503640529	232	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-375165	NCAM signaling for neurite out-growth	0.260481233904398	-1.34522445913834	266	26	0.0371428571428571	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,8912,5908,8649,5682,1742,283455,5747,9252,9491,2260,3667,817,5906,6464,783,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,CACNA1H,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,RPS6KA5,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,CACNB2,VCL,SPTAN1
R-HSA-170968	Frs2-mediated activation	0.260771048331355	-1.34411246609122	233	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-453279	Mitotic G1-G1/S phases	0.260953470891306	-1.34341315999897	135	14	0.02	700	8202	4175,55388,5558,5422,4174,4609,1019,5001,5682,5520,4171,9491,1021,6117	MCM6,MCM10,PRIM2,POLA1,MCM5,MYC,CDK4,ORC5,PSMA1,PPP2R2A,MCM2,PSMF1,CDK6,RPA1
R-HSA-72766	Translation	0.262822271267224	-1.33627724989232	146	15	0.0214285714285714	700	8202	58477,8663,6158,6730,8669,6235,1974,1965,2107,6748,8891,9669,26986,6727,8667	SRPRB,EIF3C,RPL28,SRP68,EIF3J,RPS29,EIF4A2,EIF2S1,ETF1,SSR4,EIF2B3,EIF5B,PABPC1,SRP14,EIF3H
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.264463604725999	-1.33005163743135	21	3	0.00428571428571429	700	8202	55690,162,8907	PACS1,AP1B1,AP1M1
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.264463604725999	-1.33005163743135	21	3	0.00428571428571429	700	8202	50515,1462,55454	CHST11,VCAN,CSGALNACT2
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.264463604725999	-1.33005163743135	21	3	0.00428571428571429	700	8202	4893,9252,5567	NRAS,RPS6KA5,PRKACB
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.264463604725999	-1.33005163743135	21	3	0.00428571428571429	700	8202	8881,7324,10393	CDC16,UBE2E1,ANAPC10
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.264463604725999	-1.33005163743135	21	3	0.00428571428571429	700	8202	204,654364,51727	AK2,NME1-NME2,CMPK1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.26664805210593	-1.32182564702154	51	6	0.00857142857142857	700	8202	3373,50515,8372,221914,1462,55454	HYAL1,CHST11,HYAL3,GPC2,VCAN,CSGALNACT2
R-HSA-397795	G-protein beta:gamma signalling	0.26664805210593	-1.32182564702154	51	6	0.00857142857142857	700	8202	54331,6464,23236,5291,2787,2788	GNG2,SHC1,PLCB1,PIK3CB,GNG5,GNG7
R-HSA-451927	Interleukin-2 signaling	0.26742859072685	-1.31890269883755	245	24	0.0342857142857143	700	8202	2254,200734,673,4893,2335,8831,4763,2247,5786,5908,8649,5682,1742,283455,5747,5291,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PIK3CB,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-70263	Gluconeogenesis	0.270080034343706	-1.30903694041332	31	4	0.00571428571428571	700	8202	8604,5106,5567,6576	SLC25A12,PCK2,PRKACB,SLC25A1
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.270080034343706	-1.30903694041332	31	4	0.00571428571428571	700	8202	4088,4221,4609,4092	SMAD3,MEN1,MYC,SMAD7
R-HSA-180746	Nuclear import of Rev protein	0.270080034343706	-1.30903694041332	31	4	0.00571428571428571	700	8202	348995,23279,81929,9883	NUP43,NUP160,SEH1L,POM121
R-HSA-1236394	Signaling by ERBB4	0.270782039006962	-1.30644106581958	312	30	0.0428571428571429	700	8202	2254,200734,673,4893,8831,2335,2308,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,5291,2260,4734,3667,57761,817,5906,6464,7414,192669,27327,6709,6199	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,PIK3CB,FGFR1,NEDD4,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,VCL,AGO3,TNRC6A,SPTAN1,RPS6KB2
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.272399968041175	-1.30048382202993	104	11	0.0157142857142857	700	8202	3667,57761,2254,6464,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,SHC1,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	843,3551	CASP10,IKBKB
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	328,6117	APEX1,RPA1
R-HSA-190239	FGFR3 ligand binding and activation	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	5558,5422	PRIM2,POLA1
R-HSA-190372	FGFR3c ligand binding and activation	0.273270875166698	-1.297291758991	12	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-187687	Signalling to ERKs	0.274145578321698	-1.29409600594463	246	24	0.0342857142857143	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,57498,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,KIDINS220,VCL,SPTAN1
R-HSA-1500620	Meiosis	0.275222728856273	-1.29017458601258	115	12	0.0171428571428571	700	8202	54386,675,10274,65057,1019,3014,7156,472,672,4438,4292,6117	TERF2IP,BRCA2,STAG1,ACD,CDK4,H2AFX,TOP3A,ATM,BRCA1,MSH4,MLH1,RPA1
R-HSA-2586552	Signaling by Leptin	0.281393402006839	-1.26800158160289	236	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-75153	Apoptotic execution  phase	0.281672179861109	-1.26701136701324	52	6	0.00857142857142857	700	8202	7431,5747,3836,329,4137,6709	VIM,PTK2,KPNA1,BIRC2,MAPT,SPTAN1
R-HSA-912446	Meiotic recombination	0.287394613213681	-1.2468990486803	84	9	0.0128571428571429	700	8202	675,1019,3014,7156,472,672,4292,4438,6117	BRCA2,CDK4,H2AFX,TOP3A,ATM,BRCA1,MLH1,MSH4,RPA1
R-HSA-5655332	Signaling by FGFR3 in disease	0.288458227708175	-1.24320499482341	22	3	0.00428571428571429	700	8202	2254,4893,2247	FGF9,NRAS,FGF2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.288458227708175	-1.24320499482341	22	3	0.00428571428571429	700	8202	5947,157506,4647	RBP1,RDH10,MYO7A
R-HSA-373753	Nephrin interactions	0.288458227708175	-1.24320499482341	22	3	0.00428571428571429	700	8202	84063,5291,6709	KIRREL2,PIK3CB,SPTAN1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.288458227708175	-1.24320499482341	22	3	0.00428571428571429	700	8202	4247,9334,6480	MGAT2,B4GALT5,ST6GAL1
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.289727462769524	-1.23881458142841	32	4	0.00571428571428571	700	8202	348995,23279,81929,9883	NUP43,NUP160,SEH1L,POM121
R-HSA-392518	Signal amplification	0.289727462769524	-1.23881458142841	32	4	0.00571428571428571	700	8202	54331,2787,2788,2770	GNG2,GNG5,GNG7,GNAI1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.289727462769524	-1.23881458142841	32	4	0.00571428571428571	700	8202	2254,673,2247,2260	FGF9,BRAF,FGF2,FGFR1
R-HSA-376176	Signaling by Robo receptor	0.289727462769524	-1.23881458142841	32	4	0.00571428571428571	700	8202	27,25,55740,51466	ABL2,ABL1,ENAH,EVL
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.289752522524283	-1.23872809093552	63	7	0.01	700	8202	2965,2967,5984,5983,51426,6117,27339	GTF2H1,GTF2H3,RFC4,RFC3,POLK,RPA1,PRPF19
R-HSA-948021	Transport to the Golgi and subsequent modification	0.290891870198169	-1.23480366093865	95	10	0.0142857142857143	700	8202	4247,83696,9871,149111,4905,9334,6480,122553,8775,4121	MGAT2,TRAPPC9,SEC24D,CNIH3,NSF,B4GALT5,ST6GAL1,TRAPPC6B,NAPA,MAN1A1
R-HSA-212436	Generic Transcription Pathway	0.296529011966077	-1.21561021721624	553	51	0.0728571428571429	700	8202	9534,51123,5565,4092,8649,163051,7587,54541,54807,93134,7586,4609,9862,374655,7551,10794,10498,55534,171392,10780,80205,7678,7748,340252,5468,2649,7003,147657,57677,4221,79970,10168,79027,7025,7638,4088,7562,2744,6498,7421,84449,2539,28996,51586,6834,80818,10670,80264,6907,9477,51385	ZNF254,ZNF706,PRKAB2,SMAD7,LAMTOR3,ZNF709,ZNF37A,DDIT4,ZNF586,ZNF561,ZKSCAN1,MYC,MED24,ZNF710,ZNF3,ZNF460,CARM1,MAML3,ZNF675,ZNF234,CHD9,ZNF124,ZNF195,ZNF680,PPARG,NR6A1,TEAD1,ZNF480,ZFP14,MEN1,ZNF767P,ZNF197,ZNF655,NR2F1,ZNF221,SMAD3,ZNF708,GLS,SKIL,VDR,ZNF333,G6PD,HIPK2,MED15,SURF1,ZNF436,RRAGA,ZNF430,TBL1X,MED20,ZNF589
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	5829	PXN
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	6616	SNAP25
R-HSA-71262	Carnitine synthesis	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	55217	TMLHE
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	7048	TGFBR2
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	7048	TGFBR2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	81539	SLC38A1
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	5366	PMAIP1
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	7048	TGFBR2
R-HSA-75072	mRNA Editing	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	104	ADARB1
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	8829	NRP1
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	2308	FOXO1
R-HSA-1855191	Synthesis of IPs in the nucleus	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	51447	IP6K2
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	328	APEX1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	6566	SLC16A1
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	27010	TPK1
R-HSA-165158	Activation of AKT2	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	57761	TRIB3
R-HSA-167060	NGF processing	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	5046	PCSK6
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.300158766810881	-1.20344372161195	4	1	0.00142857142857143	700	8202	81539	SLC38A1
R-HSA-167044	Signalling to RAS	0.302582658553783	-1.19540078742015	239	23	0.0328571428571429	700	8202	2254,200734,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-6782135	Dual incision in TC-NER	0.303664938850669	-1.19183036025059	64	7	0.01	700	8202	2965,2967,5984,5983,51426,6117,27339	GTF2H1,GTF2H3,RFC4,RFC3,POLK,RPA1,PRPF19
R-HSA-3214841	PKMTs methylate histone lysines	0.303664938850669	-1.19183036025059	64	7	0.01	700	8202	58508,10919,4297,55904,63976,64754,79813	KMT2C,EHMT2,KMT2A,KMT2E,PRDM16,SMYD3,EHMT1
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.30370540119134	-1.19169712246118	43	5	0.00714285714285714	700	8202	4088,6498,4221,4609,4092	SMAD3,SKIL,MEN1,MYC,SMAD7
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.30370540119134	-1.19169712246118	43	5	0.00714285714285714	700	8202	54331,5576,2787,2788,5567	GNG2,PRKAR2A,GNG5,GNG7,PRKACB
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.304138588245437	-1.19027179907241	107	11	0.0157142857142857	700	8202	57459,2967,10919,1107,25885,3014,2965,84172,9533,30834,64425	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,POLR1E
R-HSA-2172127	DAP12 interactions	0.304630540763736	-1.18865557840042	340	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	3992,51	FADS1,ACOX1
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	3992,51	FADS1,ACOX1
R-HSA-75205	Dissolution of Fibrin Clot	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	3273,6281	HRG,S100A10
R-HSA-174403	Glutathione synthesis and recycling	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	2678,2686	GGT1,GGT7
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	5520,7112	PPP2R2A,TMPO
R-HSA-2995410	Nuclear Envelope Reassembly	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	5520,7112	PPP2R2A,TMPO
R-HSA-5626467	RHO GTPases activate IQGAPs	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	4221,10788	MEN1,IQGAP2
R-HSA-4641265	Repression of WNT target genes	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	7090,6934	TLE3,TCF7L2
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	5747,8935	PTK2,SKAP2
R-HSA-190375	FGFR2c ligand binding and activation	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-175474	Assembly Of The HIV Virion	0.306057287619306	-1.18398298011002	13	2	0.00285714285714286	700	8202	137492,79720	VPS37A,VPS37B
R-HSA-416482	G alpha (12/13) signalling events	0.308265100123767	-1.17679515152348	75	8	0.0114285714285714	700	8202	54331,2788,7204,84033,23365,11214,2787,5364	GNG2,GNG7,TRIO,OBSCN,ARHGEF12,AKAP13,GNG5,PLXNB1
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.312240215963578	-1.16398246445111	54	6	0.00857142857142857	700	8202	22916,348995,51692,23279,9883,81929	NCBP2,NUP43,CPSF3,NUP160,POM121,SEH1L
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.312240215963578	-1.16398246445111	54	6	0.00857142857142857	700	8202	25977,162,8775,55330,10717,8907	NECAP1,AP1B1,NAPA,BLOC1S4,AP4B1,AP1M1
R-HSA-73980	RNA Polymerase III Transcription Termination	0.312603330426196	-1.16282020709695	23	3	0.00428571428571429	700	8202	9533,4774,10622	POLR1C,NFIA,POLR3G
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.312603330426196	-1.16282020709695	23	3	0.00428571428571429	700	8202	8881,7324,10393	CDC16,UBE2E1,ANAPC10
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.312603330426196	-1.16282020709695	23	3	0.00428571428571429	700	8202	22916,6827,6829	NCBP2,SUPT4H1,SUPT5H
R-HSA-428930	Thromboxane signalling through TP receptor	0.312603330426196	-1.16282020709695	23	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-71387	Metabolism of carbohydrates	0.31301538326403	-1.1615029418413	274	26	0.0371428571428571	700	8202	9942,50515,9334,57214,6513,8604,348995,23279,9883,5226,8372,221914,3038,51181,2539,1462,3099,3373,5106,960,5631,55454,81929,5567,6576,9653	XYLB,CHST11,B4GALT5,CEMIP,SLC2A1,SLC25A12,NUP43,NUP160,POM121,PGD,HYAL3,GPC2,HAS3,DCXR,G6PD,VCAN,HK2,HYAL1,PCK2,CD44,PRPS1,CSGALNACT2,SEH1L,PRKACB,SLC25A1,HS2ST1
R-HSA-5693607	Processing of DNA double-strand break ends	0.313537640500927	-1.15983586072273	97	10	0.0142857142857143	700	8202	8924,9156,5984,9577,5983,3014,7156,472,672,6117	HERC2,EXO1,RFC4,BRE,RFC3,H2AFX,TOP3A,ATM,BRCA1,RPA1
R-HSA-2559580	Oxidative Stress Induced Senescence	0.315766868925668	-1.15275109423587	119	12	0.0171428571428571	700	8202	1912,23135,23043,1019,3014,22955,648,1021,5606,6015,192669,27327	PHC2,KDM6B,TNIK,CDK4,H2AFX,SCMH1,BMI1,CDK6,MAP2K3,RING1,AGO3,TNRC6A
R-HSA-397014	Muscle contraction	0.317709286213592	-1.1466185086293	65	7	0.01	700	8202	7134,7431,7273,5829,7168,7414,7171	TNNC1,VIM,TTN,PXN,TPM1,VCL,TPM4
R-HSA-194315	Signaling by Rho GTPases	0.319982495995015	-1.13948898470004	399	37	0.0528571428571429	700	8202	23092,71,5048,3798,10096,7204,4983,348995,100288637,10144,23279,5881,23028,10788,1123,25,93663,752,8379,114793,81929,55114,51466,1742,84033,23365,11214,5747,9743,4221,401541,58480,3014,94134,101928168,79658,23081	ARHGAP26,ACTG1,PAFAH1B1,KIF5A,ACTR3,TRIO,OPHN1,NUP43,LOC100288637,FAM13A,NUP160,RAC3,KDM1A,IQGAP2,CHN1,ABL1,ARHGAP18,FMNL1,MAD1L1,FMNL2,SEH1L,ARHGAP17,EVL,DLG4,OBSCN,ARHGEF12,AKAP13,PTK2,ARHGAP32,MEN1,CENPP,RHOU,H2AFX,ARHGAP12,LOC101928168,ARHGAP10,KDM4C
R-HSA-1250342	PI3K events in ERBB4 signaling	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-5654720	PI-3K cascade:FGFR4	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-5654689	PI-3K cascade:FGFR1	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-5654695	PI-3K cascade:FGFR2	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-5654710	PI-3K cascade:FGFR3	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-1257604	PIP3 activates AKT signaling	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-1963642	PI3K events in ERBB2 signaling	0.325010111741205	-1.12389898408654	98	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-5696398	Nucleotide Excision Repair	0.325805374726367	-1.1214550859387	109	11	0.0157142857142857	700	8202	2967,5984,5983,51138,7508,51426,10038,6612,2965,6117,27339	GTF2H3,RFC4,RFC3,COPS4,XPC,POLK,PARP2,SUMO3,GTF2H1,RPA1,PRPF19
R-HSA-73864	RNA Polymerase I Transcription	0.325805374726367	-1.1214550859387	109	11	0.0157142857142857	700	8202	57459,2967,10919,1107,25885,3014,2965,84172,9533,30834,64425	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,POLR1E
R-HSA-69206	G1/S Transition	0.325805374726367	-1.1214550859387	109	11	0.0157142857142857	700	8202	4175,55388,5558,5422,4174,4609,5001,5682,4171,9491,6117	MCM6,MCM10,PRIM2,POLA1,MCM5,MYC,ORC5,PSMA1,MCM2,PSMF1,RPA1
R-HSA-1500931	Cell-Cell communication	0.326099380313908	-1.12055309648334	131	13	0.0185714285714286	700	8202	667,2318,1308,5829,8935,84063,25945,10979,5747,3691,5291,56288,6709	DST,FLNC,COL17A1,PXN,SKAP2,KIRREL2,PVRL3,FERMT2,PTK2,ITGB4,PIK3CB,PARD3,SPTAN1
R-HSA-72702	Ribosomal scanning and start codon recognition	0.327726850663158	-1.11557478991396	55	6	0.00857142857142857	700	8202	1965,8663,8669,8667,6235,1974	EIF2S1,EIF3C,EIF3J,EIF3H,RPS29,EIF4A2
R-HSA-177243	Interactions of Rev with host cellular proteins	0.329518040205319	-1.11012417629456	34	4	0.00571428571428571	700	8202	348995,23279,81929,9883	NUP43,NUP160,SEH1L,POM121
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.329518040205319	-1.11012417629456	34	4	0.00571428571428571	700	8202	9140,7187,3093,9636	ATG12,TRAF3,UBE2K,ISG15
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.329953973374129	-1.10880210887295	254	24	0.0342857142857143	700	8202	2254,200734,673,4893,2335,8831,4763,2247,5786,5908,8649,5682,1742,283455,5747,5291,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PIK3CB,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.334386712752443	-1.09545713315301	77	8	0.0114285714285714	700	8202	2967,5984,5983,51138,51426,2965,27339,6117	GTF2H3,RFC4,RFC3,COPS4,POLK,GTF2H1,PRPF19,RPA1
R-HSA-186797	Signaling by PDGF	0.335245813662396	-1.09289124410966	345	32	0.0457142857142857	700	8202	200734,673,2335,2308,4763,5786,8649,5578,9491,5906,6464,7414,5567,6709,6199,2254,4893,8831,2247,5908,283455,1742,5682,5747,5291,2260,3667,817,57761,5576,192669,27327	SPRED2,BRAF,FN1,FOXO1,NF1,PTPRA,LAMTOR3,PRKCA,PSMF1,RAP1A,SHC1,VCL,PRKACB,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,KSR2,DLG4,PSMA1,PTK2,PIK3CB,FGFR1,IRS1,CAMK2D,TRIB3,PRKAR2A,AGO3,TNRC6A
R-HSA-5610787	Hedgehog 'off' state	0.336567140546323	-1.08895762365942	99	10	0.0142857142857143	700	8202	55081,51684,57539,54903,5682,9742,79659,5576,9491,5567	IFT57,SUFU,WDR35,MKS1,PSMA1,IFT140,DYNC2H1,PRKAR2A,PSMF1,PRKACB
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.336794401318462	-1.08828261991584	24	3	0.00428571428571429	700	8202	7187,4793,3551	TRAF3,NFKBIB,IKBKB
R-HSA-5260271	Diseases of Immune System	0.336794401318462	-1.08828261991584	24	3	0.00428571428571429	700	8202	7187,4793,3551	TRAF3,NFKBIB,IKBKB
R-HSA-422475	Axon guidance	0.338294133141979	-1.0838395455215	516	47	0.0671428571428571	700	8202	1948,200734,26052,673,2335,71,4763,5786,10096,7204,8912,8649,55740,9723,9252,57556,9491,5364,25,27,5906,6464,783,5962,4233,7414,6709,2254,4893,51466,8831,3915,3786,2247,287,5908,5682,1742,283455,23365,5747,2260,3667,817,3673,23114,8829	EFNB2,SPRED2,DNM3,BRAF,FN1,ACTG1,NF1,PTPRA,ACTR3,TRIO,CACNA1H,LAMTOR3,ENAH,SEMA3E,RPS6KA5,SEMA6A,PSMF1,PLXNB1,ABL1,ABL2,RAP1A,SHC1,CACNB2,RDX,MET,VCL,SPTAN1,FGF9,NRAS,EVL,SYNGAP1,LAMC1,KCNQ3,FGF2,ANK2,RAP1B,PSMA1,DLG4,KSR2,ARHGEF12,PTK2,FGFR1,IRS1,CAMK2D,ITGA2,NFASC,NRP1
R-HSA-162594	Early Phase of HIV Life Cycle	0.33854842617205	-1.08308813579249	14	2	0.00285714285714286	700	8202	3836,7518	KPNA1,XRCC4
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.33854842617205	-1.08308813579249	14	2	0.00285714285714286	700	8202	22916,51692	NCBP2,CPSF3
R-HSA-190322	FGFR4 ligand binding and activation	0.33854842617205	-1.08308813579249	14	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.33854842617205	-1.08308813579249	14	2	0.00285714285714286	700	8202	5163,5166	PDK1,PDK4
R-HSA-418885	DCC mediated attractive signaling	0.33854842617205	-1.08308813579249	14	2	0.00285714285714286	700	8202	5747,7204	PTK2,TRIO
R-HSA-1474228	Degradation of the extracellular matrix	0.348185394346722	-1.05502019868886	89	9	0.0128571428571429	700	8202	1308,4316,3915,4323,8754,85007,960,4325,3911	COL17A1,MMP7,LAMC1,MMP14,ADAM9,PHYKPL,CD44,MMP16,LAMA5
R-HSA-432720	Lysosome Vesicle Biogenesis	0.349541810818426	-1.05113209408165	35	4	0.00571428571428571	700	8202	27243,162,10717,8907	CHMP2A,AP1B1,AP4B1,AP1M1
R-HSA-112043	PLC beta mediated events	0.355799936686198	-1.03338668169815	46	5	0.00714285714285714	700	8202	5578,23236,5576,5567,2770	PRKCA,PLCB1,PRKAR2A,PRKACB,GNAI1
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.355799936686198	-1.03338668169815	46	5	0.00714285714285714	700	8202	2254,5578,2247,5576,5567	FGF9,PRKCA,FGF2,PRKAR2A,PRKACB
R-HSA-198203	PI3K/AKT activation	0.359889337181067	-1.0219586915073	101	10	0.0142857142857143	700	8202	3667,57761,2254,2308,2247,5291,192669,2260,27327,6199	IRS1,TRIB3,FGF9,FOXO1,FGF2,PIK3CB,AGO3,FGFR1,TNRC6A,RPS6KB2
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	7035	TFPI
R-HSA-75157	FasL/ CD95L signaling	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	843	CASP10
R-HSA-3000471	Scavenging by Class B Receptors	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	949	SCARB1
R-HSA-74713	IRS activation	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	3667	IRS1
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	5567	PRKACB
R-HSA-114516	Disinhibition of SNARE formation	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	5578	PRKCA
R-HSA-71032	Propionyl-CoA catabolism	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	5095	PCCA
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	317	APAF1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	4121	MAN1A1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	317	APAF1
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	5565	PRKAB2
R-HSA-391906	Leukotriene receptors	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	1241	LTB4R
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	115677	NOSTRIN
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	440193	CCDC88C
R-HSA-1169092	Activation of RAS in B cells	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	4893	NRAS
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.359915886013684	-1.02188492479437	5	1	0.00142857142857143	700	8202	6612	SUMO3
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.360935453993996	-1.01905613443605	25	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-1296059	G protein gated Potassium channels	0.360935453993996	-1.01905613443605	25	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-210991	Basigin interactions	0.360935453993996	-1.01905613443605	25	3	0.00428571428571429	700	8202	6566,6520,23657	SLC16A1,SLC3A2,SLC7A11
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.360935453993996	-1.01905613443605	25	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-1296041	Activation of G protein gated Potassium channels	0.360935453993996	-1.01905613443605	25	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-2871796	FCERI mediated MAPK activation	0.368828254845783	-0.997424177311914	248	23	0.0328571428571429	700	8202	2254,200734,673,4893,2335,8831,4763,2247,5786,5908,8649,5682,1742,283455,5747,9491,2260,3667,817,5906,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,VCL,SPTAN1
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.369576384626835	-0.995397835663856	36	4	0.00571428571428571	700	8202	25,5747,71,10096	ABL1,PTK2,ACTG1,ACTR3
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.370556062007911	-0.992750531231577	15	2	0.00285714285714286	700	8202	4893,6464	NRAS,SHC1
R-HSA-975577	N-Glycan antennae elongation	0.370556062007911	-0.992750531231577	15	2	0.00285714285714286	700	8202	9334,6480	B4GALT5,ST6GAL1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.370556062007911	-0.992750531231577	15	2	0.00285714285714286	700	8202	4893,6464	NRAS,SHC1
R-HSA-112040	G-protein mediated events	0.373281159631774	-0.985423364113504	47	5	0.00714285714285714	700	8202	5578,23236,5576,5567,2770	PRKCA,PLCB1,PRKAR2A,PRKACB,GNAI1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.386812926312889	-0.949814097365501	137	13	0.0185714285714286	700	8202	10019,25,3048,2627,3798,5890,11311,56992,5576,57572,5567,23028,4602	SH2B3,ABL1,HBG2,GATA6,KIF5A,RAD51B,VPS45,KIF15,PRKAR2A,DOCK6,PRKACB,KDM1A,MYB
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.387491572902554	-0.948061177773461	81	8	0.0114285714285714	700	8202	10010,3551,9140,7187,4793,3093,843,9636	TANK,IKBKB,ATG12,TRAF3,NFKBIB,UBE2K,CASP10,ISG15
R-HSA-438064	Post NMDA receptor activation events	0.389569473456454	-0.942713063834754	37	4	0.00571428571428571	700	8202	1742,817,673,5567	DLG4,CAMK2D,BRAF,PRKACB
R-HSA-156590	Glutathione conjugation	0.389569473456454	-0.942713063834754	37	4	0.00571428571428571	700	8202	2678,2941,2686,4257	GGT1,GSTA4,GGT7,MGST1
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.390760139256344	-0.939661361824382	48	5	0.00714285714285714	700	8202	1965,8663,8669,8667,6235	EIF2S1,EIF3C,EIF3J,EIF3H,RPS29
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.390760139256344	-0.939661361824382	48	5	0.00714285714285714	700	8202	54331,6464,5291,2787,2788	GNG2,SHC1,PIK3CB,GNG5,GNG7
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.390760139256344	-0.939661361824382	48	5	0.00714285714285714	700	8202	2254,5578,2247,5576,5567	FGF9,PRKCA,FGF2,PRKAR2A,PRKACB
R-HSA-913531	Interferon Signaling	0.390760798625052	-0.939659674425679	194	18	0.0257142857142857	700	8202	3460,1974,348995,51447,23279,9636,4734,9883,2317,7324,5771,817,3836,8651,10581,960,4281,81929	IFNGR2,EIF4A2,NUP43,IP6K2,NUP160,ISG15,NEDD4,POM121,FLNB,UBE2E1,PTPN2,CAMK2D,KPNA1,SOCS1,IFITM2,CD44,MID1,SEH1L
R-HSA-194138	Signaling by VEGF	0.394665265052796	-0.929717303599099	320	29	0.0414285714285714	700	8202	2254,200734,5829,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,5578,9491,5291,2260,3667,57761,817,5906,6464,8829,7414,5567,6709	FGF9,SPRED2,PXN,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PRKCA,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,NRP1,VCL,PRKACB,SPTAN1
R-HSA-427413	NoRC negatively regulates rRNA expression	0.395223580859848	-0.928303646720866	104	10	0.0142857142857143	700	8202	2967,25885,3014,2965,84172,9533,30834,29115,64425,8819	GTF2H3,POLR1A,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,SAP30BP,POLR1E,SAP30
R-HSA-1852241	Organelle biogenesis and maintenance	0.401445036458648	-0.912684650461638	321	29	0.0414285714285714	700	8202	80205,55081,51134,7846,5048,56652,5565,133522,124995,54903,92399,55173,79969,4209,11232,64979,1778,57539,50807,80184,10806,200894,60412,23107,9742,6907,79659,10498,4208	CHD9,IFT57,CEP83,TUBA1A,PAFAH1B1,C10orf2,PRKAB2,PPARGC1B,MRPL10,MKS1,MRRF,MRPS10,ATAT1,MEF2D,POLG2,MRPL36,DYNC1H1,WDR35,ASAP1,CEP290,SDCCAG8,ARL13B,EXOC4,MRPS27,IFT140,TBL1X,DYNC2H1,CARM1,MEF2C
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.401926158955343	-0.911486891425811	16	2	0.00285714285714286	700	8202	8091,57634	HMGA2,EP400
R-HSA-163615	PKA activation	0.401926158955343	-0.911486891425811	16	2	0.00285714285714286	700	8202	5576,5567	PRKAR2A,PRKACB
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.401926158955343	-0.911486891425811	16	2	0.00285714285714286	700	8202	7048,56288	TGFBR2,PARD3
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.401926158955343	-0.911486891425811	16	2	0.00285714285714286	700	8202	5578,4905	PRKCA,NSF
R-HSA-1369062	ABC transporters in lipid homeostasis	0.401926158955343	-0.911486891425811	16	2	0.00285714285714286	700	8202	21,10347	ABCA3,ABCA7
R-HSA-425407	SLC-mediated transmembrane transport	0.403433553468895	-0.907743480250476	264	24	0.0342857142857143	700	8202	10723,30061,6520,6528,81539,6513,348995,23279,6553,9883,148867,23516,6541,7781,23657,92745,7922,54407,3099,6566,9497,861,81929,8501	SLC12A7,SLC40A1,SLC3A2,SLC5A5,SLC38A1,SLC2A1,NUP43,NUP160,SLC9A5,POM121,SLC30A7,SLC39A14,SLC7A1,SLC30A3,SLC7A11,SLC38A5,SLC39A7,SLC38A2,HK2,SLC16A1,SLC4A7,RUNX1,SEH1L,SLC43A1
R-HSA-73886	Chromosome Maintenance	0.40705076787289	-0.898817364530101	105	10	0.0142857142857143	700	8202	54386,5984,5983,328,5558,65057,5422,3014,401541,6117	TERF2IP,RFC4,RFC3,APEX1,PRIM2,ACD,POLA1,H2AFX,CENPP,RPA1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.408726089712632	-0.894710054597524	27	3	0.00428571428571429	700	8202	5202,84617,7846	PFDN2,TUBB6,TUBA1A
R-HSA-182971	EGFR downregulation	0.408726089712632	-0.894710054597524	27	3	0.00428571428571429	700	8202	8027,58513,5796	STAM,EPS15L1,PTPRK
R-HSA-5655253	Signaling by FGFR2 in disease	0.408726089712632	-0.894710054597524	27	3	0.00428571428571429	700	8202	2254,4893,2247	FGF9,NRAS,FGF2
R-HSA-400685	Sema4D in semaphorin signaling	0.408726089712632	-0.894710054597524	27	3	0.00428571428571429	700	8202	23365,4233,5364	ARHGEF12,MET,PLXNB1
R-HSA-437239	Recycling pathway of L1	0.408726089712632	-0.894710054597524	27	3	0.00428571428571429	700	8202	5962,26052,9252	RDX,DNM3,RPS6KA5
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	11343	MGLL
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	55253	TYW1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	51	ACOX1
R-HSA-1482798	Acyl chain remodeling of CL	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	253558	LCLAT1
R-HSA-1566977	Fibronectin matrix formation	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	2335	FN1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	4247	MGAT2
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	472	ATM
R-HSA-947581	Molybdenum cofactor biosynthesis	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	10243	GPHN
R-HSA-77111	Synthesis of Ketone Bodies	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	56898	BDH2
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	6612	SUMO3
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	5001	ORC5
R-HSA-3065679	SUMO is proteolytically processed	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	6612	SUMO3
R-HSA-211916	Vitamins	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	1591	CYP24A1
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	673	BRAF
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	22943	DKK1
R-HSA-189483	Heme degradation	0.414577210858159	-0.880496047065804	6	1	0.00142857142857143	700	8202	3163	HMOX2
R-HSA-69300	Removal of licensing factors from origins	0.417947535960854	-0.872399366390052	72	7	0.01	700	8202	5682,4175,55388,4171,4174,9491,5001	PSMA1,MCM6,MCM10,MCM2,MCM5,PSMF1,ORC5
R-HSA-1980143	Signaling by NOTCH1	0.417947535960854	-0.872399366390052	72	7	0.01	700	8202	55869,6907,182,3091,7090,4609,55534	HDAC8,TBL1X,JAG1,HIF1A,TLE3,MYC,MAML3
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.418511137942511	-0.871051775446152	312	28	0.04	700	8202	2254,200734,5829,673,4893,8831,2335,2247,4763,5786,5908,8649,5682,1742,283455,5747,5578,9491,5291,2260,3667,57761,817,5906,6464,7414,5567,6709	FGF9,SPRED2,PXN,BRAF,NRAS,SYNGAP1,FN1,FGF2,NF1,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PRKCA,PSMF1,PIK3CB,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,VCL,PRKACB,SPTAN1
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.425577001353534	-0.854309380587905	50	5	0.00714285714285714	700	8202	22916,348995,23279,9883,81929	NCBP2,NUP43,NUP160,POM121,SEH1L
R-HSA-112310	Neurotransmitter Release Cycle	0.425577001353534	-0.854309380587905	50	5	0.00714285714285714	700	8202	2744,6616,6857,10550,54407	GLS,SNAP25,SYT1,ARL6IP5,SLC38A2
R-HSA-977444	GABA B receptor activation	0.429238355624807	-0.845742906829795	39	4	0.00571428571428571	700	8202	54331,2787,2788,2770	GNG2,GNG5,GNG7,GNAI1
R-HSA-991365	Activation of GABAB receptors	0.429238355624807	-0.845742906829795	39	4	0.00571428571428571	700	8202	54331,2787,2788,2770	GNG2,GNG5,GNG7,GNAI1
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.430713855234873	-0.842311318331354	107	10	0.0142857142857143	700	8202	2967,25885,3014,2965,84172,9533,30834,29115,64425,8819	GTF2H3,POLR1A,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,SAP30BP,POLR1E,SAP30
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.432225782683729	-0.838807182168183	28	3	0.00428571428571429	700	8202	55690,162,8907	PACS1,AP1B1,AP1M1
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.432225782683729	-0.838807182168183	28	3	0.00428571428571429	700	8202	5202,84617,7846	PFDN2,TUBB6,TUBA1A
R-HSA-111933	Calmodulin induced events	0.432225782683729	-0.838807182168183	28	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-111997	CaM pathway	0.432225782683729	-0.838807182168183	28	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.432225782683729	-0.838807182168183	28	3	0.00428571428571429	700	8202	5565,10670,8649	PRKAB2,RRAGA,LAMTOR3
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.432301607854753	-0.838631768012314	73	7	0.01	700	8202	2744,5565,2539,10670,54541,6834,8649	GLS,PRKAB2,G6PD,RRAGA,DDIT4,SURF1,LAMTOR3
R-HSA-3700989	Transcriptional Regulation by TP53	0.432301607854753	-0.838631768012314	73	7	0.01	700	8202	2744,5565,2539,10670,54541,6834,8649	GLS,PRKAB2,G6PD,RRAGA,DDIT4,SURF1,LAMTOR3
R-HSA-2033519	Activated point mutants of FGFR2	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	5576,5567	PRKAR2A,PRKACB
R-HSA-1839126	FGFR2 mutant receptor activation	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	1742,817	DLG4,CAMK2D
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	1742,817	DLG4,CAMK2D
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	677,23404	ZFP36L1,EXOSC2
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	23404,5073	EXOSC2,PARN
R-HSA-1482925	Acyl chain remodelling of PG	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	81579,79888	PLA2G12A,LPCAT1
R-HSA-164378	PKA activation in glucagon signalling	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	5576,5567	PRKAR2A,PRKACB
R-HSA-1482801	Acyl chain remodelling of PS	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	81579,10162	PLA2G12A,LPCAT3
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.432534421649028	-0.838093368149321	17	2	0.00285714285714286	700	8202	6616,6857	SNAP25,SYT1
R-HSA-5663202	Diseases of signal transduction	0.433428390868387	-0.836028684714852	268	24	0.0342857142857143	700	8202	2254,4893,2308,2247,1523,5682,55869,54894,7048,5291,9491,6934,2260,22943,3667,4088,182,6464,4609,6907,7750,5947,6199,55534	FGF9,NRAS,FOXO1,FGF2,CUX1,PSMA1,HDAC8,RNF43,TGFBR2,PIK3CB,PSMF1,TCF7L2,FGFR1,DKK1,IRS1,SMAD3,JAG1,SHC1,MYC,TBL1X,ZMYM2,RBP1,RPS6KB2,MAML3
R-HSA-445717	Aquaporin-mediated transport	0.442851887134447	-0.814519905395561	51	5	0.00714285714285714	700	8202	54331,5576,2787,2788,5567	GNG2,PRKAR2A,GNG5,GNG7,PRKACB
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.442851887134447	-0.814519905395561	51	5	0.00714285714285714	700	8202	2254,5578,2247,5576,5567	FGF9,PRKCA,FGF2,PRKAR2A,PRKACB
R-HSA-392499	Metabolism of proteins	0.444613086443975	-0.810550843688244	943	82	0.117142857142857	700	8202	93183,21,8663,5589,3798,6235,4240,5283,84617,348995,79642,23279,6015,148867,58477,1912,440,6464,149111,89978,2107,374378,2395,81929,7709,468,7846,8669,3309,6612,672,8869,8667,10469,2627,197370,286053,3014,1803,55568,8891,7518,648,8924,9871,7508,6480,9334,3800,8604,54344,6748,5073,9883,4121,54872,23203,26986,23404,83696,10274,57188,1974,617,22955,122553,9669,9709,6934,4758,6117,4247,29880,6158,4905,6730,60412,1965,5202,8775,6727,1649	PIGM,ABCA3,EIF3C,PRKCSH,KIF5A,RPS29,MFGE8,PIGH,TUBB6,NUP43,ARSJ,NUP160,RING1,SLC30A7,SRPRB,PHC2,ASNS,SHC1,CNIH3,DPH6,ETF1,GALNT18,FXN,SEH1L,ZBTB17,ATF4,TUBA1A,EIF3J,HSPA5,SUMO3,BRCA1,ST3GAL5,EIF3H,TIMM44,GATA6,NSMCE1,NSMCE2,H2AFX,DPP4,GALNT10,EIF2B3,XRCC4,BMI1,HERC2,SEC24D,XPC,ST6GAL1,B4GALT5,KIF5C,SLC25A12,DPM3,SSR4,PARN,POM121,MAN1A1,PIGG,PMPCA,PABPC1,EXOSC2,TRAPPC9,STAG1,ADAMTSL3,EIF4A2,BCS1L,SCMH1,TRAPPC6B,EIF5B,HERPUD1,TCF7L2,NEU1,RPA1,MGAT2,ALG5,RPL28,NSF,SRP68,EXOC4,EIF2S1,PFDN2,NAPA,SRP14,DDIT3
R-HSA-109703	PKB-mediated events	0.448826094203369	-0.801119784299471	40	4	0.00571428571428571	700	8202	5140,5565,10670,8649	PDE3B,PRKAB2,RRAGA,LAMTOR3
R-HSA-446728	Cell junction organization	0.45416518243194	-0.789294309157953	86	8	0.0114285714285714	700	8202	667,2318,1308,5829,25945,10979,3691,56288	DST,FLNC,COL17A1,PXN,PVRL3,FERMT2,ITGB4,PARD3
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.455375176264134	-0.7866336365788	29	3	0.00428571428571429	700	8202	192669,27327,55534	AGO3,TNRC6A,MAML3
R-HSA-5339562	Uptake and actions of bacterial toxins	0.455375176264134	-0.7866336365788	29	3	0.00428571428571429	700	8202	6616,6857,5606	SNAP25,SYT1,MAP2K3
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.455375176264134	-0.7866336365788	29	3	0.00428571428571429	700	8202	2254,673,2247	FGF9,BRAF,FGF2
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.455375176264134	-0.7866336365788	29	3	0.00428571428571429	700	8202	847,9588,475	CAT,PRDX6,ATOX1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.455375176264134	-0.7866336365788	29	3	0.00428571428571429	700	8202	1742,817,673	DLG4,CAMK2D,BRAF
R-HSA-1268020	Mitochondrial protein import	0.459998664499894	-0.776531692764311	52	5	0.00714285714285714	700	8202	8604,2395,10469,23203,617	SLC25A12,FXN,TIMM44,PMPCA,BCS1L
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.459998664499894	-0.776531692764311	52	5	0.00714285714285714	700	8202	54344,29880,8869,6480,4758	DPM3,ALG5,ST3GAL5,ST6GAL1,NEU1
R-HSA-3214858	RMTs methylate histone arginines	0.460849010356644	-0.774684815975292	75	7	0.01	700	8202	6599,57492,317772,1019,10498,6598,3014	SMARCC1,ARID1B,HIST2H2AB,CDK4,CARM1,SMARCB1,H2AFX
R-HSA-69304	Regulation of DNA replication	0.460849010356644	-0.774684815975292	75	7	0.01	700	8202	5682,4175,55388,4171,4174,9491,5001	PSMA1,MCM6,MCM10,MCM2,MCM5,PSMF1,ORC5
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.462282352814748	-0.771579421299832	18	2	0.00285714285714286	700	8202	7750,1523	ZMYM2,CUX1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.462282352814748	-0.771579421299832	18	2	0.00285714285714286	700	8202	7187,10010	TRAF3,TANK
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.462282352814748	-0.771579421299832	18	2	0.00285714285714286	700	8202	6616,6857	SNAP25,SYT1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.462282352814748	-0.771579421299832	18	2	0.00285714285714286	700	8202	6616,6857	SNAP25,SYT1
R-HSA-73780	RNA Polymerase III Chain Elongation	0.462282352814748	-0.771579421299832	18	2	0.00285714285714286	700	8202	9533,10622	POLR1C,POLR3G
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	5567	PRKACB
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	5095	PCCA
R-HSA-447043	Neurofascin interactions	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	23114	NFASC
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	7112	TMPO
R-HSA-199920	CREB phosphorylation	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	9252	RPS6KA5
R-HSA-447038	NrCAM interactions	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	1742	DLG4
R-HSA-111471	Apoptotic factor-mediated response	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	317	APAF1
R-HSA-75158	TRAIL  signaling	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	843	CASP10
R-HSA-196791	Vitamin D (calciferol) metabolism	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	1591	CYP24A1
R-HSA-3595177	Defective CHSY1 causes TPBS	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	1462	VCAN
R-HSA-426117	Cation-coupled Chloride cotransporters	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	10723	SLC12A7
R-HSA-190371	FGFR3b ligand binding and activation	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	2254	FGF9
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	1462	VCAN
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	5095	PCCA
R-HSA-74182	Ketone body metabolism	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	56898	BDH2
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	25945	PVRL3
R-HSA-5603029	IkBA variant leads to EDA-ID	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	1462	VCAN
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	10783	NEK6
R-HSA-164843	2-LTR circle formation	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	7518	XRCC4
R-HSA-2142789	Ubiquinol biosynthesis	0.464576717010265	-0.76662857395611	7	1	0.00142857142857143	700	8202	57107	PDSS2
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.465459296206501	-0.764730627105388	342	30	0.0428571428571429	700	8202	2254,200734,673,4893,2335,8831,2308,4763,2247,5786,5908,8649,5682,1742,283455,5747,5291,9491,2260,3667,57761,817,5906,6464,3551,7414,192669,27327,6709,6199	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FOXO1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,PIK3CB,PSMF1,FGFR1,IRS1,TRIB3,CAMK2D,RAP1A,SHC1,IKBKB,VCL,AGO3,TNRC6A,SPTAN1,RPS6KB2
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.467181500235859	-0.76103744535001	168	15	0.0214285714285714	700	8202	3667,57761,2254,4893,2308,2247,3551,5682,4793,5291,9491,2260,192669,27327,6199	IRS1,TRIB3,FGF9,NRAS,FOXO1,FGF2,IKBKB,PSMA1,NFKBIB,PIK3CB,PSMF1,FGFR1,AGO3,TNRC6A,RPS6KB2
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.467388814761036	-0.760593787927447	87	8	0.0114285714285714	700	8202	23404,5682,677,5578,5073,26986,9491,3304	EXOSC2,PSMA1,ZFP36L1,PRKCA,PARN,PABPC1,PSMF1,HSPA1B
R-HSA-168325	Viral Messenger RNA Synthesis	0.468196287817371	-0.758867652582622	41	4	0.00571428571428571	700	8202	348995,23279,81929,9883	NUP43,NUP160,SEH1L,POM121
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.468196287817371	-0.758867652582622	41	4	0.00571428571428571	700	8202	1742,817,673,5567	DLG4,CAMK2D,BRAF,PRKACB
R-HSA-5620924	Intraflagellar transport	0.468196287817371	-0.758867652582622	41	4	0.00571428571428571	700	8202	9742,79659,55081,57539	IFT140,DYNC2H1,IFT57,WDR35
R-HSA-111996	Ca-dependent events	0.478118903913556	-0.737895824467338	30	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.478118903913556	-0.737895824467338	30	3	0.00428571428571429	700	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-420092	Glucagon-type ligand receptors	0.478118903913556	-0.737895824467338	30	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.478118903913556	-0.737895824467338	30	3	0.00428571428571429	700	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-5687128	MAPK6/MAPK4 signaling	0.480543212447793	-0.732838122361981	88	8	0.0114285714285714	700	8202	10435,2308,4609,5682,9491,5567,192669,27327	CDC42EP2,FOXO1,MYC,PSMA1,PSMF1,PRKACB,AGO3,TNRC6A
R-HSA-73777	RNA Polymerase I Chain Elongation	0.480543212447793	-0.732838122361981	88	8	0.0114285714285714	700	8202	2967,25885,3014,2965,84172,9533,30834,64425	GTF2H3,POLR1A,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,POLR1E
R-HSA-1630316	Glycosaminoglycan metabolism	0.482072282470175	-0.72966121254389	123	11	0.0157142857142857	700	8202	50515,8372,221914,3038,9334,57214,1462,3373,960,55454,9653	CHST11,HYAL3,GPC2,HAS3,B4GALT5,CEMIP,VCAN,HYAL1,CD44,CSGALNACT2,HS2ST1
R-HSA-5358351	Signaling by Hedgehog	0.485924377609965	-0.721702268814419	135	12	0.0171428571428571	700	8202	55081,51684,57539,54903,5682,9742,79659,79577,5576,9491,5567,8405	IFT57,SUFU,WDR35,MKS1,PSMA1,IFT140,DYNC2H1,CDC73,PRKAR2A,PSMF1,PRKACB,SPOP
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.487313328142215	-0.718847978506882	42	4	0.00571428571428571	700	8202	4221,6659,7090,6934	MEN1,SOX4,TLE3,TCF7L2
R-HSA-3928662	EPHB-mediated forward signaling	0.487313328142215	-0.718847978506882	42	4	0.00571428571428571	700	8202	1948,5747,71,10096	EFNB2,PTK2,ACTG1,ACTR3
R-HSA-72737	Cap-dependent Translation Initiation	0.489444152829356	-0.714484913756607	112	10	0.0142857142857143	700	8202	8663,6158,8669,6235,1974,1965,8891,9669,26986,8667	EIF3C,RPL28,EIF3J,RPS29,EIF4A2,EIF2S1,EIF2B3,EIF5B,PABPC1,EIF3H
R-HSA-72613	Eukaryotic Translation Initiation	0.489444152829356	-0.714484913756607	112	10	0.0142857142857143	700	8202	8663,6158,8669,6235,1974,1965,8891,9669,26986,8667	EIF3C,RPL28,EIF3J,RPS29,EIF4A2,EIF2S1,EIF2B3,EIF5B,PABPC1,EIF3H
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	4893,6464	NRAS,SHC1
R-HSA-416700	Other semaphorin interactions	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	9723,57556	SEMA3E,SEMA6A
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	221914,1462	GPC2,VCAN
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	84617,7846	TUBB6,TUBA1A
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	221914,1462	GPC2,VCAN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	221914,1462	GPC2,VCAN
R-HSA-1181150	Signaling by NODAL	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	4088,5046	SMAD3,PCSK6
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	1742,817	DLG4,CAMK2D
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	6616,6857	SNAP25,SYT1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	4893,6464	NRAS,SHC1
R-HSA-1643713	Signaling by EGFR in Cancer	0.491093765532946	-0.711120200920907	19	2	0.00285714285714286	700	8202	4893,6464	NRAS,SHC1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.49885248208897	-0.695444854013128	66	6	0.00857142857142857	700	8202	83696,122553,9871,149111,4905,8775	TRAPPC9,TRAPPC6B,SEC24D,CNIH3,NSF,NAPA
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.500408782791276	-0.692329949002089	31	3	0.00428571428571429	700	8202	2254,673,2247	FGF9,BRAF,FGF2
R-HSA-167287	HIV elongation arrest and recovery	0.500408782791276	-0.692329949002089	31	3	0.00428571428571429	700	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-1296065	Inwardly rectifying K+ channels	0.500408782791276	-0.692329949002089	31	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-167290	Pausing and recovery of HIV elongation	0.500408782791276	-0.692329949002089	31	3	0.00428571428571429	700	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.500408782791276	-0.692329949002089	31	3	0.00428571428571429	700	8202	4316,4325,4323	MMP7,MMP16,MMP14
R-HSA-68882	Mitotic Anaphase	0.50503248224762	-0.683132530492886	172	15	0.0214285714285714	700	8202	8881,10274,5048,10393,8379,5682,5520,55869,348995,23279,9491,7324,81929,7112,401541	CDC16,STAG1,PAFAH1B1,ANAPC10,MAD1L1,PSMA1,PPP2R2A,HDAC8,NUP43,NUP160,PSMF1,UBE2E1,SEH1L,TMPO,CENPP
R-HSA-917937	Iron uptake and transport	0.506144910399637	-0.680932266505789	43	4	0.00571428571428571	700	8202	535,30061,3163,28982	ATP6V0A1,SLC40A1,HMOX2,FLVCR1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	54894	RNF43
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	6513	SLC2A1
R-HSA-1253288	Downregulation of ERBB4 signaling	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	4734	NEDD4
R-HSA-428643	Organic anion transporters	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	6528	SLC5A5
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	5366	PMAIP1
R-HSA-1483115	Hydrolysis of LPC	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	56261	GPCPD1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	23236	PLCB1
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	5578	PRKCA
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	23236	PLCB1
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	57761	TRIB3
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	89978	DPH6
R-HSA-2046105	Linoleic acid (LA) metabolism	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	3992	FADS1
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	5829	PXN
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.510311469674081	-0.672734014829153	8	1	0.00142857142857143	700	8202	57142	RTN4
R-HSA-1640170	Cell Cycle	0.512266898348186	-0.66890950392859	572	49	0.07	700	8202	8924,4175,114799,55388,5048,5520,348995,4292,5578,23279,9491,9883,54386,9577,10783,65057,80184,4174,4609,9663,10393,8379,4438,1021,81929,7112,5984,5983,7846,328,5558,10274,5422,1019,7156,5682,55869,672,4171,7324,6117,401541,1778,8881,675,10806,5001,3014,472	HERC2,MCM6,ESCO1,MCM10,PAFAH1B1,PPP2R2A,NUP43,MLH1,PRKCA,NUP160,PSMF1,POM121,TERF2IP,BRE,NEK6,ACD,CEP290,MCM5,MYC,LPIN2,ANAPC10,MAD1L1,MSH4,CDK6,SEH1L,TMPO,RFC4,RFC3,TUBA1A,APEX1,PRIM2,STAG1,POLA1,CDK4,TOP3A,PSMA1,HDAC8,BRCA1,MCM2,UBE2E1,RPA1,CENPP,DYNC1H1,CDC16,BRCA2,SDCCAG8,ORC5,H2AFX,ATM
R-HSA-5663220	RHO GTPases Activate Formins	0.512563772954697	-0.668330140677415	114	10	0.0142857142857143	700	8202	51466,71,5048,752,8379,348995,23279,114793,81929,401541	EVL,ACTG1,PAFAH1B1,FMNL1,MAD1L1,NUP43,NUP160,FMNL2,SEH1L,CENPP
R-HSA-373755	Semaphorin interactions	0.513876508241776	-0.665772298732106	67	6	0.00857142857142857	700	8202	23365,9723,8829,4233,57556,5364	ARHGEF12,SEMA3E,NRP1,MET,SEMA6A,PLXNB1
R-HSA-5658442	Regulation of RAS by GAPs	0.513876508241776	-0.665772298732106	67	6	0.00857142857142857	700	8202	5682,200734,4893,8831,4763,9491	PSMA1,SPRED2,NRAS,SYNGAP1,NF1,PSMF1
R-HSA-68867	Assembly of the pre-replicative complex	0.513876508241776	-0.665772298732106	67	6	0.00857142857142857	700	8202	5682,4175,4171,4174,9491,5001	PSMA1,MCM6,MCM2,MCM5,PSMF1,ORC5
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.514407286977581	-0.664739940183984	173	15	0.0214285714285714	700	8202	8881,10274,5048,10393,8379,5682,5520,55869,348995,23279,9491,7324,81929,7112,401541	CDC16,STAG1,PAFAH1B1,ANAPC10,MAD1L1,PSMA1,PPP2R2A,HDAC8,NUP43,NUP160,PSMF1,UBE2E1,SEH1L,TMPO,CENPP
R-HSA-1483191	Synthesis of PC	0.518911701502051	-0.656021542270969	20	2	0.00285714285714286	700	8202	171586,9663	ABHD3,LPIN2
R-HSA-190241	FGFR2 ligand binding and activation	0.518911701502051	-0.656021542270969	20	2	0.00285714285714286	700	8202	2254,2247	FGF9,FGF2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.518911701502051	-0.656021542270969	20	2	0.00285714285714286	700	8202	11343,5567	MGLL,PRKACB
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.518911701502051	-0.656021542270969	20	2	0.00285714285714286	700	8202	1803,6934	DPP4,TCF7L2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.522203402104431	-0.649698107793041	32	3	0.00428571428571429	700	8202	54331,2787,2788	GNG2,GNG5,GNG7
R-HSA-1280215	Cytokine Signaling in Immune system	0.524230531132798	-0.645823746498563	539	46	0.0657142857142857	700	8202	200734,673,2335,4763,5786,8649,348995,51447,23279,329,9491,4734,9883,2317,5771,5906,6464,8651,3551,9020,960,7414,81929,6709,2254,4893,8831,3460,2247,1974,5908,5682,1742,283455,5747,3570,5291,9636,7324,2260,3667,817,3836,7187,10581,4281	SPRED2,BRAF,FN1,NF1,PTPRA,LAMTOR3,NUP43,IP6K2,NUP160,BIRC2,PSMF1,NEDD4,POM121,FLNB,PTPN2,RAP1A,SHC1,SOCS1,IKBKB,MAP3K14,CD44,VCL,SEH1L,SPTAN1,FGF9,NRAS,SYNGAP1,IFNGR2,FGF2,EIF4A2,RAP1B,PSMA1,DLG4,KSR2,PTK2,IL6R,PIK3CB,ISG15,UBE2E1,FGFR1,IRS1,CAMK2D,KPNA1,TRAF3,IFITM2,MID1
R-HSA-5362517	Signaling by Retinoic Acid	0.524661959755389	-0.645001109954457	44	4	0.00571428571428571	700	8202	5163,1374,5166,157506	PDK1,CPT1A,PDK4,RDH10
R-HSA-418555	G alpha (s) signalling events	0.526026887998622	-0.642402949682798	127	11	0.0157142857142857	700	8202	3363,54331,5141,10846,2788,5142,5138,5140,2787,5139,2770	HTR7,GNG2,PDE4A,PDE10A,GNG7,PDE4B,PDE2A,PDE3B,GNG5,PDE3A,GNAI1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.52872708055943	-0.637282896020841	68	6	0.00857142857142857	700	8202	8924,472,672,9577,7518,3014	HERC2,ATM,BRCA1,BRE,XRCC4,H2AFX
R-HSA-199977	ER to Golgi Anterograde Transport	0.52872708055943	-0.637282896020841	68	6	0.00857142857142857	700	8202	83696,122553,9871,149111,4905,8775	TRAPPC9,TRAPPC6B,SEC24D,CNIH3,NSF,NAPA
R-HSA-112315	Transmission across Chemical Synapses	0.529038372497291	-0.636694311952515	210	18	0.0257142857142857	700	8202	673,81539,2788,1742,6616,5578,6857,23236,2770,54331,2744,817,4905,783,10550,54407,2787,5567	BRAF,SLC38A1,GNG7,DLG4,SNAP25,PRKCA,SYT1,PLCB1,GNAI1,GNG2,GLS,CAMK2D,NSF,CACNB2,ARL6IP5,SLC38A2,GNG5,PRKACB
R-HSA-168898	Toll-Like Receptors Cascades	0.538257853777734	-0.619417551524592	140	12	0.0171428571428571	700	8202	26052,8651,10010,3551,30849,7187,4793,9252,329,8411,5606,4208	DNM3,SOCS1,TANK,IKBKB,PIK3R4,TRAF3,NFKBIB,RPS6KA5,BIRC2,EEA1,MAP2K3,MEF2C
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.538885879624733	-0.618251456603946	223	19	0.0271428571428571	700	8202	8924,25847,5682,25898,3093,23352,9491,4734,7324,8881,8651,57630,10393,10533,51444,26046,642,90678,55521	HERC2,ANAPC13,PSMA1,RCHY1,UBE2K,UBR4,PSMF1,NEDD4,UBE2E1,CDC16,SOCS1,SH3RF1,ANAPC10,ATG7,RNF138,LTN1,BLMH,LRSAM1,TRIM36
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.540041450668444	-0.616109381872635	424	36	0.0514285714285714	700	8202	200734,673,2335,4763,5786,4923,7204,8649,5578,1241,57406,9491,23566,5583,5906,6464,7414,11343,2787,6709,2254,4893,8831,2247,2788,5908,5682,1742,283455,5747,23236,2260,3667,54331,817,221955	SPRED2,BRAF,FN1,NF1,PTPRA,NTSR1,TRIO,LAMTOR3,PRKCA,LTB4R,ABHD6,PSMF1,LPAR3,PRKCH,RAP1A,SHC1,VCL,MGLL,GNG5,SPTAN1,FGF9,NRAS,SYNGAP1,FGF2,GNG7,RAP1B,PSMA1,DLG4,KSR2,PTK2,PLCB1,FGFR1,IRS1,GNG2,CAMK2D,DAGLB
R-HSA-193648	NRAGE signals death through JNK	0.542838538731645	-0.610943353667725	45	4	0.00571428571428571	700	8202	84033,23365,11214,7204	OBSCN,ARHGEF12,AKAP13,TRIO
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.542928244170737	-0.610778114795606	57	5	0.00714285714285714	700	8202	55869,6907,182,4609,55534	HDAC8,TBL1X,JAG1,MYC,MAML3
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.542928244170737	-0.610778114795606	57	5	0.00714285714285714	700	8202	55869,6907,182,4609,55534	HDAC8,TBL1X,JAG1,MYC,MAML3
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.542928244170737	-0.610778114795606	57	5	0.00714285714285714	700	8202	55869,6907,182,4609,55534	HDAC8,TBL1X,JAG1,MYC,MAML3
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.542928244170737	-0.610778114795606	57	5	0.00714285714285714	700	8202	55869,6907,182,4609,55534	HDAC8,TBL1X,JAG1,MYC,MAML3
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.542928244170737	-0.610778114795606	57	5	0.00714285714285714	700	8202	55869,6907,182,4609,55534	HDAC8,TBL1X,JAG1,MYC,MAML3
R-HSA-113510	E2F mediated regulation of DNA replication	0.543467694570847	-0.609785013799535	33	3	0.00428571428571429	700	8202	5558,5422,5001	PRIM2,POLA1,ORC5
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.543467694570847	-0.609785013799535	33	3	0.00428571428571429	700	8202	5087,2247,2649	PBX1,FGF2,NR6A1
R-HSA-4085001	Sialic acid metabolism	0.543467694570847	-0.609785013799535	33	3	0.00428571428571429	700	8202	8869,6480,4758	ST3GAL5,ST6GAL1,NEU1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.545695711704632	-0.605693763159417	21	2	0.00285714285714286	700	8202	57761,9020	TRIB3,MAP3K14
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.545695711704632	-0.605693763159417	21	2	0.00285714285714286	700	8202	4793,3551	NFKBIB,IKBKB
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.545695711704632	-0.605693763159417	21	2	0.00285714285714286	700	8202	84617,7846	TUBB6,TUBA1A
R-HSA-198753	ERK/MAPK targets	0.545695711704632	-0.605693763159417	21	2	0.00285714285714286	700	8202	9252,4208	RPS6KA5,MEF2C
R-HSA-445144	Signal transduction by L1	0.545695711704632	-0.605693763159417	21	2	0.00285714285714286	700	8202	8829,2260	NRP1,FGFR1
R-HSA-5620916	VxPx cargo-targeting to cilium	0.545695711704632	-0.605693763159417	21	2	0.00285714285714286	700	8202	50807,60412	ASAP1,EXOC4
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.549484054504669	-0.598775523749362	153	13	0.0185714285714286	700	8202	4809,10946,9128,22916,2521,348995,51692,10081,23279,9883,81929,27339,10291	SNU13,SF3A3,PRPF4,NCBP2,FUS,NUP43,CPSF3,PDCD7,NUP160,POM121,SEH1L,PRPF19,SF3A1
R-HSA-425986	Sodium/Proton exchangers	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	6553	SLC9A5
R-HSA-425381	Bicarbonate transporters	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	9497	SLC4A7
R-HSA-73614	Pyrimidine salvage reactions	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	7378	UPP1
R-HSA-112411	MAPK1 (ERK2) activation	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	3570	IL6R
R-HSA-419408	Lysosphingolipid and LPA receptors	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	23566	LPAR3
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	3091	HIF1A
R-HSA-193697	p75NTR regulates axonogenesis	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	57142	RTN4
R-HSA-1296052	Ca2+ activated K+ channels	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	3778	KCNMA1
R-HSA-3215018	Processing and activation of SUMO	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	6612	SUMO3
R-HSA-1462054	Alpha-defensins	0.55214475881588	-0.593945022853382	9	1	0.00142857142857143	700	8202	5646	PRSS3
R-HSA-68949	Orc1 removal from chromatin	0.557846811894087	-0.583670884947023	70	6	0.00857142857142857	700	8202	5682,4175,4171,4174,9491,5001	PSMA1,MCM6,MCM2,MCM5,PSMF1,ORC5
R-HSA-69052	Switching of origins to a post-replicative state	0.557846811894087	-0.583670884947023	70	6	0.00857142857142857	700	8202	5682,4175,4171,4174,9491,5001	PSMA1,MCM6,MCM2,MCM5,PSMF1,ORC5
R-HSA-1483249	Inositol phosphate metabolism	0.560651738924741	-0.578655352457403	46	4	0.00571428571428571	700	8202	51447,23236,8867,3628	IP6K2,PLCB1,SYNJ1,INPP1
R-HSA-4791275	Signaling by WNT in cancer	0.564172499837432	-0.572395223471303	34	3	0.00428571428571429	700	8202	54894,6934,22943	RNF43,TCF7L2,DKK1
R-HSA-1489509	DAG and IP3 signaling	0.564172499837432	-0.572395223471303	34	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.564172499837432	-0.572395223471303	34	3	0.00428571428571429	700	8202	2254,673,2247	FGF9,BRAF,FGF2
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.568797476437434	-0.564230837145997	143	12	0.0171428571428571	700	8202	2110,5163,8802,91942,517,5166,728294,6834,6566,4725,51660,4709	ETFDH,PDK1,SUCLG1,NDUFAF2,ATP5G2,PDK4,D2HGDH,SURF1,SLC16A1,NDUFS5,MPC1,NDUFB3
R-HSA-3371571	HSF1-dependent transactivation	0.571419460092617	-0.559631732900464	22	2	0.00285714285714286	700	8202	817,3304	CAMK2D,HSPA1B
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.571419460092617	-0.559631732900464	22	2	0.00285714285714286	700	8202	2247,2649	FGF2,NR6A1
R-HSA-166208	mTORC1-mediated signalling	0.571419460092617	-0.559631732900464	22	2	0.00285714285714286	700	8202	10670,8649	RRAGA,LAMTOR3
R-HSA-449147	Signaling by Interleukins	0.575394978047507	-0.552698555661715	311	26	0.0371428571428571	700	8202	2254,200734,673,4893,2335,8831,4763,2247,5786,5908,8649,5682,1742,283455,5747,3570,5291,9491,2260,3667,817,5906,6464,3551,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,NF1,FGF2,PTPRA,RAP1B,LAMTOR3,PSMA1,DLG4,KSR2,PTK2,IL6R,PIK3CB,PSMF1,FGFR1,IRS1,CAMK2D,RAP1A,SHC1,IKBKB,VCL,SPTAN1
R-HSA-5617833	Assembly of the primary cilium	0.578529185814012	-0.547266282775697	180	15	0.0214285714285714	700	8202	1778,55081,51134,7846,57539,50807,80184,5048,10806,200894,60412,54903,9742,79969,79659	DYNC1H1,IFT57,CEP83,TUBA1A,WDR35,ASAP1,CEP290,PAFAH1B1,SDCCAG8,ARL13B,EXOC4,MKS1,IFT140,ATAT1,DYNC2H1
R-HSA-3858494	Beta-catenin independent WNT signaling	0.578799665634027	-0.54679886191325	144	12	0.0171428571428571	700	8202	54331,7976,2788,5682,5578,23236,2787,9491,5881,6934,192669,27327	GNG2,FZD3,GNG7,PSMA1,PRKCA,PLCB1,GNG5,PSMF1,RAC3,TCF7L2,AGO3,TNRC6A
R-HSA-1280218	Adaptive Immune System	0.580117139826697	-0.544525230615458	668	56	0.08	700	8202	8924,26052,2308,9871,3798,25898,55740,162,10666,55824,9491,4734,10225,5906,6464,8651,3551,51164,10393,8907,26046,79659,9020,90678,5567,6199,2254,51466,4893,25847,2247,7879,3309,11069,56992,5908,5682,3093,5291,23352,2260,7324,1525,114876,1778,3667,57761,8881,57630,51444,10533,4793,642,192669,27327,55521	HERC2,DNM3,FOXO1,SEC24D,KIF5A,RCHY1,ENAH,AP1B1,CD226,PAG1,PSMF1,NEDD4,CD96,RAP1A,SHC1,SOCS1,IKBKB,DCTN4,ANAPC10,AP1M1,LTN1,DYNC2H1,MAP3K14,LRSAM1,PRKACB,RPS6KB2,FGF9,EVL,NRAS,ANAPC13,FGF2,RAB7A,HSPA5,RAPGEF4,KIF15,RAP1B,PSMA1,UBE2K,PIK3CB,UBR4,FGFR1,UBE2E1,CXADR,OSBPL1A,DYNC1H1,IRS1,TRIB3,CDC16,SH3RF1,RNF138,ATG7,NFKBIB,BLMH,AGO3,TNRC6A,TRIM36
R-HSA-446203	Asparagine N-linked glycosylation	0.587424759162413	-0.532007110676209	181	15	0.0214285714285714	700	8202	4247,29880,83696,9871,149111,4905,5589,9334,6480,54344,122553,8775,8869,4758,4121	MGAT2,ALG5,TRAPPC9,SEC24D,CNIH3,NSF,PRKCSH,B4GALT5,ST6GAL1,DPM3,TRAPPC6B,NAPA,ST3GAL5,NEU1,MAN1A1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.589698669314434	-0.528143602524886	60	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	22916	NCBP2
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	5565	PRKAB2
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-209968	Thyroxine biosynthesis	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	6528	SLC5A5
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	30849	PIK3R4
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	4595	MUTYH
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	10038	PARP2
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	5001	ORC5
R-HSA-2474795	Diseases associated with visual transduction	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	5947	RBP1
R-HSA-937039	IRAK1 recruits IKK complex	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-2470946	Cohesin Loading onto Chromatin	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	10274	STAG1
R-HSA-418886	Netrin mediated repulsion signals	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	5747	PTK2
R-HSA-549127	Organic cation transport	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	861	RUNX1
R-HSA-110056	MAPK3 (ERK1) activation	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	3570	IL6R
R-HSA-2453864	Retinoid cycle disease events	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	5947	RBP1
R-HSA-190377	FGFR2b ligand binding and activation	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	2247	FGF2
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.590408968357067	-0.52693981550456	10	1	0.00142857142857143	700	8202	6117	RPA1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.590577367241986	-0.526654632042256	121	10	0.0142857142857143	700	8202	26052,8651,10010,3551,7187,4793,9252,329,5606,4208	DNM3,SOCS1,TANK,IKBKB,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.593893664337388	-0.521054991911841	97	8	0.0114285714285714	700	8202	10010,3551,7187,4793,9252,329,5606,4208	TANK,IKBKB,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.593893664337388	-0.521054991911841	97	8	0.0114285714285714	700	8202	10010,3551,7187,4793,9252,329,5606,4208	TANK,IKBKB,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.593893664337388	-0.521054991911841	97	8	0.0114285714285714	700	8202	10010,3551,7187,4793,9252,329,5606,4208	TANK,IKBKB,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.59606861530447	-0.517399492193536	23	2	0.00285714285714286	700	8202	1803,6934	DPP4,TCF7L2
R-HSA-1482839	Acyl chain remodelling of PE	0.59606861530447	-0.517399492193536	23	2	0.00285714285714286	700	8202	81579,10162	PLA2G12A,LPCAT3
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.59606861530447	-0.517399492193536	23	2	0.00285714285714286	700	8202	4088,6498	SMAD3,SKIL
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.59606861530447	-0.517399492193536	23	2	0.00285714285714286	700	8202	22916,51692	NCBP2,CPSF3
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.59606861530447	-0.517399492193536	23	2	0.00285714285714286	700	8202	6616,6857	SNAP25,SYT1
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.59606861530447	-0.517399492193536	23	2	0.00285714285714286	700	8202	2678,1800	GGT1,DPEP1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.596426952896705	-0.5167985044623	85	7	0.01	700	8202	3667,2254,2308,2247,5291,2260,6199	IRS1,FGF9,FOXO1,FGF2,PIK3CB,FGFR1,RPS6KB2
R-HSA-157118	Signaling by NOTCH	0.60322280005999	-0.505468664494796	110	9	0.0128571428571429	700	8202	182,3091,7090,4609,55869,6907,192669,27327,55534	JAG1,HIF1A,TLE3,MYC,HDAC8,TBL1X,AGO3,TNRC6A,MAML3
R-HSA-167021	PLC-gamma1 signalling	0.603813921680762	-0.504489205200174	36	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.603813921680762	-0.504489205200174	36	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.604693532341376	-0.503033507408629	61	5	0.00714285714285714	700	8202	3667,2254,2247,5291,2260	IRS1,FGF9,FGF2,PIK3CB,FGFR1
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.613397742735785	-0.488741707230856	74	6	0.00857142857142857	700	8202	8924,472,25,672,9577,3014	HERC2,ATM,ABL1,BRCA1,BRE,H2AFX
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.619638998383296	-0.478618231194677	24	2	0.00285714285714286	700	8202	2308,6199	FOXO1,RPS6KB2
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.619638998383296	-0.478618231194677	24	2	0.00285714285714286	700	8202	23365,5364	ARHGEF12,PLXNB1
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.619638998383296	-0.478618231194677	24	2	0.00285714285714286	700	8202	9871,3309	SEC24D,HSPA5
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.619638998383296	-0.478618231194677	24	2	0.00285714285714286	700	8202	329,3551	BIRC2,IKBKB
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.619638998383296	-0.478618231194677	24	2	0.00285714285714286	700	8202	9252,4208	RPS6KA5,MEF2C
R-HSA-933542	TRAF6 mediated NF-kB activation	0.619638998383296	-0.478618231194677	24	2	0.00285714285714286	700	8202	4793,3551	NFKBIB,IKBKB
R-HSA-212165	Epigenetic regulation of gene expression	0.622214662079314	-0.474470129898604	124	10	0.0142857142857143	700	8202	2967,25885,3014,2965,84172,9533,30834,29115,64425,8819	GTF2H3,POLR1A,H2AFX,GTF2H1,POLR1B,POLR1C,ZNRD1,SAP30BP,POLR1E,SAP30
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.622717843595356	-0.473661762310563	37	3	0.00428571428571429	700	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-166054	Activated TLR4 signalling	0.625199661844009	-0.469684221311467	112	9	0.0128571428571429	700	8202	8651,10010,3551,7187,4793,9252,329,5606,4208	SOCS1,TANK,IKBKB,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-2467813	Separation of Sister Chromatids	0.625275441871945	-0.469563019333429	161	13	0.0185714285714286	700	8202	8881,10274,5048,10393,8379,5682,55869,348995,23279,9491,7324,81929,401541	CDC16,STAG1,PAFAH1B1,ANAPC10,MAD1L1,PSMA1,HDAC8,NUP43,NUP160,PSMF1,UBE2E1,SEH1L,CENPP
R-HSA-2022923	Dermatan sulfate biosynthesis	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	1462	VCAN
R-HSA-5625970	RHO GTPases activate KTN1	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	3798	KIF5A
R-HSA-71288	Creatine metabolism	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	6535	SLC6A8
R-HSA-68689	CDC6 association with the ORC:origin complex	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	5001	ORC5
R-HSA-1980148	Signaling by NOTCH3	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-71064	Lysine catabolism	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	85007	PHYKPL
R-HSA-1059683	Interleukin-6 signaling	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	3570	IL6R
R-HSA-5655291	Signaling by FGFR4 in disease	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	4893	NRAS
R-HSA-1980150	Signaling by NOTCH4	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.625408202021822	-0.469350719202978	11	1	0.00142857142857143	700	8202	22916	NCBP2
R-HSA-5693606	DNA Double Strand Break Response	0.626662849907397	-0.467346602418102	75	6	0.00857142857142857	700	8202	8924,472,25,672,9577,3014	HERC2,ATM,ABL1,BRCA1,BRE,H2AFX
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.628910926328071	-0.463765643870656	100	8	0.0114285714285714	700	8202	10274,5048,8379,55869,348995,23279,81929,401541	STAG1,PAFAH1B1,MAD1L1,HDAC8,NUP43,NUP160,SEH1L,CENPP
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.629237015026175	-0.463247280815427	198	16	0.0228571428571429	700	8202	2254,4893,2308,2247,5682,5291,9491,2260,3667,57761,6464,3551,4793,192669,6199,27327	FGF9,NRAS,FOXO1,FGF2,PSMA1,PIK3CB,PSMF1,FGFR1,IRS1,TRIB3,SHC1,IKBKB,NFKBIB,AGO3,RPS6KB2,TNRC6A
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.63372054692301	-0.456147199439925	63	5	0.00714285714285714	700	8202	1778,7846,80184,5048,10806	DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.63372054692301	-0.456147199439925	63	5	0.00714285714285714	700	8202	1778,7846,80184,5048,10806	DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-69278	Cell Cycle, Mitotic	0.638744102972914	-0.448251369643178	477	39	0.0557142857142857	700	8202	4175,114799,55388,5048,5520,348995,5578,23279,9491,9883,10783,80184,4174,4609,9663,10393,8379,1021,81929,7112,5984,5983,7846,5558,10274,328,5422,1019,5682,55869,4171,7324,401541,6117,1778,8881,10806,5001,3014	MCM6,ESCO1,MCM10,PAFAH1B1,PPP2R2A,NUP43,PRKCA,NUP160,PSMF1,POM121,NEK6,CEP290,MCM5,MYC,LPIN2,ANAPC10,MAD1L1,CDK6,SEH1L,TMPO,RFC4,RFC3,TUBA1A,PRIM2,STAG1,APEX1,POLA1,CDK4,PSMA1,HDAC8,MCM2,UBE2E1,CENPP,RPA1,DYNC1H1,CDC16,SDCCAG8,ORC5,H2AFX
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.64021048344167	-0.445958276320108	101	8	0.0114285714285714	700	8202	23516,30061,7781,7922,6513,6566,861,148867	SLC39A14,SLC40A1,SLC30A3,SLC39A7,SLC2A1,SLC16A1,RUNX1,SLC30A7
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.640996055774196	-0.444731975318782	38	3	0.00428571428571429	700	8202	5533,317,5366	PPP3CC,APAF1,PMAIP1
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.640996055774196	-0.444731975318782	38	3	0.00428571428571429	700	8202	51138,7508,10038	COPS4,XPC,PARP2
R-HSA-69236	G1 Phase	0.640996055774196	-0.444731975318782	38	3	0.00428571428571429	700	8202	5520,1021,1019	PPP2R2A,CDK6,CDK4
R-HSA-69231	Cyclin D associated events in G1	0.640996055774196	-0.444731975318782	38	3	0.00428571428571429	700	8202	5520,1021,1019	PPP2R2A,CDK6,CDK4
R-HSA-5673000	RAF activation	0.642134958774898	-0.442956781224219	25	2	0.00285714285714286	700	8202	673,4893	BRAF,NRAS
R-HSA-114452	Activation of BH3-only proteins	0.642134958774898	-0.442956781224219	25	2	0.00285714285714286	700	8202	5533,5366	PPP3CC,PMAIP1
R-HSA-982772	Growth hormone receptor signaling	0.642134958774898	-0.442956781224219	25	2	0.00285714285714286	700	8202	3667,8651	IRS1,SOCS1
R-HSA-383280	Nuclear Receptor transcription pathway	0.643661344514107	-0.440582553747724	51	4	0.00571428571428571	700	8202	7421,5468,2649,7025	VDR,PPARG,NR6A1,NR2F1
R-HSA-382551	Transmembrane transport of small molecules	0.644227330333678	-0.439703617754168	586	48	0.0685714285714286	700	8202	10723,7226,21,6528,6513,348995,133308,3163,23279,51076,9883,10347,148867,23657,92745,7922,54407,1185,57719,2787,5567,81929,30061,6520,10257,81539,2788,535,6262,1244,10110,57198,28982,23,6553,374868,54331,6541,23516,7781,3099,1965,6566,9497,8714,861,5576,8501	SLC12A7,TRPM2,ABCA3,SLC5A5,SLC2A1,NUP43,SLC9B2,HMOX2,NUP160,CUTC,POM121,ABCA7,SLC30A7,SLC7A11,SLC38A5,SLC39A7,SLC38A2,CLCN6,ANO8,GNG5,PRKACB,SEH1L,SLC40A1,SLC3A2,ABCC4,SLC38A1,GNG7,ATP6V0A1,RYR2,ABCC2,SGK2,ATP8B2,FLVCR1,ABCF1,SLC9A5,ATP9B,GNG2,SLC7A1,SLC39A14,SLC30A3,HK2,EIF2S1,SLC16A1,SLC4A7,ABCC3,RUNX1,PRKAR2A,SLC43A1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.645551320173097	-0.437650567327334	89	7	0.01	700	8202	4793,9252,8411,3551,5606,4208,30849	NFKBIB,RPS6KA5,EEA1,IKBKB,MAP2K3,MEF2C,PIK3R4
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.647734820990717	-0.434273893252206	64	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.652387789468241	-0.427116124737468	77	6	0.00857142857142857	700	8202	54386,472,8091,57634,65057,3014	TERF2IP,ATM,HMGA2,EP400,ACD,H2AFX
R-HSA-162909	Host Interactions of HIV factors	0.652557552646294	-0.426855940385631	127	10	0.0142857142857143	700	8202	3836,8907,5682,55690,348995,162,23279,9491,9883,81929	KPNA1,AP1M1,PSMA1,PACS1,NUP43,AP1B1,NUP160,PSMF1,POM121,SEH1L
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.657270636997605	-0.419659416857698	90	7	0.01	700	8202	1778,51134,7846,80184,5048,10806,54903	DYNC1H1,CEP83,TUBA1A,CEP290,PAFAH1B1,SDCCAG8,MKS1
R-HSA-3371511	HSF1 activation	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	6117	RPA1
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	1742	DLG4
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	221914	GPC2
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	1742	DLG4
R-HSA-390666	Serotonin receptors	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	3363	HTR7
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	55534	MAML3
R-HSA-71384	Ethanol oxidation	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	128	ADH5
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	221914	GPC2
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	23404	EXOSC2
R-HSA-211979	Eicosanoids	0.657420686295056	-0.419431151415546	12	1	0.00142857142857143	700	8202	6916	TBXAS1
R-HSA-6783310	Fanconi Anemia Pathway	0.658642530785932	-0.417574333557451	39	3	0.00428571428571429	700	8202	146956,6117,22909	EME1,RPA1,FAN1
R-HSA-165159	mTOR signalling	0.658642530785932	-0.417574333557451	39	3	0.00428571428571429	700	8202	5565,10670,8649	PRKAB2,RRAGA,LAMTOR3
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	221914,1462	GPC2,VCAN
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	4793,3551	NFKBIB,IKBKB
R-HSA-3781865	Diseases of glycosylation	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	221914,1462	GPC2,VCAN
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	4793,3551	NFKBIB,IKBKB
R-HSA-983189	Kinesins	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	3798,56992	KIF5A,KIF15
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	221914,1462	GPC2,VCAN
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	51384,79971	WNT16,WLS
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	329,3551	BIRC2,IKBKB
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.663567952703396	-0.410124014925132	26	2	0.00285714285714286	700	8202	9533,10622	POLR1C,POLR3G
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.672917009031752	-0.396133271901574	104	8	0.0114285714285714	700	8202	8663,6158,8669,6235,1974,1965,26986,8667	EIF3C,RPL28,EIF3J,RPS29,EIF4A2,EIF2S1,PABPC1,EIF3H
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.676790299177128	-0.390393804159974	142	11	0.0157142857142857	700	8202	54331,817,673,4905,2788,1742,5578,23236,2787,5567,2770	GNG2,CAMK2D,BRAF,NSF,GNG7,DLG4,PRKCA,PLCB1,GNG5,PRKACB,GNAI1
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.683407912812133	-0.380663360772524	105	8	0.0114285714285714	700	8202	8663,6158,8669,6235,1974,1965,9669,8667	EIF3C,RPL28,EIF3J,RPS29,EIF4A2,EIF2S1,EIF5B,EIF3H
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.683407912812133	-0.380663360772524	105	8	0.0114285714285714	700	8202	8881,10919,1019,79813,10393,3014,1021,7324	CDC16,EHMT2,CDK4,EHMT1,ANAPC10,H2AFX,CDK6,UBE2E1
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.683955301737675	-0.379862711831615	27	2	0.00285714285714286	700	8202	9533,10622	POLR1C,POLR3G
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.683955301737675	-0.379862711831615	27	2	0.00285714285714286	700	8202	23236,8867	PLCB1,SYNJ1
R-HSA-1502540	Signaling by Activin	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	4088	SMAD3
R-HSA-209560	NF-kB is activated and signals survival	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-211227	Activation of DNA fragmentation factor	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	3836	KPNA1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	1803	DPP4
R-HSA-350054	Notch-HLH transcription pathway	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	55534	MAML3
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	6513	SLC2A1
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	5589	PRKCSH
R-HSA-5210891	Uptake and function of anthrax toxins	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	5606	MAP2K3
R-HSA-171007	p38MAPK events	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	4893	NRAS
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	783	CACNB2
R-HSA-209543	p75NTR recruits signalling complexes	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-140342	Apoptosis induced DNA fragmentation	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	3836	KPNA1
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	30849	PIK3R4
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	57019	CIAPIN1
R-HSA-75892	Platelet Adhesion to exposed collagen	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	3673	ITGA2
R-HSA-1483213	Synthesis of PE	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	9663	LPIN2
R-HSA-177504	Retrograde neurotrophin signalling	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	26052	DNM3
R-HSA-1663150	The activation of arylsulfatases	0.686700969519442	-0.375856351503522	13	1	0.00142857142857143	700	8202	79642	ARSJ
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.687059975354257	-0.375333690200146	267	21	0.03	700	8202	8924,25847,9871,3309,5682,25898,3093,23352,9491,4734,7324,8881,8651,57630,10393,51444,10533,26046,642,90678,55521	HERC2,ANAPC13,SEC24D,HSPA5,PSMA1,RCHY1,UBE2K,UBR4,PSMF1,NEDD4,UBE2E1,CDC16,SOCS1,SH3RF1,ANAPC10,RNF138,ATG7,LTN1,BLMH,LRSAM1,TRIM36
R-HSA-1474244	Extracellular matrix organization	0.687059975354257	-0.375333690200146	267	21	0.03	700	8202	3910,1308,3915,2335,2247,7148,3908,5578,7042,667,4316,1462,3673,4323,8754,85007,652,3691,960,3911,4325	LAMA4,COL17A1,LAMC1,FN1,FGF2,TNXB,LAMA2,PRKCA,TGFB2,DST,MMP7,VCAN,ITGA2,MMP14,ADAM9,PHYKPL,BMP4,ITGB4,CD44,LAMA5,MMP16
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.687702991473856	-0.374398232696554	67	5	0.00714285714285714	700	8202	54344,29880,8869,6480,4758	DPM3,ALG5,ST3GAL5,ST6GAL1,NEU1
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.688223396259693	-0.373641789887852	54	4	0.00571428571428571	700	8202	2965,2967,51138,27339	GTF2H1,GTF2H3,COPS4,PRPF19
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.69368753255702	-0.365733661136674	106	8	0.0114285714285714	700	8202	6158,6235,9887,5520,26019,22916,2107,26986	RPL28,RPS29,SMG7,PPP2R2A,UPF2,NCBP2,ETF1,PABPC1
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.69368753255702	-0.365733661136674	106	8	0.0114285714285714	700	8202	6158,6235,9887,5520,26019,22916,2107,26986	RPL28,RPS29,SMG7,PPP2R2A,UPF2,NCBP2,ETF1,PABPC1
R-HSA-199991	Membrane Trafficking	0.695728533855443	-0.362795732296171	256	20	0.0285714285714286	700	8202	27243,83696,137492,9871,5565,10717,25977,162,122553,55330,8027,4905,149111,8773,79720,60412,8907,22989,8775,92421	CHMP2A,TRAPPC9,VPS37A,SEC24D,PRKAB2,AP4B1,NECAP1,AP1B1,TRAPPC6B,BLOC1S4,STAM,NSF,CNIH3,SNAP23,VPS37B,EXOC4,AP1M1,MYH15,NAPA,CHMP4C
R-HSA-3214815	HDACs deacetylate histones	0.70175311062813	-0.35417363107718	94	7	0.01	700	8202	57459,55869,6907,1107,317772,23028,8819	GATAD2B,HDAC8,TBL1X,CHD3,HIST2H2AB,KDM1A,SAP30
R-HSA-381070	IRE1alpha activates chaperones	0.702169625282307	-0.353580272688227	55	4	0.00571428571428571	700	8202	7709,58477,6464,3309	ZBTB17,SRPRB,SHC1,HSPA5
R-HSA-977443	GABA receptor activation	0.702169625282307	-0.353580272688227	55	4	0.00571428571428571	700	8202	54331,2787,2788,2770	GNG2,GNG5,GNG7,GNAI1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.702169625282307	-0.353580272688227	55	4	0.00571428571428571	700	8202	5682,9491,26986,3304	PSMA1,PSMF1,PABPC1,HSPA1B
R-HSA-72172	mRNA Splicing	0.706203073294889	-0.347852443621238	120	9	0.0128571428571429	700	8202	4809,10946,22916,9128,2521,51692,10081,27339,10291	SNU13,SF3A3,NCBP2,PRPF4,FUS,CPSF3,PDCD7,PRPF19,SF3A1
R-HSA-193704	p75 NTR receptor-mediated signalling	0.711752673611555	-0.340024796439679	82	6	0.00857142857142857	700	8202	84033,57142,23365,11214,3551,7204	OBSCN,RTN4,ARHGEF12,AKAP13,IKBKB,TRIO
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.712580399281928	-0.338862532107966	69	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.712580399281928	-0.338862532107966	69	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	6916	TBXAS1
R-HSA-3371568	Attenuation phase	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	3304	HSPA1B
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	10274	STAG1
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	2770	GNAI1
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	80270	HSD3B7
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	8829	NRP1
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	2770	GNAI1
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	7187	TRAF3
R-HSA-5682910	LGI-ADAM interactions	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	1742	DLG4
R-HSA-5675482	Regulation of necroptotic cell death	0.713481934375321	-0.337598162112045	14	1	0.00142857142857143	700	8202	329	BIRC2
R-HSA-68877	Mitotic Prometaphase	0.713602817884003	-0.337428748895655	108	8	0.0114285714285714	700	8202	10274,5048,8379,55869,348995,23279,81929,401541	STAG1,PAFAH1B1,MAD1L1,HDAC8,NUP43,NUP160,SEH1L,CENPP
R-HSA-109581	Apoptosis	0.722940152024735	-0.324428837532125	160	12	0.0171428571428571	700	8202	3836,5366,5682,7431,5533,317,5747,329,79658,9491,4137,6709	KPNA1,PMAIP1,PSMA1,VIM,PPP3CC,APAF1,PTK2,BIRC2,ARHGAP10,PSMF1,MAPT,SPTAN1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.724482982930668	-0.32229700551565	70	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-69473	G2/M DNA damage checkpoint	0.724482982930668	-0.32229700551565	70	5	0.00714285714285714	700	8202	8924,472,672,9577,3014	HERC2,ATM,BRCA1,BRE,H2AFX
R-HSA-71291	Metabolism of amino acids and derivatives	0.734472363807225	-0.308602909934176	212	16	0.0228571428571429	700	8202	6723,10295,29968,6528,3028,5682,6535,4953,9491,5831,2744,440,85007,26275,5832,55217	SRM,BCKDK,PSAT1,SLC5A5,HSD17B10,PSMA1,SLC6A8,ODC1,PSMF1,PYCR1,GLS,ASNS,PHYKPL,HIBCH,ALDH18A1,TMLHE
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	80153	EDC3
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	80270	HSD3B7
R-HSA-391903	Eicosanoid ligand-binding receptors	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	1241	LTB4R
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	5533	PPP3CC
R-HSA-159418	Recycling of bile acids and salts	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	8714	ABCC3
R-HSA-901042	Calnexin/calreticulin cycle	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	5589	PRKCSH
R-HSA-549132	Organic cation/anion/zwitterion transport	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	861	RUNX1
R-HSA-194223	HDL-mediated lipid transport	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	949	SCARB1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	5001	ORC5
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	22943	DKK1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.737976639549011	-0.303843108610282	15	1	0.00142857142857143	700	8202	5578	PRKCA
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.739082930022867	-0.302345145083945	30	2	0.00285714285714286	700	8202	9252,4208	RPS6KA5,MEF2C
R-HSA-5683826	Surfactant metabolism	0.739082930022867	-0.302345145083945	30	2	0.00285714285714286	700	8202	21,2627	ABCA3,GATA6
R-HSA-5357801	Programmed Cell Death	0.746099566239509	-0.292896220875284	163	12	0.0171428571428571	700	8202	3836,5366,5682,7431,5533,317,5747,329,79658,9491,4137,6709	KPNA1,PMAIP1,PSMA1,VIM,PPP3CC,APAF1,PTK2,BIRC2,ARHGAP10,PSMF1,MAPT,SPTAN1
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.747216604956073	-0.291400169407479	72	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.751306650620977	-0.285941387495295	45	3	0.00428571428571429	700	8202	192669,27327,55534	AGO3,TNRC6A,MAML3
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.753418443901794	-0.28313450313482	59	4	0.00571428571428571	700	8202	5682,51684,9491,5567	PSMA1,SUFU,PSMF1,PRKACB
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.753418443901794	-0.28313450313482	59	4	0.00571428571428571	700	8202	5682,51684,9491,5567	PSMA1,SUFU,PSMF1,PRKACB
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.753418443901794	-0.28313450313482	59	4	0.00571428571428571	700	8202	5682,51684,9491,5567	PSMA1,SUFU,PSMF1,PRKACB
R-HSA-2980736	Peptide hormone metabolism	0.753972211083871	-0.282399766979786	86	6	0.00857142857142857	700	8202	3800,1803,3798,6934,60412,148867	KIF5C,DPP4,KIF5A,TCF7L2,EXOC4,SLC30A7
R-HSA-2129379	Molecules associated with elastic fibres	0.755543216032663	-0.280318297008997	31	2	0.00285714285714286	700	8202	652,7042	BMP4,TGFB2
R-HSA-168638	NOD1/2 Signaling Pathway	0.755543216032663	-0.280318297008997	31	2	0.00285714285714286	700	8202	329,3551	BIRC2,IKBKB
R-HSA-5357905	Regulation of TNFR1 signaling	0.755543216032663	-0.280318297008997	31	2	0.00285714285714286	700	8202	329,3551	BIRC2,IKBKB
R-HSA-2022928	HS-GAG biosynthesis	0.755543216032663	-0.280318297008997	31	2	0.00285714285714286	700	8202	221914,9653	GPC2,HS2ST1
R-HSA-380287	Centrosome maturation	0.758050602566642	-0.277005137564496	73	5	0.00714285714285714	700	8202	1778,7846,80184,5048,10806	DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.758050602566642	-0.277005137564496	73	5	0.00714285714285714	700	8202	1778,7846,80184,5048,10806	DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.758050602566642	-0.277005137564496	73	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-72163	mRNA Splicing - Major Pathway	0.759564219998035	-0.275010404894819	113	8	0.0114285714285714	700	8202	4809,10946,22916,9128,2521,51692,27339,10291	SNU13,SF3A3,NCBP2,PRPF4,FUS,CPSF3,PRPF19,SF3A1
R-HSA-1482922	Acyl chain remodelling of PI	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	81579	PLA2G12A
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-399956	CRMPs in Sema3A signaling	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	8829	NRP1
R-HSA-193639	p75NTR signals via NF-kB	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-1295596	Spry regulation of FGF signaling	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	673	BRAF
R-HSA-5218859	Regulated Necrosis	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	329	BIRC2
R-HSA-5625900	RHO GTPases activate CIT	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	1742	DLG4
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	517	ATP5G2
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	8829	NRP1
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.760380004920656	-0.273936964188798	16	1	0.00142857142857143	700	8202	329	BIRC2
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.763790431003641	-0.269461832413163	87	6	0.00857142857142857	700	8202	4221,7090,4609,79577,6934,3014	MEN1,TLE3,MYC,CDC73,TCF7L2,H2AFX
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.764608156091666	-0.268391790641398	46	3	0.00428571428571429	700	8202	51703,6576,26027	ACSL5,SLC25A1,ACOT11
R-HSA-450294	MAP kinase activation in TLR cascade	0.765112713526627	-0.267732118065466	60	4	0.00571428571428571	700	8202	9252,3551,5606,4208	RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-202433	Generation of second messenger molecules	0.771099203628922	-0.25993824491652	32	2	0.00285714285714286	700	8202	55740,51466	ENAH,EVL
R-HSA-1980145	Signaling by NOTCH2	0.771099203628922	-0.25993824491652	32	2	0.00285714285714286	700	8202	182,55534	JAG1,MAML3
R-HSA-389356	CD28 co-stimulation	0.771099203628922	-0.25993824491652	32	2	0.00285714285714286	700	8202	57761,9020	TRIB3,MAP3K14
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.776370199922345	-0.2531258108011	61	4	0.00571428571428571	700	8202	25,5747,71,10096	ABL1,PTK2,ACTG1,ACTR3
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.776370199922345	-0.2531258108011	61	4	0.00571428571428571	700	8202	84033,23365,11214,7204	OBSCN,ARHGEF12,AKAP13,TRIO
R-HSA-1221632	Meiotic synapsis	0.778666254145904	-0.250172753480647	75	5	0.00714285714285714	700	8202	54386,672,10274,65057,3014	TERF2IP,BRCA1,STAG1,ACD,H2AFX
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.780870353893341	-0.247346143058566	17	1	0.00142857142857143	700	8202	5589	PRKCSH
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.780870353893341	-0.247346143058566	17	1	0.00142857142857143	700	8202	5606	MAP2K3
R-HSA-69205	G1/S-Specific Transcription	0.780870353893341	-0.247346143058566	17	1	0.00142857142857143	700	8202	5422	POLA1
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.780870353893341	-0.247346143058566	17	1	0.00142857142857143	700	8202	5095	PCCA
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.780870353893341	-0.247346143058566	17	1	0.00142857142857143	700	8202	23404	EXOSC2
R-HSA-5694530	Cargo concentration in the ER	0.785785107436225	-0.241071924141945	33	2	0.00285714285714286	700	8202	149111,9871	CNIH3,SEC24D
R-HSA-72187	mRNA 3'-end processing	0.785785107436225	-0.241071924141945	33	2	0.00285714285714286	700	8202	22916,51692	NCBP2,CPSF3
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.787197750460603	-0.239275790894768	62	4	0.00571428571428571	700	8202	22989,5565,8773,60412	MYH15,PRKAB2,SNAP23,EXOC4
R-HSA-73887	Death Receptor Signalling	0.789473551746278	-0.236388945852292	48	3	0.00428571428571429	700	8202	329,843,3551	BIRC2,CASP10,IKBKB
R-HSA-70326	Glucose metabolism	0.797904433832555	-0.225766445805844	77	5	0.00714285714285714	700	8202	8604,5106,5567,6576,3099	SLC25A12,PCK2,PRKACB,SLC25A1,HK2
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.797904433832555	-0.225766445805844	77	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-209776	Amine-derived hormones	0.799610824528872	-0.223630139017718	18	1	0.00142857142857143	700	8202	6528	SLC5A5
R-HSA-912631	Regulation of signaling by CBL	0.799610824528872	-0.223630139017718	18	1	0.00142857142857143	700	8202	5291	PIK3CB
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.799610824528872	-0.223630139017718	18	1	0.00142857142857143	700	8202	30849	PIK3R4
R-HSA-156584	Cytosolic sulfonation of small molecules	0.799610824528872	-0.223630139017718	18	1	0.00142857142857143	700	8202	6819	SULT1C2
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.799610824528872	-0.223630139017718	18	1	0.00142857142857143	700	8202	3091	HIF1A
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.799610824528872	-0.223630139017718	18	1	0.00142857142857143	700	8202	5095	PCCA
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.799635895423097	-0.223598785638762	34	2	0.00285714285714286	700	8202	2342,5578	FNTB,PRKCA
R-HSA-390466	Chaperonin-mediated protein folding	0.801065860559186	-0.221812112373564	49	3	0.00428571428571429	700	8202	5202,84617,7846	PFDN2,TUBB6,TUBA1A
R-HSA-936837	Ion transport by P-type ATPases	0.801065860559186	-0.221812112373564	49	3	0.00428571428571429	700	8202	57198,51076,374868	ATP8B2,CUTC,ATP9B
R-HSA-171306	Packaging Of Telomere Ends	0.801065860559186	-0.221812112373564	49	3	0.00428571428571429	700	8202	54386,65057,3014	TERF2IP,ACD,H2AFX
R-HSA-913709	O-linked glycosylation of mucins	0.807594195513092	-0.213695579898293	64	4	0.00571428571428571	700	8202	55568,374378,9334,6480	GALNT10,GALNT18,B4GALT5,ST6GAL1
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.808549456800739	-0.21251343077742	92	6	0.00857142857142857	700	8202	4793,8651,9252,3551,5606,4208	NFKBIB,SOCS1,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.808549456800739	-0.21251343077742	92	6	0.00857142857142857	700	8202	4793,8651,9252,3551,5606,4208	NFKBIB,SOCS1,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.808549456800739	-0.21251343077742	92	6	0.00857142857142857	700	8202	4793,8651,9252,3551,5606,4208	NFKBIB,SOCS1,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.808549456800739	-0.21251343077742	92	6	0.00857142857142857	700	8202	4793,8651,9252,3551,5606,4208	NFKBIB,SOCS1,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-877300	Interferon gamma signaling	0.808549456800739	-0.21251343077742	92	6	0.00857142857142857	700	8202	5771,817,960,8651,3460,4281	PTPN2,CAMK2D,CD44,SOCS1,IFNGR2,MID1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.812118261258552	-0.208109307481188	50	3	0.00428571428571429	700	8202	5682,9491,1019	PSMA1,PSMF1,CDK4
R-HSA-169911	Regulation of Apoptosis	0.812118261258552	-0.208109307481188	50	3	0.00428571428571429	700	8202	5682,9491,79658	PSMA1,PSMF1,ARHGAP10
R-HSA-72165	mRNA Splicing - Minor Pathway	0.812118261258552	-0.208109307481188	50	3	0.00428571428571429	700	8202	22916,4809,10081	NCBP2,SNU13,PDCD7
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.812118261258552	-0.208109307481188	50	3	0.00428571428571429	700	8202	5682,9491,1019	PSMA1,PSMF1,CDK4
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.812118261258552	-0.208109307481188	50	3	0.00428571428571429	700	8202	5682,4953,9491	PSMA1,ODC1,PSMF1
R-HSA-112316	Neuronal System	0.812628530551478	-0.207481185841219	289	21	0.03	700	8202	673,3786,81539,3778,2788,1742,6616,23416,5578,6857,23236,2770,54331,2744,817,4905,783,10550,54407,2787,5567	BRAF,KCNQ3,SLC38A1,KCNMA1,GNG7,DLG4,SNAP25,KCNH3,PRKCA,SYT1,PLCB1,GNAI1,GNG2,GLS,CAMK2D,NSF,CACNB2,ARL6IP5,SLC38A2,GNG5,PRKACB
R-HSA-2514856	The phototransduction cascade	0.8126869116983	-0.207409346067439	35	2	0.00285714285714286	700	8202	2342,5578	FNTB,PRKCA
R-HSA-194068	Bile acid and bile salt metabolism	0.8126869116983	-0.207409346067439	35	2	0.00285714285714286	700	8202	8714,80270	ABCC3,HSD3B7
R-HSA-71403	Citric acid cycle (TCA cycle)	0.816750661133654	-0.20242141903247	19	1	0.00142857142857143	700	8202	8802	SUCLG1
R-HSA-3928664	Ephrin signaling	0.816750661133654	-0.20242141903247	19	1	0.00142857142857143	700	8202	1948	EFNB2
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.822646818541517	-0.195228309486298	51	3	0.00428571428571429	700	8202	50807,200894,60412	ASAP1,ARL13B,EXOC4
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.822646818541517	-0.195228309486298	51	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.824973558153277	-0.192403943884392	36	2	0.00285714285714286	700	8202	89978,79642	DPH6,ARSJ
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.826370541130863	-0.190712009039986	66	4	0.00571428571428571	700	8202	4793,9533,3551,10622	NFKBIB,POLR1C,IKBKB,POLR3G
R-HSA-1169091	Activation of NF-kappaB in B cells	0.826370541130863	-0.190712009039986	66	4	0.00571428571428571	700	8202	5682,4793,9491,3551	PSMA1,NFKBIB,PSMF1,IKBKB
R-HSA-68875	Mitotic Prophase	0.831560849305799	-0.184450802863374	136	9	0.0128571428571429	700	8202	10783,9663,3014,348995,5578,23279,9883,81929,7112	NEK6,LPIN2,H2AFX,NUP43,PRKCA,NUP160,POM121,SEH1L,TMPO
R-HSA-611105	Respiratory electron transport	0.832410955893848	-0.183429022735425	81	5	0.00714285714285714	700	8202	2110,4725,91942,6834,4709	ETFDH,NDUFS5,NDUFAF2,SURF1,NDUFB3
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.832410955893848	-0.183429022735425	81	5	0.00714285714285714	700	8202	1778,7846,80184,5048,10806	DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-210745	Regulation of gene expression in beta cells	0.832426395854082	-0.183410474424722	20	1	0.00142857142857143	700	8202	2308	FOXO1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.832668058370952	-0.183120205583873	52	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.832668058370952	-0.183120205583873	52	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-69541	Stabilization of p53	0.832668058370952	-0.183120205583873	52	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-69610	p53-Independent DNA Damage Response	0.832668058370952	-0.183120205583873	52	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-5653656	Vesicle-mediated transport	0.835402098351662	-0.179842115129468	294	21	0.03	700	8202	27243,83696,137492,9871,5565,10717,25977,162,122553,55330,8027,4905,149111,8773,79720,60412,8907,22989,949,8775,92421	CHMP2A,TRAPPC9,VPS37A,SEC24D,PRKAB2,AP4B1,NECAP1,AP1B1,TRAPPC6B,BLOC1S4,STAM,NSF,CNIH3,SNAP23,VPS37B,EXOC4,AP1M1,MYH15,SCARB1,NAPA,CHMP4C
R-HSA-419037	NCAM1 interactions	0.836531027573441	-0.17849166710515	37	2	0.00285714285714286	700	8202	783,8912	CACNB2,CACNA1H
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.840245909294448	-0.174060680827395	82	5	0.00714285714285714	700	8202	4793,9252,3551,5606,4208	NFKBIB,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.840245909294448	-0.174060680827395	82	5	0.00714285714285714	700	8202	4793,9252,3551,5606,4208	NFKBIB,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.840245909294448	-0.174060680827395	82	5	0.00714285714285714	700	8202	4793,9252,3551,5606,4208	NFKBIB,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-381038	XBP1(S) activates chaperone genes	0.84219883538038	-0.171739146085496	53	3	0.00428571428571429	700	8202	7709,58477,6464	ZBTB17,SRPRB,SHC1
R-HSA-909733	Interferon alpha/beta signaling	0.843603248926014	-0.170072979121285	68	4	0.00571428571428571	700	8202	51447,8651,10581,9636	IP6K2,SOCS1,IFITM2,ISG15
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.846762930088247	-0.166334517146051	21	1	0.00142857142857143	700	8202	55824	PAG1
R-HSA-2024096	HS-GAG degradation	0.846762930088247	-0.166334517146051	21	1	0.00142857142857143	700	8202	221914	GPC2
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.846762930088247	-0.166334517146051	21	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-4641263	Regulation of FZD by ubiquitination	0.846762930088247	-0.166334517146051	21	1	0.00142857142857143	700	8202	54894	RNF43
R-HSA-390918	Peroxisomal lipid metabolism	0.846762930088247	-0.166334517146051	21	1	0.00142857142857143	700	8202	51	ACOX1
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.846762930088247	-0.166334517146051	21	1	0.00142857142857143	700	8202	5646	PRSS3
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.847777662747972	-0.165136867723775	83	5	0.00714285714285714	700	8202	4793,9252,3551,5606,4208	NFKBIB,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-453276	Regulation of mitotic cell cycle	0.847777662747972	-0.165136867723775	83	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.847777662747972	-0.165136867723775	83	5	0.00714285714285714	700	8202	5682,8881,9491,7324,10393	PSMA1,CDC16,PSMF1,UBE2E1,ANAPC10
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.851256214148608	-0.161042121517327	54	3	0.00428571428571429	700	8202	221914,1462,9653	GPC2,VCAN,HS2ST1
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.851256214148608	-0.161042121517327	54	3	0.00428571428571429	700	8202	667,4316,3691	DST,MMP7,ITGB4
R-HSA-195258	RHO GTPase Effectors	0.851890917829398	-0.160296791066122	285	20	0.0285714285714286	700	8202	51466,71,5048,3798,10096,1742,348995,5747,4221,23279,23028,401541,10788,25,752,8379,3014,114793,23081,81929	EVL,ACTG1,PAFAH1B1,KIF5A,ACTR3,DLG4,NUP43,PTK2,MEN1,NUP160,KDM1A,CENPP,IQGAP2,ABL1,FMNL1,MAD1L1,H2AFX,FMNL2,KDM4C,SEH1L
R-HSA-2187338	Visual phototransduction	0.853195675869281	-0.158766360530367	98	6	0.00857142857142857	700	8202	2342,221914,5578,5947,157506,4647	FNTB,GPC2,PRKCA,RBP1,RDH10,MYO7A
R-HSA-5419276	Mitochondrial translation termination	0.855013395515033	-0.156638142899063	84	5	0.00714285714285714	700	8202	92399,55173,124995,23107,64979	MRRF,MRPS10,MRPL10,MRPS27,MRPL36
R-HSA-5632684	Hedgehog 'on' state	0.855013395515033	-0.156638142899063	84	5	0.00714285714285714	700	8202	5682,51684,9491,79577,8405	PSMA1,SUFU,PSMF1,CDC73,SPOP
R-HSA-351202	Metabolism of polyamines	0.855013395515033	-0.156638142899063	84	5	0.00714285714285714	700	8202	5682,6723,6535,4953,9491	PSMA1,SRM,SLC6A8,ODC1,PSMF1
R-HSA-2672351	Stimuli-sensing channels	0.859739338334946	-0.151126030636509	99	6	0.00857142857142857	700	8202	6262,57719,7226,133308,10110,1185	RYR2,ANO8,TRPM2,SLC9B2,SGK2,CLCN6
R-HSA-1296071	Potassium Channels	0.859739338334946	-0.151126030636509	99	6	0.00857142857142857	700	8202	54331,23416,3786,2787,3778,2788	GNG2,KCNH3,KCNQ3,GNG5,KCNMA1,GNG7
R-HSA-391251	Protein folding	0.859857363509485	-0.150988759874594	55	3	0.00428571428571429	700	8202	5202,84617,7846	PFDN2,TUBB6,TUBA1A
R-HSA-2142753	Arachidonic acid metabolism	0.859857363509485	-0.150988759874594	55	3	0.00428571428571429	700	8202	2678,1800,6916	GGT1,DPEP1,TBXAS1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.859874523879244	-0.150968802845379	22	1	0.00142857142857143	700	8202	9140	ATG12
R-HSA-203765	eNOS activation and regulation	0.859874523879244	-0.150968802845379	22	1	0.00142857142857143	700	8202	115677	NOSTRIN
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.859874523879244	-0.150968802845379	22	1	0.00142857142857143	700	8202	5520	PPP2R2A
R-HSA-5205647	Mitophagy	0.859874523879244	-0.150968802845379	22	1	0.00142857142857143	700	8202	9140	ATG12
R-HSA-202131	Metabolism of nitric oxide	0.859874523879244	-0.150968802845379	22	1	0.00142857142857143	700	8202	115677	NOSTRIN
R-HSA-195721	Signaling by Wnt	0.860429860332351	-0.150323177016027	326	23	0.0328571428571429	700	8202	7090,79971,7976,2788,5682,54894,4221,6659,5578,23236,5881,9491,79577,6934,22943,54331,4609,3014,51384,440193,2787,192669,27327	TLE3,WLS,FZD3,GNG7,PSMA1,RNF43,MEN1,SOX4,PRKCA,PLCB1,RAC3,PSMF1,CDC73,TCF7L2,DKK1,GNG2,MYC,H2AFX,WNT16,CCDC88C,GNG5,AGO3,TNRC6A
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.86196047440826	-0.148545862724428	85	5	0.00714285714285714	700	8202	4793,9252,3551,5606,4208	NFKBIB,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.86196047440826	-0.148545862724428	85	5	0.00714285714285714	700	8202	4793,9252,3551,5606,4208	NFKBIB,RPS6KA5,IKBKB,MAP2K3,MEF2C
R-HSA-5675221	Negative regulation of MAPK pathway	0.867172773017457	-0.142517045217842	40	2	0.00285714285714286	700	8202	673,4893	BRAF,NRAS
R-HSA-1660662	Glycosphingolipid metabolism	0.867172773017457	-0.142517045217842	40	2	0.00285714285714286	700	8202	79642,4758	ARSJ,NEU1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.86862641659116	-0.140842146505792	86	5	0.00714285714285714	700	8202	25,5747,71,5291,10096	ABL1,PTK2,ACTG1,PIK3CB,ACTR3
R-HSA-202403	TCR signaling	0.870855210404912	-0.138279549696661	115	7	0.01	700	8202	5682,55740,51466,5291,55824,9491,3551	PSMA1,ENAH,EVL,PIK3CB,PAG1,PSMF1,IKBKB
R-HSA-3214847	HATs acetylate histones	0.871392301977322	-0.137662999423974	143	9	0.0128571428571429	700	8202	6314,57634,284058,23587,102157402,6883,317772,55689,7994	ATXN7,EP400,KANSL1,ELP5,AK6,TAF12,HIST2H2AB,YEATS2,KAT6A
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.871865701543404	-0.137119878925731	23	1	0.00142857142857143	700	8202	192669	AGO3
R-HSA-112409	RAF-independent MAPK1/3 activation	0.871865701543404	-0.137119878925731	23	1	0.00142857142857143	700	8202	3570	IL6R
R-HSA-201451	Signaling by BMP	0.871865701543404	-0.137119878925731	23	1	0.00142857142857143	700	8202	4092	SMAD7
R-HSA-5578749	Transcriptional regulation by small RNAs	0.87210575848029	-0.136844579766421	101	6	0.00857142857142857	700	8202	348995,23279,9883,81929,27327,3014	NUP43,NUP160,POM121,SEH1L,TNRC6A,H2AFX
R-HSA-373080	Class B/2 (Secretin family receptors)	0.875018854742081	-0.133509844580019	87	5	0.00714285714285714	700	8202	54331,51384,2787,7976,2788	GNG2,WNT16,GNG5,FZD3,GNG7
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.875759618416761	-0.132663633902609	57	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.875759618416761	-0.132663633902609	57	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-211000	Gene Silencing by RNA	0.876002560570296	-0.132386265024566	130	8	0.0114285714285714	700	8202	7247,3014,348995,23279,81929,192669,9883,27327	TSN,H2AFX,NUP43,NUP160,SEH1L,AGO3,POM121,TNRC6A
R-HSA-75893	TNF signaling	0.876154301475853	-0.13221306031987	41	2	0.00285714285714286	700	8202	329,3551	BIRC2,IKBKB
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.877939953879445	-0.130177077344646	102	6	0.00857142857142857	700	8202	2110,4725,91942,517,6834,4709	ETFDH,NDUFS5,NDUFAF2,ATP5G2,SURF1,NDUFB3
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.882832079929852	-0.124620266417643	24	1	0.00142857142857143	700	8202	80270	HSD3B7
R-HSA-5365859	RA biosynthesis pathway	0.882832079929852	-0.124620266417643	24	1	0.00142857142857143	700	8202	157506	RDH10
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.88309479287783	-0.124322730937594	58	3	0.00428571428571429	700	8202	5682,9491,5001	PSMA1,PSMF1,ORC5
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.88309479287783	-0.124322730937594	58	3	0.00428571428571429	700	8202	5682,9020,9491	PSMA1,MAP3K14,PSMF1
R-HSA-168249	Innate Immune System	0.884124510442366	-0.123157377346067	752	56	0.08	700	8202	200734,26052,673,2335,2308,71,4763,5589,5786,10096,5646,8649,30849,5578,9252,329,8411,9491,5606,25,5906,6464,8651,10010,3551,9020,7414,5567,843,6199,6709,2254,4893,8831,2247,5908,5682,1742,9140,283455,5747,3093,5291,9636,2260,10622,3667,57761,817,7187,9533,4793,5576,192669,27327,4208	SPRED2,DNM3,BRAF,FN1,FOXO1,ACTG1,NF1,PRKCSH,PTPRA,ACTR3,PRSS3,LAMTOR3,PIK3R4,PRKCA,RPS6KA5,BIRC2,EEA1,PSMF1,MAP2K3,ABL1,RAP1A,SHC1,SOCS1,TANK,IKBKB,MAP3K14,VCL,PRKACB,CASP10,RPS6KB2,SPTAN1,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,PSMA1,DLG4,ATG12,KSR2,PTK2,UBE2K,PIK3CB,ISG15,FGFR1,POLR3G,IRS1,TRIB3,CAMK2D,TRAF3,POLR1C,NFKBIB,PRKAR2A,AGO3,TNRC6A,MEF2C
R-HSA-373752	Netrin-1 signaling	0.884572984931816	-0.122650253318092	42	2	0.00285714285714286	700	8202	5747,7204	PTK2,TRIO
R-HSA-73856	RNA Polymerase II Transcription Termination	0.884572984931816	-0.122650253318092	42	2	0.00285714285714286	700	8202	22916,51692	NCBP2,CPSF3
R-HSA-975634	Retinoid metabolism and transport	0.884572984931816	-0.122650253318092	42	2	0.00285714285714286	700	8202	221914,5947	GPC2,RBP1
R-HSA-1566948	Elastic fibre formation	0.884572984931816	-0.122650253318092	42	2	0.00285714285714286	700	8202	652,7042	BMP4,TGFB2
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.884572984931816	-0.122650253318092	42	2	0.00285714285714286	700	8202	22916,51692	NCBP2,CPSF3
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.887014136167467	-0.119894359744909	89	5	0.00714285714285714	700	8202	2107,22916,6158,26986,6235	ETF1,NCBP2,RPL28,PABPC1,RPS29
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.890041740123136	-0.116486918340917	59	3	0.00428571428571429	700	8202	5682,9020,9491	PSMA1,MAP3K14,PSMF1
R-HSA-168254	Influenza Infection	0.89049625221341	-0.115976384893046	147	9	0.0128571428571429	700	8202	3836,6158,6235,348995,23279,9883,81929,9636,3304	KPNA1,RPL28,RPS29,NUP43,NUP160,POM121,SEH1L,ISG15,HSPA1B
R-HSA-68886	M Phase	0.891995972074914	-0.114293662023406	296	20	0.0285714285714286	700	8202	10274,5048,5682,5520,55869,348995,5578,23279,9491,9883,7324,401541,8881,10783,9663,10393,8379,3014,81929,7112	STAG1,PAFAH1B1,PSMA1,PPP2R2A,HDAC8,NUP43,PRKCA,NUP160,PSMF1,POM121,UBE2E1,CENPP,CDC16,NEK6,LPIN2,ANAPC10,MAD1L1,H2AFX,SEH1L,TMPO
R-HSA-1296072	Voltage gated Potassium channels	0.892459310463288	-0.113774356884947	43	2	0.00285714285714286	700	8202	23416,3786	KCNH3,KCNQ3
R-HSA-5368287	Mitochondrial translation	0.89263254402442	-0.113580267643835	90	5	0.00714285714285714	700	8202	92399,55173,124995,23107,64979	MRRF,MRPS10,MRPL10,MRPS27,MRPL36
R-HSA-977068	Termination of O-glycan biosynthesis	0.892861126661974	-0.113324223455546	25	1	0.00142857142857143	700	8202	6480	ST6GAL1
R-HSA-3295583	TRP channels	0.892861126661974	-0.113324223455546	25	1	0.00142857142857143	700	8202	7226	TRPM2
R-HSA-2262749	Cellular response to hypoxia	0.892861126661974	-0.113324223455546	25	1	0.00142857142857143	700	8202	3091	HIF1A
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.892861126661974	-0.113324223455546	25	1	0.00142857142857143	700	8202	51703	ACSL5
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.892861126661974	-0.113324223455546	25	1	0.00142857142857143	700	8202	3091	HIF1A
R-HSA-69615	G1/S DNA Damage Checkpoints	0.896616952060902	-0.109126540389677	60	3	0.00428571428571429	700	8202	5682,472,9491	PSMA1,ATM,PSMF1
R-HSA-73923	Lipid digestion, mobilization, and transport	0.896616952060902	-0.109126540389677	60	3	0.00428571428571429	700	8202	949,11343,5567	SCARB1,MGLL,PRKACB
R-HSA-416476	G alpha (q) signalling events	0.896621890562201	-0.109121032477199	190	12	0.0171428571428571	700	8202	54331,5583,221955,2788,4923,7204,1241,57406,11343,23236,23566,2787	GNG2,PRKCH,DAGLB,GNG7,NTSR1,TRIO,LTB4R,ABHD6,MGLL,PLCB1,LPAR3,GNG5
R-HSA-4086400	PCP/CE pathway	0.898008524212507	-0.107575718283446	91	5	0.00714285714285714	700	8202	5682,5578,5881,9491,7976	PSMA1,PRKCA,RAC3,PSMF1,FZD3
R-HSA-912694	Regulation of IFNA signaling	0.902032853619478	-0.103104336501357	26	1	0.00142857142857143	700	8202	8651	SOCS1
R-HSA-2029485	Role of phospholipids in phagocytosis	0.902032853619478	-0.103104336501357	26	1	0.00142857142857143	700	8202	5291	PIK3CB
R-HSA-77387	Insulin receptor recycling	0.902032853619478	-0.103104336501357	26	1	0.00142857142857143	700	8202	535	ATP6V0A1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.903856079995471	-0.101085134809023	107	6	0.00857142857142857	700	8202	58477,6748,6158,6730,6727,6235	SRPRB,SSR4,RPL28,SRP68,SRP14,RPS29
R-HSA-168255	Influenza Life Cycle	0.904032589027231	-0.100889869430856	136	8	0.0114285714285714	700	8202	3836,6158,6235,348995,23279,9883,81929,3304	KPNA1,RPL28,RPS29,NUP43,NUP160,POM121,SEH1L,HSPA1B
R-HSA-5621481	C-type lectin receptors (CLRs)	0.909920203373572	-0.0943983719165819	123	7	0.01	700	8202	5682,4893,9020,9252,9491,5567,3551	PSMA1,NRAS,MAP3K14,RPS6KA5,PSMF1,PRKACB,IKBKB
R-HSA-192105	Synthesis of bile acids and bile salts	0.910420451762034	-0.0938487512731663	27	1	0.00142857142857143	700	8202	80270	HSD3B7
R-HSA-72689	Formation of a pool of free 40S subunits	0.912759393458231	-0.0912829671181021	94	5	0.00714285714285714	700	8202	8663,6158,8669,8667,6235	EIF3C,RPL28,EIF3J,EIF3H,RPS29
R-HSA-4608870	Asymmetric localization of PCP proteins	0.914272232201219	-0.0896269048283277	63	3	0.00428571428571429	700	8202	5682,9491,7976	PSMA1,PSMF1,FZD3
R-HSA-2022854	Keratan sulfate biosynthesis	0.918090871804745	-0.0854589043666666	28	1	0.00142857142857143	700	8202	9334	B4GALT5
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.918090871804745	-0.0854589043666666	28	1	0.00142857142857143	700	8202	57761	TRIB3
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.919251774020853	-0.0841952289458295	47	2	0.00285714285714286	700	8202	329,3551	BIRC2,IKBKB
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.919518693025795	-0.0839049055894339	64	3	0.00428571428571429	700	8202	23028,23081,3014	KDM1A,KDM4C,H2AFX
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.921522156163568	-0.0817284585763112	96	5	0.00714285714285714	700	8202	5682,7187,9020,329,9491	PSMA1,TRAF3,MAP3K14,BIRC2,PSMF1
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.923830002621907	-0.0792272041132422	81	4	0.00571428571428571	700	8202	5682,7090,9491,6934	PSMA1,TLE3,PSMF1,TCF7L2
R-HSA-69202	Cyclin E associated events during G1/S transition	0.924470552797768	-0.0785340806927817	65	3	0.00428571428571429	700	8202	5682,9491,4609	PSMA1,PSMF1,MYC
R-HSA-917977	Transferrin endocytosis and recycling	0.925105355507263	-0.0778476501098892	29	1	0.00142857142857143	700	8202	535	ATP6V0A1
R-HSA-168256	Immune System	0.925319070043224	-0.0776166603607694	1371	104	0.148571428571429	700	8202	200734,26052,71,4763,5589,5786,3798,10096,25898,55740,348995,162,5578,23279,329,8411,55824,2317,5606,10225,5906,6464,8651,3551,10393,8907,7414,5567,81929,843,51466,4893,7879,3309,56992,1742,9140,535,283455,23352,2260,1525,114876,817,8881,57630,10533,7187,642,4281,27327,55521,4208,8924,673,2335,2308,9871,5646,30849,8649,51447,9252,10666,9491,4734,9883,5771,25,10010,51164,26046,79659,9020,960,90678,6709,6199,2254,8831,3460,25847,2247,11069,1974,5908,5682,5747,3570,3093,5291,9636,7324,10622,3667,1778,57761,3836,51444,10581,9533,4793,5576,192669	SPRED2,DNM3,ACTG1,NF1,PRKCSH,PTPRA,KIF5A,ACTR3,RCHY1,ENAH,NUP43,AP1B1,PRKCA,NUP160,BIRC2,EEA1,PAG1,FLNB,MAP2K3,CD96,RAP1A,SHC1,SOCS1,IKBKB,ANAPC10,AP1M1,VCL,PRKACB,SEH1L,CASP10,EVL,NRAS,RAB7A,HSPA5,KIF15,DLG4,ATG12,ATP6V0A1,KSR2,UBR4,FGFR1,CXADR,OSBPL1A,CAMK2D,CDC16,SH3RF1,ATG7,TRAF3,BLMH,MID1,TNRC6A,TRIM36,MEF2C,HERC2,BRAF,FN1,FOXO1,SEC24D,PRSS3,PIK3R4,LAMTOR3,IP6K2,RPS6KA5,CD226,PSMF1,NEDD4,POM121,PTPN2,ABL1,TANK,DCTN4,LTN1,DYNC2H1,MAP3K14,CD44,LRSAM1,SPTAN1,RPS6KB2,FGF9,SYNGAP1,IFNGR2,ANAPC13,FGF2,RAPGEF4,EIF4A2,RAP1B,PSMA1,PTK2,IL6R,UBE2K,PIK3CB,ISG15,UBE2E1,POLR3G,IRS1,DYNC1H1,TRIB3,KPNA1,RNF138,IFITM2,POLR1C,NFKBIB,PRKAR2A,AGO3
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.929141981917523	-0.0734937187809327	66	3	0.00428571428571429	700	8202	5682,9491,4609	PSMA1,PSMF1,MYC
R-HSA-156580	Phase II conjugation	0.929497604949243	-0.0731110485326801	98	5	0.00714285714285714	700	8202	2678,2941,6819,2686,4257	GGT1,GSTA4,SULT1C2,GGT7,MGST1
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.930163600945438	-0.0723947933109687	49	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.930163600945438	-0.0723947933109687	49	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.931519921893555	-0.0709377022732642	30	1	0.00142857142857143	700	8202	182	JAG1
R-HSA-174824	Lipoprotein metabolism	0.931519921893555	-0.0709377022732642	30	1	0.00142857142857143	700	8202	949	SCARB1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.931519921893555	-0.0709377022732642	30	1	0.00142857142857143	700	8202	6464	SHC1
R-HSA-420029	Tight junction interactions	0.931519921893555	-0.0709377022732642	30	1	0.00142857142857143	700	8202	56288	PARD3
R-HSA-216083	Integrin cell surface interactions	0.933546692178748	-0.0687642988487232	67	3	0.00428571428571429	700	8202	2335,960,3673	FN1,CD44,ITGA2
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.935082156782694	-0.0671208853368507	50	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-69275	G2/M Transition	0.935477270713044	-0.0666984299682386	115	6	0.00857142857142857	700	8202	5520,1778,7846,80184,5048,10806	PPP2R2A,DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-5389840	Mitochondrial translation elongation	0.936042686505619	-0.0660941983033869	84	4	0.00571428571428571	700	8202	55173,124995,23107,64979	MRPS10,MRPL10,MRPS27,MRPL36
R-HSA-5368286	Mitochondrial translation initiation	0.936042686505619	-0.0660941983033869	84	4	0.00571428571428571	700	8202	55173,124995,23107,64979	MRPS10,MRPL10,MRPS27,MRPL36
R-HSA-418990	Adherens junctions interactions	0.937385812081828	-0.0646603290018977	31	1	0.00142857142857143	700	8202	25945	PVRL3
R-HSA-70171	Glycolysis	0.937385812081828	-0.0646603290018977	31	1	0.00142857142857143	700	8202	3099	HK2
R-HSA-180534	Vpu mediated degradation of CD4	0.939671354244318	-0.0622250879948503	51	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-453274	Mitotic G2-G2/M phases	0.941778096736864	-0.0599855982525722	117	6	0.00857142857142857	700	8202	5520,1778,7846,80184,5048,10806	PPP2R2A,DYNC1H1,TUBA1A,CEP290,PAFAH1B1,SDCCAG8
R-HSA-186712	Regulation of beta-cell development	0.942749896226814	-0.0589542529186549	32	1	0.00142857142857143	700	8202	2308	FOXO1
R-HSA-1474290	Collagen formation	0.943168123475514	-0.0585107264756318	86	4	0.00571428571428571	700	8202	667,1308,4316,3691	DST,COL17A1,MMP7,ITGB4
R-HSA-5173105	O-linked glycosylation	0.946363688104268	-0.0551283354983965	103	5	0.00714285714285714	700	8202	55568,57188,374378,9334,6480	GALNT10,ADAMTSL3,GALNT18,B4GALT5,ST6GAL1
R-HSA-933541	TRAF6 mediated IRF7 activation	0.947655045876312	-0.0537647186038249	33	1	0.00142857142857143	700	8202	10010	TANK
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.947655045876312	-0.0537647186038249	33	1	0.00142857142857143	700	8202	9334	B4GALT5
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.947941786110639	-0.0534621856688935	53	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-114604	GPVI-mediated activation cascade	0.951660461952716	-0.0495469654209185	54	2	0.00285714285714286	700	8202	6464,5291	SHC1,PIK3CB
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.951660461952716	-0.0495469654209185	54	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-4641257	Degradation of AXIN	0.951660461952716	-0.0495469654209185	54	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-3928663	EPHA-mediated growth cone collapse	0.952140474689964	-0.0490426976288601	34	1	0.00142857142857143	700	8202	5747	PTK2
R-HSA-1222556	ROS production in response to bacteria	0.952140474689964	-0.0490426976288601	34	1	0.00142857142857143	700	8202	535	ATP6V0A1
R-HSA-211945	Phase 1 - Functionalization of compounds	0.952505720976816	-0.0486591657244459	89	4	0.00571428571428571	700	8202	1591,128,314,6916	CYP24A1,ADH5,AOC2,TBXAS1
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.95512472982162	-0.0459133398867197	55	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.95512472982162	-0.0459133398867197	55	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.958350850830524	-0.042541335458354	56	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-4641258	Degradation of DVL	0.958350850830524	-0.042541335458354	56	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.959992578398556	-0.0408297253849753	36	1	0.00142857142857143	700	8202	1591	CYP24A1
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.959992578398556	-0.0408297253849753	36	1	0.00142857142857143	700	8202	10087	COL4A3BP
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.959992578398556	-0.0408297253849753	36	1	0.00142857142857143	700	8202	6464	SHC1
R-HSA-428157	Sphingolipid metabolism	0.963216220425601	-0.0374773644265158	76	3	0.00428571428571429	700	8202	79642,4758,10087	ARSJ,NEU1,COL4A3BP
R-HSA-2871837	FCERI mediated NF-kB activation	0.96560455831178	-0.0350008885059605	77	3	0.00428571428571429	700	8202	5682,9491,3551	PSMA1,PSMF1,IKBKB
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.965749209137795	-0.0348510963459497	127	6	0.00857142857142857	700	8202	348995,6158,23279,81929,6235,9883	NUP43,RPL28,NUP160,SEH1L,RPS29,POM121
R-HSA-2682334	EPH-Ephrin signaling	0.967088000913036	-0.033465783622887	95	4	0.00571428571428571	700	8202	1948,5747,71,10096	EFNB2,PTK2,ACTG1,ACTR3
R-HSA-202424	Downstream TCR signaling	0.969069124612185	-0.0314193336065779	96	4	0.00571428571428571	700	8202	5682,5291,9491,3551	PSMA1,PIK3CB,PSMF1,IKBKB
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.969425354499432	-0.0310518010754353	39	1	0.00142857142857143	700	8202	7035	TFPI
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.969425354499432	-0.0310518010754353	39	1	0.00142857142857143	700	8202	85007	PHYKPL
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.969425354499432	-0.0310518010754353	39	1	0.00142857142857143	700	8202	57188	ADAMTSL3
R-HSA-421270	Cell-cell junction organization	0.971416280119063	-0.0290001897719114	61	2	0.00285714285714286	700	8202	25945,56288	PVRL3,PARD3
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.971416280119063	-0.0290001897719114	61	2	0.00285714285714286	700	8202	1591,6916	CYP24A1,TBXAS1
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.972047215549736	-0.0283509000330044	40	1	0.00142857142857143	700	8202	949	SCARB1
R-HSA-211859	Biological oxidations	0.973821238979221	-0.0265275250593644	194	10	0.0142857142857143	700	8202	1591,2678,128,6819,314,6916,1800,2941,2686,4257	CYP24A1,GGT1,ADH5,SULT1C2,AOC2,TBXAS1,DPEP1,GSTA4,GGT7,MGST1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.974364908781192	-0.0259693958305849	99	4	0.00571428571428571	700	8202	5682,9020,9491,3551	PSMA1,MAP3K14,PSMF1,IKBKB
R-HSA-375280	Amine ligand-binding receptors	0.976636527512909	-0.0236407253170882	42	1	0.00142857142857143	700	8202	3363	HTR7
R-HSA-5358346	Hedgehog ligand biogenesis	0.977252553779308	-0.0230101610821905	64	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-1236974	ER-Phagosome pathway	0.977252553779308	-0.0230101610821905	64	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-983712	Ion channel transport	0.978346130193833	-0.0218917552073274	198	10	0.0142857142857143	700	8202	7226,1185,535,6262,57719,10110,133308,57198,51076,374868	TRPM2,CLCN6,ATP6V0A1,RYR2,ANO8,SGK2,SLC9B2,ATP8B2,CUTC,ATP9B
R-HSA-201681	TCF dependent signaling in response to WNT	0.979244970178932	-0.0209734428507852	229	12	0.0171428571428571	700	8202	7090,4609,3014,5682,54894,440193,6659,4221,9491,79577,6934,22943	TLE3,MYC,H2AFX,PSMA1,RNF43,CCDC88C,SOX4,MEN1,PSMF1,CDC73,TCF7L2,DKK1
R-HSA-72764	Eukaryotic Translation Termination	0.980077099822543	-0.0201240371237915	85	3	0.00428571428571429	700	8202	2107,6158,6235	ETF1,RPL28,RPS29
R-HSA-446652	Interleukin-1 signaling	0.980473260401601	-0.0197199051081213	44	1	0.00142857142857143	700	8202	3551	IKBKB
R-HSA-5668914	Diseases of metabolism	0.982148759026298	-0.0180124963303214	45	1	0.00142857142857143	700	8202	5095	PCCA
R-HSA-388841	Costimulation by the CD28 family	0.983268527669645	-0.0168730245529175	68	2	0.00285714285714286	700	8202	57761,9020	TRIB3,MAP3K14
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.985665685924449	-0.0144380428022049	70	2	0.00285714285714286	700	8202	3014,401541	H2AFX,CENPP
R-HSA-774815	Nucleosome assembly	0.985665685924449	-0.0144380428022049	70	2	0.00285714285714286	700	8202	3014,401541	H2AFX,CENPP
R-HSA-5625740	RHO GTPases activate PKNs	0.98594218295182	-0.0141575640786736	90	3	0.00428571428571429	700	8202	23028,23081,3014	KDM1A,KDM4C,H2AFX
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.986361881555655	-0.0137319718814839	48	1	0.00142857142857143	700	8202	1948	EFNB2
R-HSA-1461973	Defensins	0.98958173276167	-0.0104729172883892	51	1	0.00142857142857143	700	8202	5646	PRSS3
R-HSA-1236975	Antigen processing-Cross presentation	0.993943680837072	-0.00607473304838518	81	2	0.00285714285714286	700	8202	5682,9491	PSMA1,PSMF1
R-HSA-192823	Viral mRNA Translation	0.995225768012659	-0.00478566503674373	84	2	0.00285714285714286	700	8202	6158,6235	RPL28,RPS29
R-HSA-156902	Peptide chain elongation	0.995225768012659	-0.00478566503674373	84	2	0.00285714285714286	700	8202	6158,6235	RPL28,RPS29
R-HSA-73728	RNA Polymerase I Promoter Opening	0.995358608616904	-0.00465219608561344	60	1	0.00142857142857143	700	8202	3014	H2AFX
R-HSA-5334118	DNA methylation	0.996122424077729	-0.00388511321036753	62	1	0.00142857142857143	700	8202	3014	H2AFX
R-HSA-977225	Amyloid formation	0.996529281126391	-0.00347675579070099	88	2	0.00285714285714286	700	8202	4240,3014	MFGE8,H2AFX
R-HSA-156842	Eukaryotic Translation Elongation	0.996529281126391	-0.00347675579070099	88	2	0.00285714285714286	700	8202	6158,6235	RPL28,RPS29
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.996760691209153	-0.0032445667093201	64	1	0.00142857142857143	700	8202	1308	COL17A1
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.997039324310894	-0.00296506715932866	65	1	0.00142857142857143	700	8202	3014	H2AFX
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.99770387989342	-0.00229876023249015	115	3	0.00428571428571429	700	8202	10225,10666,1525	CD96,CD226,CXADR
R-HSA-212300	PRC2 methylates histones and DNA	0.998111974275051	-0.00188981029207726	70	1	0.00142857142857143	700	8202	3014	H2AFX
R-HSA-2299718	Condensation of Prophase Chromosomes	0.998274494940716	-0.00172699545784551	71	1	0.00142857142857143	700	8202	3014	H2AFX
R-HSA-162582	Signal Transduction	0.999966136657138	-3.38639162378031e-05	2357	157	0.224285714285714	700	8202	23092,71,4763,5565,3798,5786,54903,54894,100288637,5578,10144,23279,57406,5881,329,23566,5906,93663,8379,5567,81929,5796,4893,79971,2788,283455,55869,6659,2770,8405,58480,6498,51684,5533,8829,5947,27327,4208,55081,10435,2335,2308,7204,4092,30849,8649,4983,7048,79577,10019,1123,4609,10846,51384,440193,114793,8831,5141,7090,58513,11069,157506,5908,5682,84033,23286,23236,1374,6934,3667,57498,56937,3091,10670,94134,6907,79658,5576,192669,200734,154810,26052,5048,4923,5166,10096,4647,348995,1241,55824,8027,5139,23028,5364,182,6464,8651,51377,752,3551,11343,7414,2787,843,55534,283869,55114,51466,5163,1742,535,11214,2260,3363,4088,54331,817,3014,9742,56288,673,5142,57142,9252,9491,4734,10788,25,5583,26575,79659,154796,6199,6709,5046,2254,5829,2247,7976,23365,3570,5747,9743,4221,5138,5140,5291,401541,22943,57761,221914,221955,57539,2342,101928168,23081,6789	ARHGAP26,ACTG1,NF1,PRKAB2,KIF5A,PTPRA,MKS1,RNF43,LOC100288637,PRKCA,FAM13A,NUP160,ABHD6,RAC3,BIRC2,LPAR3,RAP1A,ARHGAP18,MAD1L1,PRKACB,SEH1L,PTPRK,NRAS,WLS,GNG7,KSR2,HDAC8,SOX4,GNAI1,SPOP,RHOU,SKIL,SUFU,PPP3CC,NRP1,RBP1,TNRC6A,MEF2C,IFT57,CDC42EP2,FN1,FOXO1,TRIO,SMAD7,PIK3R4,LAMTOR3,OPHN1,TGFBR2,CDC73,SH2B3,CHN1,MYC,PDE10A,WNT16,CCDC88C,FMNL2,SYNGAP1,PDE4A,TLE3,EPS15L1,RAPGEF4,RDH10,RAP1B,PSMA1,OBSCN,WWC1,PLCB1,CPT1A,TCF7L2,IRS1,KIDINS220,PMEPA1,HIF1A,RRAGA,ARHGAP12,TBL1X,ARHGAP10,PRKAR2A,AGO3,SPRED2,AMOTL1,DNM3,PAFAH1B1,NTSR1,PDK4,ACTR3,MYO7A,NUP43,LTB4R,PAG1,STAM,PDE3A,KDM1A,PLXNB1,JAG1,SHC1,SOCS1,UCHL5,FMNL1,IKBKB,MGLL,VCL,GNG5,CASP10,MAML3,NPW,ARHGAP17,EVL,PDK1,DLG4,ATP6V0A1,AKAP13,FGFR1,HTR7,SMAD3,GNG2,CAMK2D,H2AFX,IFT140,PARD3,BRAF,PDE4B,RTN4,RPS6KA5,PSMF1,NEDD4,IQGAP2,ABL1,PRKCH,RGS17,DYNC2H1,AMOT,RPS6KB2,SPTAN1,PCSK6,FGF9,PXN,FGF2,FZD3,ARHGEF12,IL6R,PTK2,ARHGAP32,MEN1,PDE2A,PDE3B,PIK3CB,CENPP,DKK1,TRIB3,GPC2,DAGLB,WDR35,FNTB,LOC101928168,KDM4C,STK4
R-HSA-418594	G alpha (i) signalling events	0.999968382392202	-3.16181076448614e-05	236	6	0.00857142857142857	700	8202	54331,283869,2787,23566,2788,2770	GNG2,NPW,GNG5,LPAR3,GNG7,GNAI1
R-HSA-375276	Peptide ligand-binding receptors	0.999999476147504	-5.23852633601569e-07	193	2	0.00285714285714286	700	8202	283869,4923	NPW,NTSR1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999999988659843	-1.13401572973641e-08	318	5	0.00714285714285714	700	8202	3363,283869,1241,23566,4923	HTR7,NPW,LTB4R,LPAR3,NTSR1
R-HSA-500792	GPCR ligand binding	0.999999996266056	-3.73394356305179e-09	444	10	0.0142857142857143	700	8202	3363,54331,283869,7976,2788,4923,51384,1241,23566,2787	HTR7,GNG2,NPW,FZD3,GNG7,NTSR1,WNT16,LTB4R,LPAR3,GNG5
R-HSA-372790	Signaling by GPCR	0.999999997857705	-2.14229539258915e-09	1230	56	0.08	700	8202	200734,673,2335,4763,5786,4923,7204,5142,8649,5578,1241,57406,9491,23566,5139,5364,5583,26575,5906,6464,10846,51384,7414,11343,2787,5567,6709,283869,2254,4893,8831,5141,2247,7976,2788,5908,5682,1742,84033,283455,23365,11214,5747,5138,5140,23236,5291,2260,2770,3363,54331,3667,817,221955,5533,5576	SPRED2,BRAF,FN1,NF1,PTPRA,NTSR1,TRIO,PDE4B,LAMTOR3,PRKCA,LTB4R,ABHD6,PSMF1,LPAR3,PDE3A,PLXNB1,PRKCH,RGS17,RAP1A,SHC1,PDE10A,WNT16,VCL,MGLL,GNG5,PRKACB,SPTAN1,NPW,FGF9,NRAS,SYNGAP1,PDE4A,FGF2,FZD3,GNG7,RAP1B,PSMA1,DLG4,OBSCN,KSR2,ARHGEF12,AKAP13,PTK2,PDE2A,PDE3B,PLCB1,PIK3CB,FGFR1,GNAI1,HTR7,GNG2,IRS1,CAMK2D,DAGLB,PPP3CC,PRKAR2A
R-HSA-388396	GPCR downstream signaling	0.99999999991173	-8.82702128800359e-11	928	29	0.0414285714285714	700	8202	283869,5141,2788,4923,7204,5142,84033,23365,11214,5138,5578,1241,23236,5140,57406,5291,23566,5139,5364,2770,3363,54331,5583,26575,6464,221955,10846,11343,2787	NPW,PDE4A,GNG7,NTSR1,TRIO,PDE4B,OBSCN,ARHGEF12,AKAP13,PDE2A,PRKCA,LTB4R,PLCB1,PDE3B,ABHD6,PIK3CB,LPAR3,PDE3A,PLXNB1,GNAI1,HTR7,GNG2,PRKCH,RGS17,SHC1,DAGLB,PDE10A,MGLL,GNG5
R-HSA-381753	Olfactory Signaling Pathway	0.999999999965916	-3.40839683383713e-11	381	0	0	700	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-70921	Histidine catabolism	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-176417	Phosphorylation of Emi1	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-1237112	Methionine salvage pathway	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-171319	Telomere Extension By Telomerase	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-174362	Transport and synthesis of PAPS	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-205025	NADE modulates death signalling	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-187015	Activation of TRKA receptors	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-444257	RSK activation	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999974205	-2.57953404531676e-11	6	0	0	700	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-916853	Degradation of GABA	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-168268	Virus Assembly and Release	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-1483101	Synthesis of PS	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-192905	vRNP Assembly	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-844623	The IPAF inflammasome	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-380612	Metabolism of serotonin	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-156582	Acetylation	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-888568	GABA synthesis	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-198765	Signalling to ERK5	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-70688	Proline catabolism	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-187042	TRKA activation by NGF	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-75094	Formation of the Editosome	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-1483226	Synthesis of PI	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999975386	-2.46141336479599e-11	2	0	0	700	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-389542	NADPH regeneration	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-3248023	Regulation by TREX1	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-169131	Inhibition of PKR	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1483076	Synthesis of CL	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-140180	COX reactions	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-1300645	Acrosome Reaction	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5619084	ABC transporter disorders	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999976044	-2.3955573635881e-11	1	0	0	700	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-70350	Fructose catabolism	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-77108	Utilization of Ketone Bodies	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-193681	Ceramide signalling	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-198745	Signalling to STAT3	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-1296067	Potassium transport channels	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-351200	Interconversion of polyamines	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999976276	-2.3724476593337e-11	3	0	0	700	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-156587	Amino Acid conjugation	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-70635	Urea cycle	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-390696	Adrenoceptors	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999980156	-1.98443437705339e-11	9	0	0	700	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-419771	Opsins	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-5621480	Dectin-2 family	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-190873	Gap junction degradation	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-2161522	Abacavir transport and metabolism	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999981586	-1.84144318295014e-11	10	0	0	700	8202
R-HSA-3000480	Scavenging by Class A Receptors	0.999999999981622	-1.83783153490134e-11	19	0	0	700	8202
R-HSA-190861	Gap junction assembly	0.999999999981622	-1.83783153490134e-11	19	0	0	700	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999981622	-1.83783153490134e-11	19	0	0	700	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999981622	-1.83783153490134e-11	19	0	0	700	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-5652084	Fructose metabolism	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-2161541	Abacavir metabolism	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-446205	Synthesis of GDP-mannose	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-167827	The proton buffering model	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-2161517	Abacavir transmembrane transport	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-444209	Free fatty acid receptors	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-70370	Galactose catabolism	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-197264	Nicotinamide salvaging	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-390651	Dopamine receptors	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-187024	NGF-independant TRKA activation	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-157881	Cyclin B2 mediated events	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-111463	SMAC binds to IAPs	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-561048	Organic anion transport	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-68911	G2 Phase	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-112307	Transmission across Electrical Synapses	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-167826	The fatty acid cycling model	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999982276	-1.772427755864e-11	5	0	0	700	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999983506	-1.64940172787357e-11	24	0	0	700	8202
R-HSA-977606	Regulation of Complement cascade	0.999999999983506	-1.64940172787357e-11	24	0	0	700	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-428540	Activation of Rac	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999984445	-1.55549333833192e-11	14	0	0	700	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-173736	Alternative complement activation	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-1296061	HCN channels	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-1296053	Classical Kir channels	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-6783984	Glycine degradation	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-888593	Reuptake of GABA	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-209563	Axonal growth stimulation	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-140179	Amine Oxidase reactions	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-428776	Class II GLUTs	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-442745	Activation of CaMK IV	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-390650	Histamine receptors	0.999999999985618	-1.43822898265888e-11	4	0	0	700	8202
R-HSA-879518	Transport of organic anions	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-376172	DSCAM interactions	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-199997	COPI Mediated Transport	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-211999	CYP2E1 reactions	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-193048	Androgen biosynthesis	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-71240	Tryptophan catabolism	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-196807	Nicotinate metabolism	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999985823	-1.41765353277755e-11	11	0	0	700	8202
R-HSA-166663	Initial triggering of complement	0.99999999998649	-1.3509842205681e-11	20	0	0	700	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999987104	-1.28961252892945e-11	16	0	0	700	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-164944	Nef and signal transduction	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-73928	Depyrimidination	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-804914	Transport of fatty acids	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-196783	Coenzyme A biosynthesis	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-444821	Relaxin receptors	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-192456	Digestion of dietary lipid	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-1483148	Synthesis of PG	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999987481	-1.25189994955199e-11	8	0	0	700	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999988027	-1.19729455689167e-11	18	0	0	700	8202
R-HSA-5635838	Activation of SMO	0.999999999988027	-1.19729455689167e-11	18	0	0	700	8202
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.999999999988027	-1.19729455689167e-11	18	0	0	700	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999988027	-1.19729455689167e-11	18	0	0	700	8202
R-HSA-3322077	Glycogen synthesis	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-211935	Fatty acids	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999988833	-1.11670307882515e-11	15	0	0	700	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999992185	-7.8147391580417e-12	22	0	0	700	8202
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999992185	-7.8147391580417e-12	22	0	0	700	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999992185	-7.8147391580417e-12	22	0	0	700	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-174577	Activation of C3 and C5	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-166665	Terminal pathway of complement	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-429593	Inositol transporters	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-5619102	SLC transporter disorders	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-448706	Interleukin-1 processing	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-427601	Multifunctional anion exchangers	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-2214320	Anchoring fibril formation	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.999999999992489	-7.51134545712214e-12	7	0	0	700	8202
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.999999999993053	-6.94702246857269e-12	31	0	0	700	8202
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.99999999999359	-6.40995411076451e-12	27	0	0	700	8202
R-HSA-389948	PD-1 signaling	0.999999999994937	-5.06336026615085e-12	23	0	0	700	8202
R-HSA-5627123	RHO GTPases activate PAKs	0.999999999994937	-5.06336026615085e-12	23	0	0	700	8202
R-HSA-211976	Endogenous sterols	0.999999999994937	-5.06336026615085e-12	23	0	0	700	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999994937	-5.06336026615085e-12	23	0	0	700	8202
R-HSA-157858	Gap junction trafficking and regulation	1.00000000000049	4.87056672714357e-13	30	0	0	700	8202
R-HSA-1251985	Nuclear signaling by ERBB4	1.00000000000054	5.41846087471112e-13	40	0	0	700	8202
R-HSA-1474165	Reproduction	1.00000000000107	1.06559872490358e-12	26	0	0	700	8202
R-HSA-975298	Ligand-gated ion channel transport	1.00000000000107	1.06559872490358e-12	26	0	0	700	8202
R-HSA-1187000	Fertilization	1.00000000000107	1.06559872490358e-12	26	0	0	700	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-2029481	FCGR activation	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-977441	GABA A receptor activation	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-198323	AKT phosphorylates targets in the cytosol	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-209822	Glycoprotein hormones	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000000173	1.72848295597371e-12	13	0	0	700	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000000221	2.20882385725219e-12	25	0	0	700	8202
R-HSA-1538133	G0 and Early G1	1.00000000000221	2.20882385725219e-12	25	0	0	700	8202
R-HSA-1461957	Beta defensins	1.00000000000239	2.39452365676964e-12	42	0	0	700	8202
R-HSA-190828	Gap junction trafficking	1.00000000000464	4.64393493806966e-12	28	0	0	700	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-156581	Methylation	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-203615	eNOS activation	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-2022857	Keratan sulfate degradation	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-210990	PECAM1 interactions	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-211958	Miscellaneous substrates	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-417957	P2Y receptors	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-202670	ERKs are inactivated	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000000495	4.94634412702465e-12	12	0	0	700	8202
R-HSA-622312	Inflammasomes	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-70221	Glycogen breakdown (glycogenolysis)	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000594	5.93903040841446e-12	17	0	0	700	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000001061	1.06136339350731e-11	29	0	0	700	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000001061	1.06136339350731e-11	29	0	0	700	8202
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1.00000000001097	1.09734493341363e-11	38	0	0	700	8202
R-HSA-166658	Complement cascade	1.00000000001097	1.09734493341363e-11	38	0	0	700	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000001376	1.37647506636345e-11	39	0	0	700	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000001633	1.63332058631633e-11	56	0	0	700	8202
R-HSA-211981	Xenobiotics	1.00000000001635	1.63494911776946e-11	21	0	0	700	8202
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.00000000001635	1.63494911776946e-11	21	0	0	700	8202
R-HSA-156588	Glucuronidation	1.00000000001635	1.63494911776946e-11	21	0	0	700	8202
